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Abstract
Understanding the relationship between genetic diseases and the genes associated
with them is an important problem regarding human health. The vast amount of
data created from a large number of high-throughput experiments performed in the
last few years has resulted in an unprecedented growth in computational methods
to tackle the disease gene association problem. Nowadays, it is clear that a genetic
disease is not a consequence of a defect in a single gene. Instead, the disease phenotype
is a reflection of various genetic components interacting in a complex network. In fact,
genetic diseases, like any other phenotype, occur as a result of various genes working
in sync with each other in a single or several biological module(s). Using a genetic
algorithm, our method tries to evolve communities containing the set of potential
disease genes likely to be involved in a given genetic disease. Having a set of known
disease genes, we first obtain a protein-protein interaction (PPI) network containing
all the known disease genes. All the other genes inside the procured PPI network are
then considered as candidate disease genes as they lie in the vicinity of the known
disease genes in the network. Our method attempts to find communities of potential
disease genes strongly working with one another and with the set of known disease
genes. As a proof of concept, we tested our approach on 16 breast cancer genes
and 15 Parkinson’s Disease genes. We obtained comparable or better results than
CIPHER, ENDEAVOUR and GPEC, three of the most reliable and frequently used
disease-gene ranking frameworks.
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Chapter 1
Introduction
Understanding the relationship between genetic diseases and the genes associated with
them is an important problem regarding human health. Acquiring more information
and knowledge about the particular genes involved with a given disorder can help to
devise diagnosis and therapeutic strategies to treat genetic diseases and disorders.
The vast amounts of data created from a large number of high-throughput exper-
iments performed in the last few years has resulted in an unprecedented growth in
computational methods to tackle the disease gene association problem. Embedded in
available resources including increasingly large genomic databases and vast amounts
of relevant literature is evidence to link genes to diseases [77]. The disease-gene asso-
ciation problem is now a major part of bioinformatics, a field which revolves around
managing, storing, and analysing the vast amount of genomic data being produced
by modern cutting edge science and technology [16].
Computational disease-gene association methods apply all the possible and po-
tential findings throughout years of research in related areas, using whatever useful
information can be found in the literature to associate genes with diseases. The most
crucial pieces of information for computational disease-gene association methods to
link diseases with particular genes is the already established set of known disease
genes, i.e. those genes that have already been observed to be involved in a given
disease. This is particularly because genes causing the same or similar diseases tend
to lie close to one another in the networks in which they interact; this is known as
the guilt by association principle which is discussed in Section 2.3.2. The genes which
we choose to assess their association with known disease genes are called candidate
genes and are acquired by several practical and computational approaches discussed
later in this thesis.
Subsequent to years of relevant studies and discoveries, it is now clear that the
1
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complexity of the interactions among the genes and their products (i.e. proteins,
discussed in Chapter 2 ) is considerable. Thus, the disease-gene association problem
is no longer a matter of establishing simple connections between diseases and genes,
and is an increasingly challenging problem. As a result, a scientific field which is
closely related to the disease-gene association problem is the science of complexity,
i.e. analysing large complex systems and networks.
In this research, inspired by notions related to community identification in complex
networks (discussed in Chapter 5), we devised a genetic algorithm to rank candidate
genes in the order of their relevance to the known disease genes. Our genetic algo-
rithm gives our method remarkable capabilities regarding disease-gene association, as
discussed in Chapter 6. The preliminary results gained by this approach are satisfac-
tory and comparable with the results given by the most reliable and frequently used
frameworks of disease-gene ranking, as seen in Chapter 8.
1.1 Thesis Structure
The remainder of this thesis is organized as follows. In Chapter 2, we give back-
ground knowledge about basic concepts regarding biology and bioinformatics and
subsequently we define the computational disease-gene association problem in detail.
Chapters 3 and 4 review pertinent studies previously performed. In Chapter 5, we
introduce the mothodologis we applied to develop our method, i.e. complex networks
and genetic algorithms. Chapter 6 describes the architecture of our method along
with the related ideas and motivations to develop it. Chapter 7 outlines the data
resources, databases we used to provide the required data for our experiments, and
the benchmark tests we used to assess the results procured in our case studies. In
Chapter 8 we present two of the experiments performed by our method for breast
cancer and Parkinson’s Disease and analyze the results. Chapter 9 discusses the po-
tential work one can pursue to continue this research and to make our method more
effective.
Chapter 2
Background
2.1 Bioinformatics: promises and applications
For the first time, in the late nineteenth century, Gregor Mendel shed light on how
characteristics are inherited in living organisms. This led to the appearance of the
science of genetics, the study of heredity and genes in living organisms [35]. Genetics
was revolutionized in 1953 after the identification of DNA (deoxyribonucleic acid-
explained in Section 8.1) as the main framework in which all genetic information is
encoded. Scientists observed that changes in the structure of the DNA led to changes
in the workings of cells and organisms in health and disease [22]. However, the main
revolution occurred in the mid-1990s when the complete nucleotide sequence of the
entire human genome was sequenced which includes three billion base-pairs.
What we are encountering now is a vast and ever-increasing flood of genetic data.
This has led to the challenging problem of extracting meaningful information and
scientific conclusions from the enormous amount of available data. This remarkably
requires development of new computational and analytical approaches to uncover new
nuggets of information. The scientific field which tries to tackle this ever-challenging
problem is bioinformatics. Here, two comprehensive definitions of bioinformatics are
provided:
“Bioinformatics is the new science at the interface of molecular biology and com-
puter science seeking to develop better ways to explore, analyze, and understand ge-
netic data [16]”.
“Bioinformatics is a new field in which several disciplines work together to man-
age, store, and analyze the [biological] data being produced around the world. [33]
Throughout a few years of development, bioinformatics can now be divided into
several areas, each trying to meet a specific challenge in the area of the bioinformatics.
3
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The research we report in this thesis is involved in one of these areas, identification
of disease-genes, which has recently been tackled via applying various computational
and analytical approaches. In this chapter, we introduce this area of research in more
detail.
Associating genes with phenotype – “the collection of all of an organism’s physical
traits [60]” (further details in Section 2.2.3) – has been one of the most demand-
ing research subjects in bioinformatics. One of the major parts of gene-phenotype
association research is to associate genes with specific phenotypes, i.e. the genetic
diseases. The specific research area dealing with this problem is called the disease-
gene association problem, or identification of disease genes, or disease gene predic-
tion/prioritization, i.e. identifying the genes which are in any way involved in the
existence of a given genetic disease or disorder, or prioritizing genes in the order of
their relevance to diseases.
Associating genes with genetic diseases and disorders is crucial to identify the
genetic basis of human diseases. Procuring more information and knowledge about the
genes behind a given disorder can lead to more effective diagnosis, improved prognosis,
and development of improved therapeutic strategies to treat the genetic diseases and
disorders. Bioinformatics tries to tackle the disease-gene association problem via
developing computational disease-gene prediction methods. These methods or tools
apply the discoveries and findings from years of research in related areas by examining
useful information from the literature, to associate genes with diseases [47]. Further
details about these methods are provided in Section 2.3 and Chapters 3 and 4.
2.2 Basic Biological Concepts
2.2.1 Genes, the living organisms’ algorithms and software
Every cell in the human body contains the same DNA sequence, which is composed
of a long string of chemicals called nucleotides. There are four types of nucleotides:
guanine (G), adenine (A), thymine (T) and cytosine (C). In fact, all the genetic
information of the living organisms is encoded in DNA. In humans, DNA contains
two long strands (see figure 2.1) each composed of almost 3 billion nucleotides.
Not all parts of DNA are the same. Some parts of the DNA handle more func-
tionalities than the others. In other words, some specific parts of the DNA have been
less subjected to mutation and more conserved in the course of evolution (refer to
[16], Chapter 8 for more details regarding this). These segments of the DNA which
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Figure 2.1: Human DNA structure, image from [17]
carry inheritable information about one or more functionalities are called genes [16].
A gene is usually defined as the molecular unit of heredity of a living organism [33].
Every cell of every individual contains two complete sets of genes, with each set lying
on one of the two strands of the DNA. If one of the sets does not function correctly,
the other one may take over the functionalities. For further details about how genes
work, refer to [16] and [33].
2.2.2 The living organisms hardware: the proteins
How is the genetic coded information inside these important functional segments of
the DNA, i.e. the genes, put into action in humans or other living species? More
precisely, how do different cells in the same organism conduct their own specific
functions using the same genetic code they all have? This question can also be
rephrased as in [16] “How do cells respond to changing environmental conditions
using the genetic instructions”?
The encoded genetic instructions in the genes are used to produce proteins, the
large biological molecules performing different functionalities within living organisms.
In fact, genes can be interpreted as algorithms which develop proteins, the most
important functional units of every living organism. The process by which genes
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are applied to develop proteins is called gene expression (figure 2.2). When the
instructions in a give gene are applied to make proteins, it is said that the gene is
expressed. Although all cells carry all of the genome (i.e. all the genes, or the entire
DNA), only a small fraction of the genome is expressed in every cell with regard to
the specific tasks and functionalities each cell performs (nerve cell, muscle cell, bone
cell, etc). As a matter of fact:
“In each cell type, a specific set of genes is activated, and the proteins they encode
give the cell the characteristics of a muscle cell, bone cell, nerve cell and so on. Fur-
thermore, cells alter their patterns of gene expression depending on their environment
in order to respond to nutrients, temperature, hormones, infectious agents, and so
on. [16].
Figure 2.2: General Schema of Gene Expression , image from [6]
2.2.3 Genetic disease as a type of phenotype
As a conclusion of what has been discussed in previous sections, it is fairly true to
suggest that all the functions of living organisms like humans depend on the proteins.
Hundreds of thousands of proteins in our body carry out thousands of chemical reac-
tions required for life [9].
CHAPTER 2. BACKGROUND 7
The question which might come to the mind now is this: how do proteins lead to
who we are? “Who we are” is a complicated question which can never be answered
clearly. But from the biological perspective, one may answer this question as: “we are
a huge set of multitudes of various phenotypes”. Phenotypes are sets of observable
properties and characteristics of the living organisms at different levels. For instance,
a phenotype at the cellular level can be the type of cell, the shape of the cell, or other
observable properties of the cell. A phenotype at a higher level can be the human skin
color, eyebrow shape, eye color and so on. A phenotype can also be as complex as
being alive. The fact that we are alive at a given moment is a complicated phenotype
depending on very many processes, interactions and other simpler phenotypes. Thus,
at any given moment, we are a set of a myriad of different phenotypes at different
levels. All these phenotypes come about subsequent to interactions of an extraordi-
narily huge number of proteins interacting with each other in a real time network all
over the cells of our bodies. This gigantic network across all the cells is referred as
the human interactome. The human interactome is scientifically believed to be one of
the most complex networks containing approximately 25000 protein-encoding genes,
and also a high number of unknown and undefined proteins and their interactions
[9]. The number of nodes of the network including genes and their products such as
proteins is estimated to exceed one hundred thousand [9]. The number of functionally
relevant interactions between the components of this network, representing the links
of the interactome, is expected to be much larger and remains largely unknown [9].
Unfortunately, phenotypes are not always handy or pretty. They can sometimes
be undesirable and even destructive. A phenotype can also be a genetic disease or
disorder. The most common reason for genetic disorders is changes or mutations
happening in the genes. The altered gene is called a mutated gene. Mutation in
the DNA is not a rare incident. As most parts of human DNA are not functionally
important, mutations in these parts do not usually lead to harmful consequences.
However, if mutation occurs in a functional part of the DNA − inside the genes
which handle some functionalities − it may adversely affect some crucial processes
required for life, consequently causing genetic diseases. The most common mutation
causing genetic disease is SNP (single nucleotide polymorphism) in which one single
nucleotide A, T, C or G is mutated and replaced by another one (see figure 2.3). If
this occurs in a coding area of DNA (genes) it may affect the protein function and
consequently lead to genetic disorders.
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Figure 2.3: The most common mutation in genes (SNP), image from [38]
2.3 Disease-Gene Association Problem
As discussed earlier, “The expression of a subset of genes and their complex and
orchestrated interactions and networks confer specific properties on the cell, thereby
establishing its phenotype[16]. Associating genes with phenotypes has been one of the
most demanding research subjects in bioinformatics. This problem has always been
one of the trickiest problems consequent to the complexity of the interaction network
between the genome and the phenotypes. One specific gene-phenotype association
problem is to associate genes with specific phenotypes, i.e. genetic disease. The re-
search area tackling this problem is called the disease-gene association problem or
identification of disease genes, or disease gene prediction/prioritization, i.e. identify-
ing the genes which are in any way involved in the existence of the genetic disease or
disorder. In this thesis, all these titles may be interchangeably used.
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2.3.1 Bioinformatics and Computational Disease-Gene Asso-
ciation
How does bioinformatics tackle the disease-gene prediction problem? More precisely,
how can one develop computational and analytical methods to meet the disease-gene
association challenge? Understanding the complex correlation between genes and
proteins requires processing of vast amount of data from a wide variety of genomic
data sources. “Thus, computational tools have become critical for the integration,
representation and visualization of heterogeneous biomedical data” [50].
Figure 2.4 depicts the general schema of computational disease gene prediction. To
be extremely general, computational disease-gene association methods apply all the
possible and potential findings throughout years of research in related areas, using
whatever useful information can be found in the literature to associate genes with
diseases.
Figure 2.4: General Schema of Computational Disease Gene Association
Disease-gene prediction methods choose potential disease genes from a set of can-
didate genes usually determined by different experimental and other computational
methods including Genomewide Association Studies (GWAS) and Linkage Analysis.
In Genomewide Association Studies hundreds of thousands of SNPs (Single Nucleotide
Polymorphisms) are statistically investigated for association with genetic disease in
hundreds of thousands of individuals. Linkage Analysis typically associates certain
chromosomal loci (linkage intervals) with a particular disease phenotype [37] and it
consists of expensive practical experiments performed in the laboratory to determine
loci on chromosomes which have the tendency to be inherited alongside the known
disease genes or mutated genes which are believed to be involved in diseases. For
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further information on Genomewide Association Studies and Linkage Analysis, see
[23].
2.3.2 Known Disease Genes and the Principle of Guilt by
Association
One of the most important pieces of information in the literature which can aid
computational disease gene prediction methods to associate diseases with genes is the
already established set of known disease genes, i.e. those genes that have already
been observed to be involved in a given disease. Our knowledge about the known
disease genes can be crucial for disease gene prediction methods to identify new novel
disease genes. This is mainly because genes causing the same or similar diseases
tend to lie close to one another in the networks in which they interact. For example,
genes related to the same disease are known to have protein products that physically
interact. Also, previous studies have shown that mutations in multiple proteins that
form a protein complex may lead to the same disease phenotype. This is called the
principle of guilt by association. According to this principle, disease genes for the
same disease tend to interact with one another, or in collaboration with each other,
in the cell. This is also called the modular nature of genetic disease, i.e. the concept
that various genes involved in the same phenotypes work together in a single biological
module [64].
2.3.3 Disease-Gene Association as a Complex Problem
The complexity of the interactions among the genes is significant. A remarkable
amount of interactions have been discovered, subsequent to years of related discov-
eries and studies, including network-based data resources, i.e. resources recording
the interactions among the genes in different aspects such as protein-protein inter-
action networks, gene co-expression networks, metabolic pathways and functional
annotations. Such network-based resources have become preferred data resources to
associate diseases with genes [9]. Disease-gene association is no longer a matter of es-
tablishing simple connections between known disease genes and candidate genes using
a set of straight-forward evidence. It is crucial to note that complex phenotypes are
far beyond the sum of independent effects of the individual genes. As a matter of fact,
“the impact of a specific genetic abnormality is not restricted to the activity of the
gene product that carries it, but can spread along the links of the network, and alter
the activity of gene products that carry no defects” [9]. Furthermore, “the phenotypic
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impact of a defect is not determined only by the known function of the mutated gene,
but also by the functions of components with which the gene and its products interact
and of their interaction partners, i.e., by its network context [9]”. From these key
assumptions, it must be concluded that genetic disorders must not be simply consid-
ered as a consequence of mutation(s) in a single gene. Instead, the disease phenotype
is a reflection of various components (genes, proteins, etc.) interacting in a complex
network. We precisely define complex networks with examples in Chapter 5.
Classic forms of disease gene prediction approaches, in the absence of considering
the notion of complex networks, were not able to process the myriad number of
interactions among the genes and proteins and identify the genes based on the complex
behavioral patterns discovered in the networks. It has been shown that it is necessary
to process and observe the interactions among the complex systems components in
order to find facts and draw conclusions about these systems. As stated in [60],
“Many of the ideas are disguised behind the interactions among the components, and
not inside the component”. As Aristotle said in 335-323 BCE, “the whole is more
than the sum of its parts” [34].
Chapter 3
Literature Review of Disease-Gene
Association
3.1 Definition of Computational Disease-Gene As-
sociation
Based on what we have learned in previous chapters, a brief, general and formal de-
scription of disease-gene association should be provided. There are many appropriate
definitions suggested by different resources, however, the one provided in [77] can
barely be surpassed:
“Genome-wide association analyses on large patient cohorts are generating large
sets of candidate disease genes. This is coupled with the availability of ever increasing
genomic databases and a rapidly expanding repository of biomedical literature. [Using
any computational and analytical techniques], Computational approaches to disease-
gene association attempt to harness these data sources to identify the most likely
disease gene candidates for further empirical analysis by translational researchers,
resulting in efficient identification of genes of diagnostic, prognostic, and therapeutic
value” [77].
What is the accurate meaning of the word association in disease-gene associa-
tion? Basically, according to the pertinent literature, there are two main approaches
for association of diseases with the genes [68]. The results obtained by a disease
gene association method could be either a prioritization of the candidate genes, i.e.
a ranking of the candidate genes based on the likelihood of their involvement, or a
selection of the candidate genes, i.e. a reduced set of candidate genes which are of
higher priority to be studied than other candidates, or that are more noteworthy
12
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in some way. In many cases, there is no strict difference between these two predic-
tion approaches. Usually, a prioritization-based method is developed over an already
developed selection-based method of prediction. Prioritization based disease-gene
association methods are also called disease-gene prioritization methods.
3.2 Classification of Existing Evidence for Disease–
Gene Prediction in the Literature
In this section, we discuss several types of existing evidence in the literature fre-
quently being applied to associate diseases with genes. This evidence can be roughly
classified into text-mining of the literature, functional evidence and pathways, phe-
notypic evidence, inherent gene properties, sequencing data and mutation evidence,
protein-protein interaction, gene expression data, and some other types of evidence.
3.2.1 Text Mining of the Literature
Natural language processing and text-mining of biomedical and bioinformatics liter-
ature is amongst the first effective approaches being used to tackle the disease-gene
association problem. There are enormous amounts of knowledge recorded by data
resources such as PubMed [1] and OMIM [39] containing a multitude of biomedical
abstracts and studies. These data resources are freely and easily available and the
information and knowledge recorded by them can be used as input for text-mining,
natural language processing, or other computational methods to discover significant
links between genetic diseases and the genes. By 2013, the PubMed database recorded
22 million citations from more than 24000 journals [68]. OMIM has recorded thou-
sands of phenotype and disease genes descriptions.
In an extensive study performed at Stanford University, Altman et al [5] collected
opinions from the leading scientists about how text mining can provide better access to
the biological literature. They also provided worthwhile instructions on how to apply
text mining techniques over different types of literature data resources to gather
evidence for different purposes. In one of the first attempts in using text mining
of the bioinformatics literature, Blaschke et al [10] designed a system for automatic
detection of protein-protein interaction extracted from scientific abstracts. JB Laurila
et al [54] studied mutations’ impact on protein properties using text mining of the
literature to find novel mutations leading to diseases. O¨zgu¨r et al [66] introduced an
automatic approach based on text mining and network analysis to predict gene-disease
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associations.
3.2.2 Functional Evidence and Pathways
Different functionalities performed by different types of cells are provided subsequent
to a series of chemical events called biological pathways. A biological pathway is
defined as a series of actions and interactions among the molecules in the cell which
lead to a specific phenotype. The suspect gene is likely to be a member of the same
molecular pathways as other disease genes. In other words, there is a good chance
that the unknown genes involved in the same pathway as other known disease genes
are connected to the disease in one way or another [11]. Two of the most reliable
and frequently used databases which constantly record functional annotations and
pathways of the genes are Gene Ontology (GO) [7] and Kyoto Encyclopedia of Genes
and Genomes (KEGG) [49].
Frances S Turner et al [83] developed POCUS, a computational approach to pri-
oritize candidate disease genes based on their functional similarities.
Apart from all capabilities of the functional annotations for disease gene predic-
tion, there is a key downside with the use of functional annotation for disease gene
prediction as there are still many unverified and unknown functional pathways. This
makes disease gene identification biased towards the better-studied functionalities and
pathways [68].
3.2.3 Phenotypic Evidence
For some unknown genetic diseases, there exists a major lack of knowledge and in-
formation about the molecular basis of the candidate genes. In such cases, one of the
possible approaches to determine associations between candidate genes and known-
disease genes is to use the phenotypic relationships of the genes. The use of phenotypic
evidence for disease-gene association is based on the observation that genes involved
with similar phenotypes often participate in the same interaction networks [11]. In
other words, genes involved in a well-studied disease could also be involved in an
unknown disease with similar symptoms. However, this is not always true [68].
One remarkable database which describes relationships between phenotypes is
MimMiner [79]. J Freudenberg et al [29] developed a statistical method that used
MimMiner for prediction of disease relevant human genes from the phenotypic ap-
pearance of a query disease. They tested their framework on colorectal neoplasms
disease family.
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3.2.4 Inherent Gene Properties
Inherent (intrinsic) properties of genes and proteins such as gene or protein length,
degree of conservation, phylogenetic breadth and so on, can also provide some clues
to discover possible correlation between genetic disorders and genes, as some of these
properties may statistically differ between disease genes and genes not involved in
disease [68].
Lo´pez et al [56] used inherent gene and protein properties including length of
amino acid sequence, phylogenetic extent, and conservation degree to develop a com-
putational method to detect disease genes. Adie et al [3] examined a variety of
intrinsic sequence-based gene features and found that for many of the cases there are
significant discrepancies between the sets of genes known to be involved in genetic
diseases and those not known to be involved in diseases. Based on these genes’ fea-
tures, they developed PROSPECTR, an automatic classifier, which ranks genes in
the order of likelihood of involvement in disease.
3.2.5 Sequencing Data and Mutation Evidence
Analytical processes and investigations of the genes’ mutations can be helpful to
find meaningful patterns regarding the mutations existing in disease genes. Such
investigations can give clues to find genes mutated in a similar way which can be
added to the candidate genes list. If there exist a large number of candidate genes for a
given disease, a high number of variations in sequences can be observed. For instance,
Tarpey et al. [76] studied 718 candidate genes on the X chromosome from 208 families
for mental retardation. They discovered mutations in three novel genes based on
mutations in several known disease genes. Najmabadi H et al. [61] studied 136
families with autosomal-recessive intellectual disability. They successfully discovered
50 novel candidate genes based on the identified mutations in 23 known disease genes.
Although using sequencing data has been successfully used to predict novel disease
genes, however, it still cannot identify many of the genetic causes of the disease due
to a shortage of knowledge about the accurate sequence of the candidate genes [68].
3.2.6 Protein-Protein Interaction
Protein-protein interaction networks (PPI) are networks representing physical in-
teractions between proteins; this is the most frequently used and powerful type of
evidence for disease gene prediction [62] , [14]. In relation to the guilt by association
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principle (see Section 2.3.2), proteins which physically interact are more likely to be
involved in the same functionality or phenotype. Therefore, harmful alteration of any
of the proteins interacting in the same functional module (which is probably caused
by deleterious mutations in the gene expressing the protein), can adversely change
the functionality or phenotype, and consequently lead to the same disorder [62].
Among the most trusted and frequently used databases recording PPI are STRING
[46] and the Human Protein Reference Database (HPRD) [70]. These data resources
have recorded myriad observed interactions from various organisms.
In some of the earliest studies to use PPI for disease-gene association, J Xu et al
[87] created a classifier based on several topological features of the underlying protein-
protein interaction network to predict disease genes and M Oti et al [65] used more
than 70000 protein-protein interactions between close to 11000 human proteins to
offer sets of candidate genes for more than 380 genetic diseases.
There have been many efforts to use PPI for disease-gene associations. In this
research, we used PPI to associate disease with genes. Chapter 4 reviews some re-
markable studies of using PPI for disease-gene association.
3.2.7 Gene Expression Data
As mentioned in Section 2.2.2, gene expression is the process of transcribing and
translating a gene to yield a protein product [16].
There are two key factors affecting how a gene is expressed:
• Cell type: Although all the cells have the whole genome, only a fraction of the
genes is activated (expressed) in every cell depending on the type of cell, which
is why different cells in the human body perform different tasks.
• Environment : Cells change their pattern of gene expression depending on their
environment in order to properly respond to nutrients, temperature, hormones,
infectious agents and attackers, and so on [16].
It is intuitively obvious that disease genes must be expressed differently than
normal genes, as if they expressed in the same way then they would never lead to
diseases. The microarray technology first developed in 1995 by Schena et al. [75] now
makes it possible to relatively measure the gene expression of a given gene. Using
this technology, researchers can compare gene expression of genes in different cells and
in different environmental circumstances. Accordingly, it is possible to compare the
expression of the disease genes to normal genes and make links between disease genes
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and candidate disease genes by measuring the similarity between their expressions on
microarrays.
3.3 Applying a Fusion of Different Evidence and
Resources
Many of the recently developed disease gene prediction approaches have tried to take
advantages of multiple evidence at the same time in order to provide more accurate
and reliable results.
There are two basic challenges involved with the use of several data resources
regarding different evidence categories. First, several data resources with different
properties have to be incorporated into the single coherent computational frame-
work. Second, for prioritization-based approaches (see 3.1), there has to be a single
integrated prioritization formula based on the different metrics connected to different
data resources.
Table 3.1 lists a number of previous works using different evidence at the same
time.
Table 3.1: Some of the well-known developed disease-gene association methods
Method evidence type reference
CIPHER phenotype, PPI [86]
ENDEAVOUR expression, PPI, functional, inherent, text mining [4]
GFINDER phenotype, expression [59]
CAESAR expression, functional, inherent, text mining [31]
CGPRIO sequence, functional, PPI, inherent [86]
GENESEEKER expression, functional, text mining, phenotype [78]
Chapter 4
Review of using PPI for
Disease-Gene Association
As discussed in Section 2.3.3, genetic disorders are normally complex and are caused
by several genes involved in various biological processes [37]. The application of
protein-protein interaction networks has remarkably extended our knowledge about
the genetic causes of genetic diseases [37], [50], [45].
As we applied protein-protein interaction information for our disease-gene associ-
ation method, we now provide a literature review of using this type of evidence.
Disease-gene association methods using PPI can be roughly classified into the
following categories: neighbourhood-based algorithms, random walk algorithms, and
graph partitioning algorithms.
4.1 Neighbourhood-based Algorithms
In neighbourhood-based approaches, the main assumption is that the proteins in
the neighborhood of the proteins expressed by disease-causing genes are likely to be
involved in either the same or a similar disease [45]. In other words, these meth-
ods presume that two genes closer to one another in the underlying protein protein
interaction network often lead to more similar phenotypes [86].
A good example of such methods is CIPHER [86],which gives scores to candidate
genes based on the closeness of the proteins derived from them to the proteins derived
from known disease genes, in the protein-protein interaction network. Dezso˝ et al [20]
ranked the candidate genes with respect to the shortest distance between disease genes
in their interaction network.
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4.2 Random Walk Algorithms
These methods basically use a random walk on the interaction network starting from
one of the known disease genes with some probability back to the one of initial nodes.
In other words, at each step of the walk, there is a probability of r that the walk
restarts and then starts again from one of the nodes associated with known disease
genes. A probability vector is then created containing the probability of randomly
visiting a node in a given time. The prioritization of the candidate genes is made
according to the visitation probability being more than a specific threshold.
To see sample studies on disease-gene association using random walk on protein-
protein interaction networks see [52], [80], [14] and [55].
4.3 Graph Partitioning Algorithms
As we already know, most cellular functionalities are conducted not by individual
proteins, but by a group of functionally associated proteins, referred to as modules
[2]. In protein-protein interaction networks, modules are considered as densely inter-
connected nodes, known as communities or clusters.
Using a community identification method named Clique Percolation Clustering
[19] PF Jonsson et al [48] showed that proteins expressed from known cancer genes
have different network properties than proteins not observed as being involved in
cancers. For instance, they observed that cancer proteins show an increase in the
number of proteins they interact with.
S.Navlakha et al [63] proposed a graph summarization technique (named GS)
based on graph compression to cluster protein interaction graphs into biologically
related modules.
Chapter 5
Methodologies
Before seeing the details of our computational approach for disease-gene association,
one should be generally familiar with complex networks, community identification
problem in complex networks, and genetic algorithms. In this chapter we provide an
overview of these methodologies.
5.1 Science of Complexity
How do hundreds of thousands of proteins interact and form various complex function-
alities and phenotypes of the human body? How do a huge number of cells organize
themselves to be our nervous system or our skin? Or, “how do independent members
of an economy, each working chiefly for its own gain, produce complex but structural
global markets; or, most mysteriously, how do the phenomena we call intelligence and
consciousness emerge from non-intelligent, non-conscious material substrates?” [60].
Many of the systems such as insect colonies, the brain, the immune system of
our body, the economy, the world wide web, the biological networks such as genetic
interactions and protein interactions, etc. are considered to be complex systems.
Complex Systems or the Science of Complexity is “an interdisciplinary field of re-
search that seeks to explain how large numbers of relatively simple entities organize
themselves, without the benefit of any central controller, into a collective whole that
creates patterns, uses information, and, in some cases, evolves and learns” [60].
As discussed in Section 2.3.3, genetic diseases and disorders occur consequent to
defects in the complex network in which genes (i.e. their products, the proteins)
interact with one another. Therefore, one should learn concepts concerning analysis
of complex systems prior to studying genetic interaction networks in order to study
genetic disorders.
20
CHAPTER 5. METHODOLOGIES 21
5.1.1 Complex Networks
All complex systems are composed of large networks of individual components (i.e
genes, proteins, websites, neurons, human individuals, etc.), each interacting with
other components based on relatively simple rules. The whole collection of interac-
tions of vast number of components leads to complex patterns and behaviours (see
Section 2.3.3). Hence, complex systems are usually modelled via complex networks,
which are large, dynamic graphs [81] in which nodes represent the complex system’s
components, and the edges replicate interactions among them. Generally, the term
complex network applies to any large graph corresponding to a complex system [81].
Protein-protein interaction networks are complex networks in which myriads of
proteins interact to one another to form different functionalities and phenotypes of
living organisms. In human protein-protein interaction network (human interactome)
more than one hundred thousands nodes interact through largely unknown number
of links (which is believed to be much larger than the number of noes). For instance,
refer to figure 1 in [51] to see a visualization of a part of the human protein protein
interaction network.
5.1.2 Community Identification Problem in Complex Net-
works
Complex networks have a tendency to form different communities, usually each pur-
suing different functionality working in sync with one another [73]. Some examples
include different regions of the brain, web pages about the same or similar topics on
the World Wide Web, or proteins interacting with one another to perform a specific
function. The network inside the communities is relatively dense compared to the
parts of the network residing outside the communities. For example, see Figure 5.1
which depicts partial map of the Internet based on available data on January 15,
2005. In this network nodes represent IP addresses and edges represent interactions
between them. As it can be seen, some parts of the network are denser than the
others. This parts can be matched to communities of IPs which closely work with
one another.
There has not been an agreement on the precise definition of a community in
complex networks [69]. Descriptively, communities are sub-graphs with a higher level
of internal interconnection than other sub-graphs of the network [53]. Based on how
great a difference there is between the number of internal and external connections of
a given community, the community can be considered a weak community or a strong
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one.
Figure 5.1: Partial map of the internet based on the January 15, 2005 data found on
opte.org, image from [85]
In 2002, the field of complex network community identification was first studied
by Newman and Girvan [32]. The community identification problem contains within
it two subproblems: (1) given a network, identify all communities working in sync
with one another in the network, and (2) given a node or a group of nodes, identify
the community or communities to which these nodes belong. Both subproblems have
been shown to be NP-complete [81]. Detailed discussions about why the community
detection problem in graphs is NP-complete are provided in [27]. The latter sub-
problem is little studied in comparison to the former one [81].
The community identification problem has been studied by several researchers
from different fields of science including physics, statistics and computer science. To
see a broad and detailed review of community identification methods in complex
networks refer to [13], [27] and [28].
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Community Identification in Biological Networks
There have been a number of algorithms and frameworks developed so far for de-
tecting communities and modules in biological networks, especially protein-protein-
protein interaction networks. For instances, G.D.Bader et al [8] developed MCODE,
an automated framework for finding modular complexes in protein interaction net-
works using a depth first search algorithm starting at nodes belonging to proteins
under study. A.J.Enright et al [22] presented an approach called TRIBE-MCL for
clustering of proteins interacting in PPI into different families using a Markov clus-
ter (MCL) [21] algorithm. See Section 4.3 for two other examples of community
identification methods on PPI.
As a part of our research, we developed a novel computational approach to identify
communities in different types of genetic interaction networks such as PPI, with the
use of a genetic algorithm. We developed this approach to associate diseases with
particular genes. See Chapter 6 for further details.
5.1.3 Disease-Gene Association as a Community Identifica-
tion Problem
Different phenotypes including diseases are fairly likely to be assigned to a group of
nodes (i.e. genes, RNA molecules, proteins and other distinct cellular components)
working closely with one another as a community of the gigantic complex network of
the human interactome, a network which is believed to contain some 25000 protein-
encoding genes and a still higher number of unknown and undefined proteins and
their interactions [9].
From the modern viewpoint of genetics (referred to as the molecular revolution
[60]), phenotype−gene association including disease−gene association can be rede-
fined as: given a number of genes known to be involved in a specific phenotype (ge-
netic disease), computationally examine the currently available human interactome
(PPI, co-expression, pathway interaction etc.) in the vicinity of the known disease
genes to detect the community or communities in which these genes closely interact
with one another. Discovering such communities sheds light on genes closely working
with known disease genes and steers us towards predicting new disease genes (see
Section 2.3.2). Therefore, with this viewpoint of the problem, computational disease
gene prediction perfectly matches the second sub-problem of community identification
mentioned in Section 5.1.2.
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5.2 What is a Genetic Algorithm?
Genetic Algorithms (GA), which are among the most common evolutionary computa-
tional approaches, have been proven to be effective in finding near-optimal solutions
for many NP-hard problems [60]. The main idea of evolutionary computational meth-
ods, including GAs, is to mimic evolution and the Darwinian natural selection process
to find a solution (close enough to optimal) for a given computational problem. The
first serious effort to apply GAs to practical problems is work done by John Holland
and his students at the University of Michigan in the 1970s [60].
Generally, a genetic algorithm contains the following key elements:
• A population of candidate solutions for the problem at hand. These candidate
solutions are also called chromosomes or individuals.
• A fitness function that takes a candidate solution and evaluates its fitness value.
The fitness value measures how good the solution is for the given problem.
• A crossover operator that is a genetic operator applied on two or more individ-
uals (chromosomes) for offspring reproduction.
• A mutation operator that mimics possible mutations while new individuals are
reproduced.
A general recipe for a Genetic Algorithm can be described as having the following
steps:
1. Generate an initial population of candidate solutions. This initial population
can be generated in many ways but often it is simply a set of random valid
candidate solutions.
2. Fitness evaluation: measure the fitness of each individual in the current gener-
ation’s population.
3. If there is a solution in the population with the desired fitness value, or if
the number of generations created so far has reached the predefined maximum
number of generations, then the program stops.
4. Tournament selection: randomly select a number (tournament size) of the indi-
viduals and select a number (usually two) of them to be the parents reproducing
individuals for the next generation.
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5. Generate the population for the next generation: all selected parents in step
4 utilize the crossover operator and possibly the mutation operator to create
offspring which will become the individuals of the next generation (new popu-
lation). This repeats until the new population becomes full.
6. Go to 2.
Applying a genetic algorithm (GA), we propose a new computational approach to
tackle the disease gene association problem. We will clarify the technical details of
our GA-based disease gene prediction method in Chapter 6.
Chapter 6
The Design of Our Computational
Approach
6.1 General Idea
Prior to clarifying the technical details of our GA-based disease gene prediction
method, we first review its general properties.
Using a genetic algorithm, our computational method tries to evolve communities
containing the set of potential disease genes likely to be involved in a given genetic
disease. Having a set of known disease genes already believed to be involved in
a disease, we first obtain a protein-protein interaction network containing all the
selected known disease genes. All the other genes inside the procured PPI network
are then considered as candidate disease genes as they lie in the vicinity of the known
disease genes in the human interactome. Our method attempts to find communities of
potential disease genes strongly working with one another and with the set of known
disease genes.
In our GA-based approach, each individual within a population is a candidate
community of genes that may be involved in a given disease. The initial population
consists of individuals that are simply randomly-created communities. At each gen-
eration, the GA tries to evolve individuals (communities) that have a relatively high
degree of collaboration between the known disease genes and the other genes within
the individual (community), and that also that have a high degree of collaboration
among all the genes inside the individual (community). The more collaborative the
genes are in the evolved individual (community) with the known disease genes and
with one another, the more likely it is that the individual (community) contains genes
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potentially involved in the disease under study. Intuitively, in our method, the GA
tries to find subnetworks of the interaction network that are as modular and collab-
orative as possible, where the subnetworks also contain the known disease genes.
6.2 Motivations and Ideas
6.2.1 Why use a Community Identification Approach?
There are still many unknown interactions among human genes/proteins in the human
interactome, however, despite the considerable noise and incompleteness of protein
interaction data, proteins relevant to the same/similar phenotype/biological processes
tend to lie near one another within the network (see Section 2.3.2). Thus, community
identification approaches can still be effective for predicting novel disease gens exist-
ing near the already known disease genes in the human interactome. As discussed
in Section 4.3, there have been few successful studies to find communities and clus-
ters in protein-protein interaction networks to associate novel genes with phenotypes,
diseases and different biological processes, but this is still a less studied approach
compared to other approaches to tackle the disease-gene association problem specifi-
cally [81]. In other problems of Bioinformatics, finding and studying protein-protein
interaction network modules has led to noteworthy discoveries in physical, logical and
evolutionary organization of the cell [63]. (See, for example, [12], [36], [41], [42] and
[72]).
6.2.2 Why use a GA for Community Identification?
As discussed earlier, there have been quite a few computational approaches developed
for community identification in complex networks in general, and more specifically to
detect communities in PPI networks (see Sections 4.3 and 5.1.2). One might ask why
a GA has been chosen to develop a community identification approach for disease
gene association. However, it should be noticed, the computational approach we
have devised in this research is not purely a community identification method. As a
matter of fact, it focuses on both community identification and disease-gene ranking
principles at the same time. In this part, we elaborate the advantages and unique
features the GA has given to our computational disease-gene association approach.
Firstly, we tries to evolve communities of disease genes, and not only a single
community. Our method works with the populations of various communities (GA
populations) which makes it able to process plenty of different potential communities
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to assess their collaboration with the known disease genes set. This creates a compet-
itive environment for many evolving genes communities and the ranking for a given
gene depends on all of the communities in the population over generations.
Secondly, GAs as an evolutionary computational approach have a unique advan-
tage which makes us able to prioritize genes in the order of their relevance to disease
genes. As discussed in Section 6.1, the idea is that the more frequently a gene is
chosen to be in the optimizing communities, i.e. the more often a gene is selected for
the more optimized communities of the higher generations, the more it is associated
with the known disease genes, and therefore should have a higher score compared to
others that are selected less often.
Thirdly, genes associated with a specific disease may act in separate communities
which work with one another, or separate communities which overlap. We intuitively
believe that GAs give our method the ability to give a high score to candidate disease
genes closely working with the known disease genes whether they are in different com-
munities or in overlapped communities for the following reasons. First, as the evolving
populations contain thousands of different communities, different communities which
work with the known disease genes would have the chance to evolve and be in the
population at the same time. Genes in all such communities will get high scores as
they are often selected in a number of the population’s communities over generations,
thereby they can increase their scores. Second, potential disease genes which lie in
more than one community working with disease genes are selected more frequently
as they can have the chance to be in many of the communities of the populations.
6.3 Details of the Genetic Algorithm
6.3.1 Fitness Evaluation
As previously stated, our GA tries to increase the degree of collaboration (i.e. the
modularity) of the nodes (i.e. genes) inside the evolving communities. This is mainly
because a community is recognized as a subgraph that is denser inside in comparison
to the areas of the network around the subgraph. Therefore, as we can see in the
community identification problem literature, measuring the modularity of a given
community revolves around comparing the density of the area residing inside the
community to the areas around the community. To see a general review of the various
metrics used to measure the quality of a given community, see [81].
Hence, reasonably enough, the fitness value should assess the modularity degree
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of the candidate communities (individuals in a given generation) to increase the like-
lihood of reproduction for the more modular individuals across the generations.
For the experiments we have performed so far, we have used the simple modularity
function Q proposed by Luo et al. [57], also known as subgraph modularity. This
modularity function simply divides the number of the edges inside the community
C by the number of all the edges involved with the community including the edges
which are completely inside the community of C and the edges connecting a node
inside the community to a node outside the community:
Q(C) =
∑
i∈C
Kini (C)
Ki(C) = Kini (C) +K
out
i (C)
(6.1)
where
Kini (C) =
∑
j∈C
E(i, j) (6.2)
is the number of edges connecting i to other nodes in C and
Kouti (C) =
∑
j /∈C
E(i, j) (6.3)
is the number of edges connecting i to the nodes out of C.
This modularity function has been observed to be one of the most effective func-
tions to evaluate the modularity degree of communities. For examples, Vasudevan
et al [81] used this modularity function and successfully discovered communities in
several real-world complex networks.
6.3.2 Individuals (Chromosomes)
As mentioned in Section 6.1, individuals (candidate solutions) are induced subnet-
works that are potential disease gene communities. Individuals are represented using
binary arrays of length N , where N is the size of the protein-protein interaction net-
work (i.e. the number of all the genes in the network). If the ith element of the array
is 1, then the ith gene of the network is considered to be in the candidate community;
otherwise it is outside of the candidate community.
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6.3.3 Linkage with known disease genes: Guilt by Associa-
tion
Like most of the computational disease gene prediction frameworks, this method also
revolves around the Guilt by Association principle. This principle is crucial here to
make sure that the final selected disease community contains the genes interacting
with a high-degree of modularity (collaboration) to the known disease genes as well
as to each other.
To provide this important feature for our GA-based method, all the individuals in
all the populations (i.e. all the induced evolving subgraphs) always hold the known
disease genes inside them. In fact, we force all evolving subnetworks to include
all known disease genes. In other words, all the known disease genes are added
to candidate communities while their fitness values (described in Section 6.3.1) are
measured. This approach steers the whole process to finding communities in which
genes are in high collaboration with the known disease genes.
6.3.4 Maximum Community Size
The maximum number of nodes (genes) that can be inside a candidate community
(individual representing a sub-network) is determined in advance of starting the GA.
As a matter of fact, we deliberately force all candidate communities to contain no
more than a specific fraction of the network’s genes. This is primarily for the follow-
ing reasons: (1) to avoid obtaining unwanted futile solutions such as a big community
containing most of the network’s genes (which cannot be considered a community any
more), (2) to provide a more competitive environment across the communities’ evo-
lution, and above all (3) to supervise the convergence trajectory of the sub-networks
towards the disease genes community we wish to obtain, i.e. the way in which the in-
dividuals converge towards the community of disease genes over generations in order
to define a scoring system to prioritize candidate genes (see Section 6.4.1).
In other words, candidate communities of the pre-determined maximum size could
be interpreted as frames that move over the various areas of the network during the
generations of the GA. Being evolved by the GA, these frames have a tendency to move
towards the areas of the network that show higher collaborations and modularity with
the known disease genes. As a matter of fact, candidate communities (individuals in
the population of the GA) converge to areas of the network that are more likely to
contain genes with a high level of collaboration with known disease genes.
To avoid acquiring biased output, we perform the same GA experiment several
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times to make sure that the population, i.e. all induced sub-networks, converges
towards the same area of the network as the disease genes community.
6.4 Prioritization of the Candidate Genes
According to the disease gene prediction literature, there are two main approaches
for disease-gene association [68]. The results obtained by a disease-gene association
method could be either a prioritization of the candidate genes, i.e. a ranking of the
candidate genes based on the likelihood of their involvement, or a selection of the can-
didate genes, i.e. a reduced set of candidate genes which have priority to be studied
over the other candidates or that are more noteworthy in some way. Our computa-
tional approach is basically a selection-based and prioritization-based method, with
the capability of offering a reduced set of candidate genes. Our GA-based approach
ranks the candidate genes according to the new scoring system we devised, introduced
in Section 6.4.1.
Furthermore, the communities with highest fitness value (modularity value) can
be considered as the reduced set of candidate disease genes that is noteworthy for
further studies.
6.4.1 Scoring System
Each experiment performed by our GA contains the following as input data:
• a set of known disease genes
• a relatively large PPI network containing all the genes existing in the known
disease gene set
• a set of candidate genes containing all the other genes in the procured PPI
network.
All the genes cumulatively gather scores while the candidate communities (individ-
uals) are evolved over generations. The scoring method is based on the idea that
genes which are more frequently selected in candidate communities, while they are
being evolved over generations, should accumulate higher scores. Therefore, genes
which survive for a greater number of generations, and which are in a greater num-
ber of communities, acquire higher scores. The cumulative score of a given gene is
proportional to the fitness value of the communities for which it is selected. In other
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words, in being selected for better communities (i.e. individuals with higher fitness
value), genes get relatively higher scores. Over generations, candidate communities
(individuals of every generation) gradually converge into sets of genes that are in
higher collaboration with the known disease genes and with one another. Therefore
as the candidate communities are evolved by the GA, they are more likely to be in
the vicinity of the community we are looking for, i.e. the predicted disease genes set.
The scoring function for a given candidate gene is calculated based upon Algorithm
1 , where Q(c) is the modularity of the community C as defined in Section 6.3.1.
for each generation do
for each candidate community C in population do
if gene i is in C then
Score(i) = Score(i) + Q(C)
end
end
end
Algorithm 1: Calculate score of gene i
Chapter 7
Datasets and Benchmark Tests
7.1 Databases
7.1.1 Protein-Protein Interaction Data
We obtained the human PPI interaction network using GeneMANIA [84], reported
to be among the best performing methods in a public large scale computational
biology challenge [71]. The homo sapiens (human) interaction database of GeneMania
recorded different types of interactions (co-expression, protein–protein interaction,
pathway, co-localization etc.) based on 395 different interaction databases developed
so far. It contains the interactions among 21435 genes from the human genome.
7.1.2 Disease-Gene Association Data
In order to select disease genes and make the association between particular dis-
eases and particular genes, we used Genotator [82], developed at Harvard University.
Genotator is a realtime aggregation tool that provides both comprehensive coverage
and reliable gene-to-disease rankings for many of the diseases. It integrates data
from 11 well-known frequently used clinical genetics resources including Pubmed [1],
OMIM [40], GeneCards [74], HuGE Navigator [88], GenAtlas [30], WikiGenes [44]
and some other phenotype-gene association data sources to rank genes in order of
disease relevance.
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7.2 Benchmark Test
7.2.1 Leave-One-Out Cross-Validation
To assess the performance of our GA-based method, we used the leave-one-out cross-
validation procedure. This procedure is the most frequently used procedure to assess
many of the state-of-the-art disease-gene associations approaches including [86], [80]
and [52].
According to leave-one-out cross-validation procedure, for every time performing
the experiment, one of the known disease genes is removed from the known disease
genes set, to observe if the method can again recover this gene as a high associative
gene or not. In other words [55], given a set of known disease genes D and a set of
candidate genes C a gene d ∈ D is left out and all genes in C ∪ {d} are ranked using
the computational approach under study. This process is repeated for every genes in
the known disease genes set.
7.2.2 Fold enrichment analysis
Fold enrichment analysis is a concept one needs to know about for using the leave-one-
out cross-validation procedure. Here, we offer the definition provided by X Wu et al
[86] as it is much simpler and clearer than other definitions we could find: if a method
successfully ranks known disease genes in the top m% of all candidate genes for n%
of the known disease genes, there is a n/m-fold enrichment on average. Therefore, a
threshold must be chosen to separate the two prediction classes. If the left-out known
disease genes in leave-one-out cross-validation do not exceed the specified threshold
in the candidate genes ranking, then it is considered as a successfully predicted gene
in the validation.
7.2.3 Receiver-Operating Characteristic (ROC) analysis
Another concept involved with the leave-one-out cross-validation performance mea-
sure is the receiver-operating characteristic (ROC) analysis. ROC is defined as a plot
to measure the performance of a binary classifier according to a defined discriminating
threshold. Here, for the disease-gene association/prioritization problem, ROC plots
the true-positive(TP) rate versus the false-positive(FP) rate, subject to the threshold
separating the prediction classes (see Section 7.2.2). Consider the sets D and C and
disease gene d introduced in Section 7.2.1 again. Suppose θ is the threshold which
the rank of known disease gene d must not exceed in order to be considered as a
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successfully predicted known disease gene. TP(true positive) is the number of test
cases where the ranking of d is less than θ, and FN(false negative) is the number of
test cases where the ranking of d exceeds θ. The sensitivity of the computational
disease-gene prioritization method for a given experiment is then defined as equation
7.1:
Sensitivity =
TP
TP + FN
(7.1)
Chapter 8
Case Studies and Results
As a proof of concept, we applied our methodology to the problem of finding genes
involved in breast cancer and Parkinson’s disease. We selected these genetic disorders
due to the diversity of related studies and because there is a significant amount of
research literature.
To see a sample of output generated by our method see appendix A.
8.1 Breast Cancer
8.1.1 Input Data
We used the same input data as Xuebing et al [86] used to demonstrate the ability
of CIPHER, one of the most well-known and frequently used disease-gene association
framework. Using OMIM[40], they selected 16 disease genes known to be involved in
breast cancer. They measured the ability of CIPHER to predict disease genes based
on these 16 genes. Table 8.1 outlines these genes.
Using GeneMania (see 7.1.1), we obtained an un-weighted protein-protein inter-
action network containing the 16 disease genes shown in Table 8.1. We defined the
candidate genes to be the first 2000 genes scored by GeneMania in the order of inter-
actions with these 16 disease genes.
8.1.2 GA Parameters
We ran our GA-based method on this PPI network 20 separate times. Each run was on
two threads and took between 5 to 10 hours. Table 8.2 outlines our GA parameters for
all 20 executions of the GA. These parameters were empirically determined. It should
36
CHAPTER 8. CASE STUDIES AND RESULTS 37
Table 8.1: Known disease genes for breast cancer
Gene NCBI ID
BRCA1 672
BRCA2 675
TP53 7157
AR 367
ATM 472
CHEK2 11200
STK11 6794
RAD51 5888
PTEN 5728
BARD1 580
RB1CC1 9821
NCOA3 8202
PIK3CA 5290
PPM1D 8493
CASP8 841
TGF1 281527
be noted that further study should be performed on determining the most appropriate
values for these parameters for other experiments (e.g. for other diseases).
Table 8.2: GA Parameter Settings for breast cancer experiment
Parameter Value
number of generations 300
population size 5000
cross-over rate 95%
mutation rate 5%
tournament size 3
fitness evaluation Q(C) (eq 6.1)
maximum community size 50
Figure 8.1 depicts the progression of the averages of best fitness values, and the
averages of average fitness values for the 20 runs of the GA over the generations.
A sample of generated candidate genes ranking regarding this experiment is pro-
vided in Appendix B.1. The community with the highest modularity (Q - equation
6.1) procured by this experiment is also provided in Appendix C.1.
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Figure 8.1: averages of best/average fitness values over generations (breast cancer
experiment)
8.2 Analysis
8.2.1 Leave-One-Out Cross-Validation
Running our GA-based method on the input data described in Section 8.1.1 and based
on the parameters outlined in Table 8.2, and using leave-one-out cross-validation
method (explained in 7.2.1), our method successfully predicted 12 out of 16 known
genes as being involved in breast cancer. The threshold (θ - see Section 7.2) was set to
the size of the community of the disease-genes the GA was evolving over generations
(here, 50). This is discussed further in chapter 9. Table 8.3 shows the 12 predicted
genes and median of their 20 different rankings as a result of running the experiment
20 times.
8.2.2 Comparison with CIPHER
Based on the results CIPHER gained over the same known genes provided in [86],
CIPHER successfully ranked known disease genes in the top 0.917% of all candidate
genes in 49.1% of test cases, giving CIPHER a fold enrichment of 53.50 on average.
Our GA-based approach, if we consider the top 1% of all candidate genes, gives fold
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Table 8.3: 12 successfully predicted genes out of the 16 known disease genes for breast
cancer listed in Table 8.1
Gene Median of rankings Best ranking Standard Deviation of rankings
BRCA1 1 1 1.47
TP53 1 1 1.15
BRCA2 5 1 2.33
ATM 6 3 1.89
AR 8 2 3.24
PPM1D 16.50 8 4.49
BARD1 19.50 5 6.04
RAD51 20 13 9.67
RB1CC1 22 10 11.22
PTEN 34.50 22 12.21
STK11 42.50 17 17.08
NCOA3 46 27 16.71
enrichment of 50 on average, fold enrichment of 56.25 for the ranking offered by the
best solution procured by the GA, and fold enrichment of 62.50 if we consider the
best rankings of the known disease genes among all 20 rankings given by the GA.
Based on the acquired results, ROC analysis (see Section 7.2.3) gives us 12 TPs
and 4 FNs, thus the sensitivity of this experiment is 75%. The sensitivity of the
experiment for CIPHER was 62.50% as a result of 10 TPs and 6 FNs.
8.2.3 Comparison with Random Walk
We briefly discussed random walk methods in Section 4.2. Random walk methods
have been observed to outperform other types of disease-gene association approaches
discussed in Chapter 4 ([62],[9] , [9]).
We performed this experiment over the same known disease genes and candidate
genes using GPEC [55], disease gene prioritization and prediction framework based
on RWRA (random walk with restart algorithm - see Section 4.2).
Applying the same threshold (θ = 50), GPEC gives sensitivity of 0.8112 (13 TPs)
and fold enrichment of 56.25 for the top 1% of all candidate genes.
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8.2.4 Summary of the Analysis for Breast Cancer Experi-
ment
Table 8.4 summarizes the analysis described in Sections 8.2.1 to 8.2.3. See Section
7.2 for description of fold enrichment, leave-one-out and sensitivity measurements.
Table 8.4: Analysis and comparison for breast cancer experiment
Method/Framework Fold enrichment Leave-one-out sensitivity
CIPHER 53.50 10/16 0.6250
GPEC(random walk) 56.25 13/16 0.8112
our method (median ranking) 50 12/16 0.75
our method (best ranking) 56.25 12/16 0.75
As table 8.4 suggests, our method outperforms CIPHER for this experiment and
the results obtained by our method are comparable to the results acquired by random
walk.
8.2.5 Predicting new Disease Genes
We briefly studied other candidate genes ranked among the top 1% of the candidate
genes on average using Genotator (see Section 7.1.2). Our GA successfully predicted
some other genes involved in breast cancer which were not in the known disease-genes
set of the performed experiment. Among the other potential breast cancer genes
ranked among the top 1% are ESR1, NBN, CHECK1 , H2AFX ,EP300, SMAD3,
and other genes most of which have evidence of being involved in breast cancer by
different data sources according to Genotator.
8.3 Parkinson’s Disease
8.3.1 Input Data
For Parkinson’s disease, we first extracted 15 genes known to be involved in this
disease from Genotator. Table 8.5 lists these 15 genes. These are the top 15 genes
scored by Genotator in terms of relevance to Parkinson’s Disease. Although some of
these genes lie on different loci (chromosomes) of the DNA, the functional proteins
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derived from these genes must physically interact with one another across the physical
interaction network (PPI) containing these genes.
Table 8.5: known disease genes for Parkinson Disease
Gene NCBI ID
LRRK2 120892
SNCA 6622
PARK2 5071
MAPT 4137
APOE 348
GBA 2629
GAK 2580
BST1 683
DRD2 1813
PINK1 65018
MAOB 4129
BDNF 627
CYP2D6 1565
PON1 5444
COMPT 1312
Using GeneMania, we obtained an un-weighted physical interaction network (protein-
protein interaction network) containing the 15 known disease genes. We defined the
candidate genes to be the first 3000 genes scored by GeneMania in the order of inter-
actions with these 15 disease genes.
8.3.2 GA Parameters
Like the previous experiments, we ran our GA 20 separate times (see Section 8.1.2).
Each run was on two threads and tool 5 to 7 days. Table 8.6 outlines the parameters
for this experiment. These parameters were empirically determined. It should be
noted that further study should be performed on determining the most appropriate
values for these parameters for other experiments (e.g. for other diseases). Figure 8.2
shows averages of best/average fitness values over generations.
A sample of generated candidate genes ranking regarding this experiment is pro-
vided in Appendix B.2. The community with the highest modularity (Q - Equation
6.1) procured by this experiment is also provided in Appendix C.2.
CHAPTER 8. CASE STUDIES AND RESULTS 42
Table 8.6: GA Parameter Settings for Parkinson Disease experiment
Parameter Value
number of generations 500
population size 30,000
cross-over rate 95%
mutation rate 5%
tournament size 4
fitness evaluation Q(C) (eq 6.1)
maximum community size 100
Figure 8.2: Averages of best/average fitness values over generations
8.3.3 Leave-One-Out Cross-Validation
For this experiment, our method successfully predicts 9 out of 15 genes in leave-one-
out cross-validation on its average performance among 20 executions. Similar to the
previous experiment, the threshold was set to the maximum community size (in this
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case 100). Table 8.7 summarizes the results.
Table 8.7: 9 Successfully predicted genes out of the 15 known disease genes for Parkin-
son’s Disease listed in Table 8.5
Gene Median of rankings Best Ranking Standard Deviation of rankings
SNCA 1 1 2.26
PARK2 10 3 3.06
APOE 18.50 8 6.23
MAPT 38.50 23 9.23
PINK1 46 14 10.19
DRD2 63.50 38 8.63
BDNF 71 38 18.75
GAK 73.50 33 19.44
LRRK2 92.50 66 21.17
8.3.4 Comparison with ENDEAVOUR and Random Walk
(GPEC)
We performed this experiment with ENDEAVOUR [4], one of the most well-known
and frequently used frameworks for disease gene prioritization, on the same known
disease genes and candidate disease genes set for Parkinson’s disease. We also per-
formed this experiment with GPEC which we introduced in Section 8.2.3. Table 8.8
outlines the results. See Section 7.2 for description of fold enrichment, leave-one-out
and sensitivity measurements.
Table 8.8: Analysis and comparison for Parkinson’s disease experiment
Framework Fold enrichment(top 1%) Leave-one-out sensitivity
ENDEAVOUR 26.06 7/15 0.46
GPEC(random walk) 40 8/15 0.53
our method (median) 33.33 9/15 0.60
our method (best) 40 9/15 0.60
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8.3.5 Predicting novel Parkinson’s disease genes
Amongst the candidate genes frequently ranked in the top 10 genes in several runs
of the experiments, there are some genes which can evidentially be associated with
Parkinson’s Disease. Interestingly, for some genes ranked among the top places the
supporting evidence and studies are fairly recent.
Epidermal Growth Factor Receptor (EGFR)
According to [24], the protein encoded by this gene is a receptor for members of the
epidermal growth factor family. EGFR is a cell surface protein that binds to epider-
mal growth factor. Increased activities of REGF or mutations in REFG have been
observed in certain types of cancers [24]. Our computational method suggested that
EGFR is one of the highest-scoring genes that closely interacts with the 15 known
Parkinsons disease genes used in this experiment. In quite a few recent studies, epi-
dermal growth factor has been suggested as a candidate gene for cognitive impairment
in Parkinsons disease [67]. Chen-Plotkin et al. [15] and Pellecchia et al. [67] have
recently observed links between epidermal growth factor and cognitive inabilities of
the Parkinsons disease patients.
ABL1 gene
The ABL1 gene (gene ID: 25 see [25]) was also one of the top 10 genes in most
of the 20 rankings obtained by our method. In a very recent study performed by
Hebron et al. [43], it was observed that a level of ABL1 activity is increased in
human postmortem Parkinson’s Disease brains. Mahul-Mellier et al. [58] is another
very recent study indicating links between the c-Abl protein derived from the ABL1
gene and Parkinson’s Disease.
Ubiquitin C (UBC) gene
UBC [26] was also frequently ranked among the very top genes in our experiment.
Mutations in UBC have been repeatedly observed to be responsible for Parkinsons
disease [18]. For instance, in a very recent research performed by Viorica Raluca
Contu et al. [18], the roles of mutation in ubiquitin C-terminal hydrolase L1 (UCH-
L1) have been studied. PubMed has recorded remarkable number of publications
discussing the UBC’s role in Parkinsons disease.
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8.4 Analysing GA capability to evolve disease gene
communities with higher modularity
To analyse the ability of GA to evolve disease gene communities with higher modu-
larity, we hereby compare the results obtained by the experiment we performed for
breast cancer (Section 8.1) with the results acquired by a random search done by GA.
To simulate a random search using GA, we set the tournament size to 1 and ran GA
for 20 times on the same candidate and known disease genes sets.
Figure 8.3 depicts fitness growth (average of average and best fitness values for 20
runs) over generations while the search is random (tournament size is 1) and while
the search is not random (tournament size is 3).
We performed a t-test on average and best fitness values generated by the two
approaches explained above. The very low p-values suggest that the results acquired
by our experiments are significantly different from the results given by the random
approach. See Table 8.9 for more details.
We ran our GA 20 different times with the tournament selection of 1 and pick the
best possible ranking out of the 20 generated rankings. We subsequently compared
this ranking with the average ranking acquired by the experiment we performed for
breast cancer explained in Section 8.1. Table 8.10 briefly outlines this comparison.
The very low p-values (close to 0) suggests that the difference is obviously signifi-
cant. See Section 7.2 for description of fold enrichment, leave-one-out and sensitivity
measurements.
Table 8.9: P-values given by t-test
P-Value
Comparing Average Fitness Values 7.0602E-278
Comparing Best Fitness Values 0
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Figure 8.3: comparing averages of best/average fitness values over generations while
t=1 and while t=3 )
Table 8.10: Comparing results for tournament size of 1 and 3
Tournament Size Fold enrichment(top 1%) Leave-one-out (sensitivity)
3 50 0.625
1 0.062 0.062
Chapter 9
Conclusions and Future Work
In this study, we demonstrated a new computational disease-gene association method
with the use of a genetic algorithm. As elaborated earlier, our method tries to evolve
different communities of candidate genes with as much collaboration with the whole
set of known disease genes as possible. It starts from randomly created communities
of genes and optimizes the communities over generations, based on the modularity of
the community (according to equation 6.1).
The main idea behind the scoring system (described in algorithm 1) is that the
more frequently a gene is chosen to be in the optimizing communities, i.e. the more
a gene is selected for the more optimized communities of the higher generations, the
more it is associated with the known disease genes, and therefore should have a higher
score compared to others that are selected less often.
Genes associated with a specific disease may act in separate communities which
work with one another, or separate communities which overlap. We intuitively believe
that our GA-based computation is capable of finding disease genes working in dif-
ferent communities or in overlapped communities for the following reasons. First, as
the evolving populations contain thousands of different communities, different com-
munities which work with the known disease genes would have the chance to evolve
and be in the population at the same time. Genes in all such communities will get
high scores as they are often selected in a number of the population’s communities
over generations, thereby they can increase their scores. Secondly, potential disease
genes which lie in more than one community working with disease genes are selected
more frequently as they can have the chance to be in many of the communities of the
populations.
As a proof of concept, we first tested our approach on 16 breast cancer genes taken
from similar experiments performed by Xuebing et al [86] to test the performance
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of CIPHER, a well-known disease gene prioritization framework (see Section 8.1).
We also tested our method on 15 Parkinson’s Disease genes taken from GeneMania
[84]. We compared our results to the results gained by CIPHER, ENDEAVOUR and
GPEC, three of the most reliable and frequently used disease-gene ranking frame-
works. The results are satisfactory as two of the first experiments using a newly
developing approach (see chapter 8), however, there should be specific and more ac-
curate strategies to determine the known disease gene set with regard to different
diseases and choosing appropriate GA parameters.
Determining an appropriate maximum community size for use in our method is
also a matter of discussion. Different maximum community sizes can obviously af-
fect the number of times each gene would be allowed inside the evolving community,
thereby affecting the scores acquired by each gene. Here we chose a maximum commu-
nity of size of 50 and 100 for the breast cancer and Parkinson’s disease respectively,
however further investigation should be conducted on this parameter, considering
supporting reasons for choosing a given value. The accuracy of the results may possi-
bly be increased as a result. Concisely speaking, appropriate strategies and different
parameter values may vary significantly from one disease to another.
Although protein-protein interaction networks have been shown to be among the
most powerful pieces of evidence for disease-gene association, there are still major
concerns about the amount, accuracy, and quality of the available data, and there are
still a considerable amount of interactions that are not well-studied. To obtain more
accurate and reliable disease genes communities one may use a fusion of different
network-based data resources along with PPI (see Section 3.3). The possibility of
adding input data regarding other evidence discussed in chapter 3 has been provided
for our method. Further studies can assess the performance of our method working
on other interaction networks such as functional annotation, co-expression network,
and regulatory networks.
It should be noted nonetheless that this is a proof of concept and that much
further study remains. Most importantly, this method should be applied to other dis-
eases. Also, as specified above, future work must include further study of appropriate
parameters, especially with respect to appropriate parameters for different diseases.
Finally, the genes in the communities with highest fitness values (modularity
value) generated by our GA, and also the genes ranked as top genes in the rank-
ings are noteworthy for further studies from a biological perspective.
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Appendix A
Sample output of genetic algorithm
Here, we provide sample output generated by our GA-based method. This shows an
excerpt containing out of generations for one of the 20 experiments we performed for
Breast Cancer.
A.1 Generations 1 to 20
********************Generation 0********************
Generation’s average fitness: 0.12110106472383664
Generation’s best fitness: 0.18787878787878787
Generation’s best individual:
[7, 3, 2, 6, 1, 7, 5, 7, 3, 3, 5, 1, 1, 3, 1, 6, 1, 3, 2, 3, 5, 1, 1, 5, 6, 5, 2, 0, 1, 2, 0, 3,
7, 0, 6, 7, 5, 2, 6, 3, 5, 3, 6, 1, 3, 3, 1, 6, 0, 0, 7, 5, 5, 0, 4, 2, 5, 5, 1, 1, 2, 6, 6, 3, 4,
2, 1, 5, 6, 5, 5, 5, 5, 0, 7, 2, 6, 5, 7, 4, 3, 3, 7, 5, 7, 4, 5, 1, 1, 1, 4, 3, 2, 1, 2, 3, 4, 4,
2, 5, 2, 2, 3, 4, 1, 3, 5, 2, 0, 0, 6, 0, 1, 1, 2, 7, 7, 7, 5, 4, 6, 7, 5, 7, 3, 2, 1, 7, 5, 7, 5,
0, 4, 1, 5, 5, 0, 5, 2, 3, 0, 5, 5, 2, 1, 6, 4, 7, 5, 1, 7, 6, 2, 4, 2, 7, 1, 1, 0, 1, 1, 5, 6, 7,
5, 1, 2, 6, 3, 1, 7, 2, 0, 6, 1, 0, 5, 2, 1, 2, 5, 4, 0, 0, 1, 0, 4, 7, 6, 1, 1, 6, 4, 5, 6, 1, 5,
6, 6, 4, 4, 1, 7, 5, 7, 0, 4, 6, 5, 1, 1, 1, 4, 5, 3, 4, 0, 7, 4, 6, 6, 5, 1, 1, 1, 7, 2, 7, 7, 7,
3, 6, 3, 1, 0, 0, 5, 1, 0, 0, 6, 5, 1, 6, 2, 2, 0, 5, 5, 2, 0, 5, 7, 3, 1, 4, 1, 0, 3, 7, 7, 0, 6,
6, 2, 7, 5, 7, 2, 6, 5, 2, 6, 0, 4, 1, 1, 7, 5, 7, 2, 6, 6, 2, 5, 4, 4, 5, 7, 5, 0, 2, 4, 1, 1, 1,
1, 3, 5, 1, 5, 4, 7, 7, 4, 6, 4, 3, 5, 1, 3, 1, 4, 7, 7, 4, 4, 5, 2, 7, 3, 2, 2, 3, 1, 6, 0, 1, 4,
7, 7, 2, 1, 3, 7, 4, 0, 1, 2, 7, 0, 6, 0, 0, 2, 3, 2, 6, 2, 4, 0, 7, 4, 7, 6, 5, 7, 6, 4, 0, 1, 3,
0, 3, 6, 2, 5, 4, 1, 4, 7, 1, 1, 1, 6, 5, 3, 4, 1, 4, 6, 2, 6, 3, 7, 4, 1, 3, 4, 4, 4, 5, 5, 3, 3,
7, 2, 5, 6, 0, 7, 0, 0, 1, 1, 2, 7, 3, 5, 7, 7, 3, 4, 4, 5, 1, 6, 2, 0, 5, 5, 1, 3, 3, 7, 7, 3, 3,
3, 2, 6, 6, 0, 7, 7, 6, 4, 4, 1, 3, 1, 6, 1, 1, 1, 5, 1, 6, 3, 2, 4, 1, 4, 6, 7, 4, 0, 3, 7, 7, 6,
2, 7, 1, 5, 4, 5, 0, 2, 4, 2, 1, 2, 1, 5, 1, 1, 0, 4, 7, 0, 1, 4, 2, 7, 6, 4, 4, 4, 1, 5, 5, 3, 4,
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3, 5, 2, 1, 5, 4, 0]
Generation’s best community (list of genes):
ATAD2 NBN RAD52 LRIT3 H2AFX FAS AP2M1 TDP1 ATF1 BAP1 VCP
RAD51D DHCR24 THRB MDC1 RIPK3 DBNL CREBBP ATR HIPK3 PER3 GPR25
TP53BP1 RASD2 ZHX1 MDM2 MDM4 TAB3 RAD54B NFYA JUND HIST2H2AB
PTK2B ESR1 DDX5 CDC25A TFCP2 SUMO2 CDS1 BCCIP NR2C2 ZNF280B
HSPA5 DCLRE1A CASP7 XRCC3 ZCCHC8 JUNB UBE2U IKBKB DCLRE1C
NR5A2 SMARCA4 RCOR1 CTBP1 SMAD3 IKBKG GTF2B APOL2 CNTN2 TAOK3
SLC9A3 ATG12 HDAC2 RALBP1 CBR3 PPARA VRK2 HDAC1 ULK1 DEDD
CLSPN AKT1 AURKB TACC1 DAXX MRAS PBK RBBP4 ERCC6 TP63 C1orf131
KPNA2 TP53INP1 VRK1 YWHAH EME1
Number of genes inside the community: 87
********************Generation 1********************
Generation’s average fitness: 0.11793895337436579
Generation’s best fitness: 0.16175507531106745
Generation’s best individual:
[0, 7, 6, 2, 1, 1, 6, 7, 5, 5, 5, 6, 2, 0, 1, 0, 1, 7, 4, 3, 1, 7, 1, 4, 7, 0, 2, 3, 2, 6, 4, 1,
4, 1, 4, 6, 6, 7, 3, 5, 6, 6, 7, 0, 5, 5, 1, 3, 7, 7, 0, 3, 2, 7, 4, 1, 3, 3, 7, 3, 6, 3, 3, 1, 2,
3, 4, 1, 1, 7, 0, 2, 2, 3, 4, 5, 1, 5, 2, 3, 4, 4, 2, 3, 3, 7, 5, 0, 1, 4, 5, 4, 6, 1, 0, 0, 1, 7,
6, 2, 7, 6, 4, 1, 4, 5, 3, 6, 3, 6, 1, 0, 3, 7, 0, 4, 2, 7, 4, 7, 0, 7, 5, 3, 7, 7, 0, 2, 0, 5, 3,
6, 5, 3, 3, 3, 0, 4, 4, 7, 2, 1, 5, 7, 1, 4, 2, 5, 0, 2, 3, 5, 3, 2, 3, 0, 4, 6, 2, 7, 0, 2, 6, 7,
3, 4, 7, 5, 1, 4, 0, 5, 4, 0, 3, 7, 2, 5, 7, 0, 4, 0, 3, 3, 2, 6, 1, 3, 0, 1, 3, 1, 4, 2, 7, 4, 4,
4, 0, 1, 0, 0, 1, 5, 5, 1, 4, 2, 2, 1, 1, 1, 7, 3, 0, 0, 7, 2, 3, 7, 4, 4, 2, 1, 2, 1, 5, 2, 7, 2,
2, 6, 3, 7, 2, 4, 1, 0, 2, 3, 3, 2, 6, 5, 2, 7, 0, 0, 6, 6, 2, 2, 5, 3, 5, 6, 4, 4, 0, 2, 1, 0, 0,
3, 4, 1, 0, 1, 5, 0, 1, 4, 5, 4, 4, 6, 2, 0, 1, 2, 5, 3, 1, 7, 5, 4, 1, 4, 6, 3, 1, 2, 3, 0, 0, 6,
5, 5, 2, 1, 5, 1, 7, 5, 1, 4, 0, 3, 0, 7, 0, 3, 6, 4, 7, 3, 5, 1, 7, 2, 5, 2, 1, 2, 2, 1, 5, 3, 1,
4, 5, 1, 1, 3, 5, 0, 5, 5, 3, 1, 0, 3, 2, 7, 0, 5, 3, 2, 6, 4, 6, 7, 4, 2, 3, 6, 5, 0, 0, 4, 0, 2,
1, 0, 0, 4, 6, 0, 3, 0, 2, 0, 4, 2, 0, 0, 1, 4, 7, 0, 1, 5, 1, 2, 2, 4, 4, 0, 1, 1, 6, 1, 5, 5, 3,
5, 1, 6, 1, 7, 6, 6, 5, 1, 2, 5, 2, 4, 4, 6, 6, 5, 0, 7, 4, 0, 3, 5, 0, 1, 7, 3, 2, 6, 3, 4, 4, 4,
4, 5, 1, 2, 7, 7, 1, 0, 2, 0, 6, 7, 2, 2, 3, 2, 4, 7, 3, 5, 2, 1, 3, 3, 0, 2, 0, 0, 7, 0, 0, 4, 5,
5, 2, 0, 6, 2, 5, 1, 4, 2, 5, 3, 4, 0, 5, 0, 1, 2, 7, 6, 1, 6, 4, 6, 1, 5, 5, 5, 4, 7, 4, 1, 1, 3,
7, 2, 1, 5, 4, 3, 4]
Generation’s best community (list of genes):
ATAD2 MAST2 LRIT3 H2AFX RAD9A AP2M1 NCOA4 WRN BAP1 SPDEF
RAD51AP1 RRM2B RAD50 SUMO1 MDC1 DBNL HSPA1A MAGEB18 RRM1
UBE2I TP53BP1 MAGI3 IRS4 ESR1 GSK3B TSSK1B NOL3 FANCE SUMO2 CDS1
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BCCIP ZNF280B SP1 COX5B MSH3 CUL9 PTK2 RB1 DENND5A NCL HIST3H3
TIPARP CTBP1 RNF14 PPM1B CASP6 PPP2R2B JUN GPS2 MAP2K6 CNTN2
FANCI DNAJA3 FASLG DDX17 AIMP2 MARK1 FANCF EEF2 FOXA1 KRAS
HDAC1 PATZ1 NR4A1 NOD1 NRIP1 TRAF2 TP53INP1 PGR SAFB FBXO11
TOP2A DRD2
Number of genes inside the community: 73
********************Generation 2********************
Generation’s average fitness: 0.12043707089977106
Generation’s best fitness: 0.15571428571428572
Generation’s best individual:
[0, 7, 4, 6, 5, 6, 4, 7, 1, 3, 3, 3, 0, 3, 2, 1, 6, 2, 7, 0, 1, 3, 3, 6, 7, 1, 6, 3, 1, 7, 5, 1,
6, 4, 7, 2, 0, 0, 4, 6, 6, 6, 5, 0, 5, 7, 2, 4, 2, 7, 2, 2, 4, 7, 5, 1, 0, 0, 5, 3, 5, 3, 6, 7, 0,
3, 4, 2, 5, 4, 4, 7, 1, 3, 1, 1, 7, 2, 3, 1, 7, 3, 0, 7, 3, 2, 0, 0, 2, 7, 7, 2, 3, 2, 4, 3, 5, 1,
2, 6, 1, 1, 1, 2, 3, 5, 3, 3, 1, 0, 6, 7, 0, 2, 1, 0, 6, 2, 4, 4, 1, 7, 6, 0, 6, 4, 3, 5, 1, 6, 2,
2, 5, 1, 0, 0, 1, 7, 5, 2, 0, 5, 5, 2, 5, 7, 7, 1, 0, 0, 0, 1, 2, 2, 6, 3, 5, 0, 0, 3, 0, 4, 4, 6,
2, 6, 6, 2, 3, 3, 1, 2, 6, 6, 7, 3, 1, 1, 4, 2, 7, 3, 2, 4, 4, 0, 5, 5, 2, 4, 7, 7, 1, 5, 2, 1, 1,
4, 0, 7, 3, 7, 3, 4, 2, 6, 3, 1, 0, 3, 2, 5, 1, 0, 5, 3, 3, 6, 7, 0, 4, 1, 1, 0, 5, 5, 5, 6, 1, 0,
7, 1, 6, 7, 1, 2, 2, 1, 2, 3, 1, 2, 5, 0, 1, 5, 3, 3, 5, 6, 3, 3, 3, 6, 7, 0, 3, 1, 3, 4, 7, 0, 3,
0, 2, 4, 3, 4, 7, 7, 0, 7, 3, 6, 5, 0, 0, 2, 5, 7, 1, 1, 1, 2, 6, 1, 3, 2, 0, 4, 5, 0, 1, 5, 6, 3,
2, 6, 4, 4, 5, 6, 2, 6, 2, 5, 3, 4, 4, 7, 6, 5, 7, 3, 6, 1, 2, 7, 4, 4, 6, 7, 2, 7, 3, 1, 2, 7, 5,
2, 0, 3, 2, 2, 2, 0, 1, 5, 1, 5, 6, 0, 1, 0, 0, 4, 5, 5, 2, 4, 7, 6, 0, 1, 7, 4, 2, 3, 2, 2, 3, 5,
7, 7, 0, 7, 0, 3, 0, 2, 6, 5, 7, 2, 0, 7, 3, 5, 3, 6, 2, 3, 6, 5, 4, 4, 3, 6, 4, 3, 7, 2, 7, 4, 1,
6, 1, 3, 5, 7, 2, 7, 7, 5, 6, 0, 0, 0, 0, 3, 3, 0, 3, 6, 7, 7, 2, 3, 4, 3, 4, 2, 6, 5, 7, 5, 0, 3,
4, 6, 5, 1, 4, 1, 4, 6, 2, 3, 6, 7, 5, 3, 4, 4, 0, 1, 0, 6, 5, 3, 7, 5, 1, 6, 7, 2, 7, 2, 3, 5, 4,
4, 6, 1, 4, 3, 7, 5, 6, 2, 1, 3, 0, 7, 0, 7, 0, 3, 4, 1, 1, 4, 4, 6, 2, 4, 2, 1, 1, 3, 2, 7, 3, 6,
6, 0, 3, 5, 4, 6, 2]
Generation’s best community (list of genes):
FRK APPL1 RAD9A TAB2 TDP1 NCOA4 SPDEF KAT5 CSTF1 ESRRB ING5
KAT2B BACH1 E2F1 CUL3 PPP1R13L VDR ABL1 NUFIP1 GPR25 NCOA1 HSBP1
PLK3 FEZ1 MRE11A MSH6 RELA CDC25A PTN GSN HSP90AA1 BAG1 NR2C2
BCL2 RAD51B IL17RD CASP7 PRMT1 ING4 MAST1 RCHY1 POU2F1 NCL MAP4K4
PRKDC NR1H4 JUN NKX2-1 NR3C1 RECQL5 SMAD6 MRPS34 FOXA1 ETS2
HTT DARS BID ERCC6 PPP2R5D NR2C1 PGR MED17 SHISA5
Number of genes inside the community: 63
********************Generation 3********************
Generation’s average fitness: 0.12294180279277041
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Generation’s best fitness: 0.15876288659793814
Generation’s best individual: [1, 5, 5, 0, 7, 6, 2, 6, 3, 3, 1, 1, 0, 6, 2, 3, 1, 2, 3, 6,
6, 1, 2, 5, 0, 7, 6, 3, 6, 5, 1, 5, 5, 3, 4, 0, 5, 4, 2, 7, 4, 1, 3, 0, 0, 3, 1, 4, 0, 5, 2, 0, 6,
5, 2, 7, 2, 3, 2, 7, 6, 4, 7, 1, 6, 3, 0, 4, 0, 3, 6, 7, 4, 2, 4, 0, 0, 3, 0, 2, 4, 7, 1, 5, 5, 5,
3, 6, 7, 0, 0, 1, 5, 4, 5, 4, 1, 6, 4, 0, 5, 1, 1, 6, 0, 4, 4, 2, 6, 1, 3, 0, 1, 4, 6, 4, 0, 5, 6,
5, 6, 3, 5, 4, 7, 7, 0, 5, 3, 6, 7, 1, 0, 0, 1, 2, 6, 0, 2, 2, 2, 1, 2, 5, 0, 3, 7, 7, 1, 1, 5, 0,
5, 2, 2, 1, 2, 2, 4, 1, 5, 2, 2, 1, 3, 3, 6, 6, 0, 2, 1, 0, 5, 7, 6, 7, 6, 1, 5, 3, 1, 1, 2, 2, 7,
4, 2, 5, 0, 6, 0, 7, 5, 2, 6, 3, 7, 0, 5, 4, 0, 4, 0, 6, 1, 7, 4, 3, 5, 0, 6, 4, 1, 7, 6, 4, 0, 2,
1, 5, 6, 0, 0, 7, 6, 0, 1, 7, 1, 5, 1, 5, 3, 1, 0, 7, 2, 2, 4, 2, 6, 7, 4, 0, 5, 5, 3, 0, 3, 5, 2,
3, 0, 6, 3, 0, 6, 4, 7, 7, 3, 4, 3, 6, 6, 5, 0, 2, 7, 0, 0, 1, 6, 4, 1, 7, 1, 0, 2, 0, 0, 2, 2, 3,
5, 0, 5, 7, 4, 5, 2, 7, 5, 0, 5, 7, 2, 7, 1, 5, 5, 3, 6, 3, 7, 3, 6, 3, 7, 1, 5, 0, 3, 0, 1, 5, 6,
0, 7, 5, 6, 6, 5, 1, 6, 3, 0, 7, 1, 2, 6, 2, 5, 2, 0, 4, 6, 0, 4, 2, 7, 5, 1, 3, 7, 7, 6, 6, 3, 6,
5, 7, 6, 7, 6, 0, 1, 2, 3, 3, 2, 3, 5, 6, 4, 3, 4, 3, 0, 0, 5, 2, 0, 1, 0, 0, 7, 4, 3, 5, 7, 2, 3,
4, 7, 6, 7, 5, 5, 7, 5, 0, 5, 0, 1, 0, 0, 1, 7, 5, 7, 0, 6, 5, 1, 6, 4, 4, 7, 6, 4, 4, 1, 4, 7, 4,
4, 5, 6, 4, 2, 1, 6, 5, 1, 2, 3, 3, 4, 5, 7, 5, 2, 3, 7, 0, 5, 1, 1, 1, 0, 3, 2, 6, 6, 2, 2, 6, 6,
3, 5, 5, 3, 4, 0, 5, 6, 4, 3, 3, 1, 0, 4, 1, 4, 6, 5, 1, 1, 4, 6, 7, 6, 0, 5, 5, 1, 6, 7, 3, 6, 5,
4, 6, 2, 2, 7, 1, 3, 5, 2, 5, 0, 2, 7, 0, 6, 3, 3, 5, 7]
Generation’s best community (list of genes):
6885 PALB2 NBN H2AFX FAS FANCD2 AP1B1 BAP1 RAD51AP1 MRC1 HRAS
HSPA1A E2F1 CUL3 MVP ATR RBBP8 PIAS1 UBE2I RAD54L RASD2 TERF2
MDM4 RNF4 FEZ1 MSH6 UIMC1 MOB4 EP300 HSP90AA1 CHUK SAFB2 BCL2
WNT2B DCLRE1A ESRRA CCND1 IKBKB AIF1 SMAD3 CDC14B CHEK1 GPS2
RECQL5 PAK6 CBR3 MRPS34 AURKA ULK1 SLC9A3R2 CLSPN EVL RHEBL1
AKT1 SETD7 ETS1 ERCC6 TRAF2 TIRAP TP53INP1 MED17
Number of genes inside the community: 61
********************Generation 4********************
Generation’s average fitness: 0.125389003768463
Generation’s best fitness: 0.15843023255813954
Generation’s best individual:
[0, 4, 2, 2, 1, 0, 6, 2, 5, 0, 0, 6, 5, 0, 6, 0, 0, 2, 4, 5, 2, 4, 2, 2, 5, 0, 5, 4, 2, 0, 5, 5,
6, 2, 2, 0, 7, 4, 2, 3, 1, 7, 1, 3, 5, 4, 1, 6, 5, 3, 7, 2, 5, 7, 0, 6, 7, 6, 1, 2, 2, 4, 1, 2, 3,
3, 3, 0, 5, 7, 0, 3, 1, 1, 3, 6, 1, 6, 3, 2, 5, 6, 2, 6, 6, 6, 5, 1, 7, 2, 6, 3, 6, 4, 3, 1, 2, 5,
7, 0, 4, 6, 3, 4, 0, 7, 4, 0, 0, 2, 5, 2, 3, 5, 0, 7, 3, 4, 6, 1, 1, 6, 7, 3, 1, 1, 3, 6, 0, 0, 1,
1, 4, 5, 1, 3, 1, 5, 0, 1, 5, 1, 2, 5, 7, 0, 1, 4, 6, 3, 1, 7, 6, 7, 4, 7, 2, 1, 7, 1, 2, 3, 1, 6,
2, 7, 3, 0, 3, 3, 1, 1, 1, 7, 0, 1, 0, 5, 1, 4, 2, 1, 0, 7, 0, 5, 6, 0, 6, 0, 6, 0, 7, 3, 6, 0, 3,
4, 1, 2, 3, 0, 7, 1, 3, 7, 3, 7, 0, 4, 7, 0, 4, 4, 3, 6, 5, 7, 6, 1, 4, 2, 4, 3, 6, 5, 6, 5, 6, 0,
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4, 6, 6, 4, 4, 3, 3, 0, 2, 1, 1, 7, 6, 3, 6, 6, 4, 5, 7, 3, 3, 5, 1, 4, 7, 2, 6, 5, 5, 2, 4, 4, 0,
7, 5, 0, 5, 2, 1, 7, 1, 3, 5, 5, 6, 4, 7, 4, 1, 7, 0, 5, 0, 2, 7, 4, 7, 3, 1, 7, 7, 3, 5, 0, 3, 1,
6, 2, 2, 6, 1, 5, 4, 3, 6, 4, 7, 3, 6, 6, 6, 3, 5, 0, 6, 2, 7, 4, 4, 5, 6, 5, 2, 4, 0, 6, 3, 6, 5,
7, 6, 5, 5, 6, 4, 6, 2, 6, 1, 6, 7, 4, 6, 5, 2, 3, 6, 5, 7, 6, 0, 2, 1, 3, 5, 4, 4, 5, 0, 7, 2, 4,
1, 7, 5, 1, 6, 4, 5, 0, 5, 3, 7, 7, 5, 3, 1, 4, 4, 5, 7, 6, 5, 2, 3, 5, 7, 3, 1, 3, 7, 3, 2, 6, 7,
3, 4, 3, 7, 2, 4, 5, 3, 3, 0, 4, 7, 3, 3, 3, 5, 7, 6, 1, 3, 4, 4, 5, 1, 6, 1, 3, 0, 0, 0, 1, 3, 4,
2, 6, 4, 2, 5, 0, 6, 1, 7, 0, 2, 2, 3, 4, 4, 3, 1, 6, 7, 0, 2, 1, 5, 5, 3, 1, 5, 5, 2, 7, 7, 1, 3,
7, 2, 2, 0, 1, 0, 2, 7, 7, 2, 6, 3, 5, 3, 5, 4, 0, 2, 4, 7, 3, 3, 0, 5, 4, 3, 2, 2, 4, 3, 5, 3, 7,
4, 2, 6, 6, 3, 4, 1]
Generation’s best community (list of genes):
ATAD2 RECQL4 STRADB BAP1 VCP SNRK KAT5 ATG13 SUMO1 THRB
TFAP2C ING1 ABL1 RPA1 FOXO3 TMF1 RBBP8 PIAS1 NCOA1 MED1 UBE2I
GCN1L1 ETV5 MDM2 MDM4 CDHR2 FEZ1 C11orf30 PSMB9 TOPBP1 HIST2H2AB
MOB4 FANCA GPRASP2 TNFSF10 TIMM13 PRMT1 DNAJC7 TOP3A RB1 DENND5A
BRE SMARCA4 APEX1 NR3C1 BCL3 DNAJA3 TINF2 FASLG MARK1 SER-
PINH1 RARA TNFRSF1A REV3L PPARG MRAS NRIP1 STAT5A PPP2R5C PEA15
PDGFRB
Number of genes inside the community: 61
********************Generation 5********************
Generation’s average fitness: 0.1278126863951778
Generation’s best fitness: 0.17342657342657342
Generation’s best individual:
[3, 3, 3, 6, 6, 1, 6, 4, 0, 5, 2, 5, 1, 5, 2, 4, 7, 3, 3, 0, 1, 7, 7, 4, 0, 6, 2, 1, 6, 1, 7, 6,
7, 5, 6, 6, 6, 5, 4, 2, 0, 4, 6, 1, 0, 2, 2, 7, 0, 3, 4, 3, 6, 7, 2, 7, 6, 5, 7, 2, 2, 1, 6, 0, 5,
4, 3, 5, 6, 5, 3, 7, 2, 1, 3, 2, 1, 3, 2, 3, 0, 1, 1, 2, 7, 5, 6, 5, 5, 7, 2, 4, 6, 7, 2, 4, 4, 6,
6, 3, 1, 1, 6, 0, 0, 6, 3, 6, 0, 5, 4, 3, 1, 1, 6, 2, 7, 2, 2, 7, 0, 0, 4, 5, 1, 5, 7, 4, 5, 0, 2,
0, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 3, 5, 3, 2, 4, 0, 6, 5, 5, 6, 1, 1, 1, 2, 4, 4, 0, 3, 7, 2, 0, 4,
3, 2, 7, 4, 7, 0, 4, 3, 2, 5, 7, 3, 0, 5, 7, 1, 3, 4, 2, 4, 3, 4, 4, 4, 4, 3, 7, 7, 6, 3, 6, 7, 1,
0, 3, 7, 5, 2, 7, 5, 0, 0, 0, 4, 3, 1, 2, 5, 6, 4, 0, 3, 5, 3, 6, 2, 4, 7, 3, 3, 6, 1, 3, 1, 0, 0,
4, 4, 5, 7, 7, 7, 5, 3, 3, 4, 3, 3, 7, 1, 4, 7, 4, 7, 7, 3, 6, 4, 7, 4, 0, 4, 1, 2, 1, 3, 7, 0, 2,
7, 1, 1, 5, 1, 2, 1, 0, 4, 7, 4, 0, 0, 6, 5, 4, 3, 3, 2, 3, 1, 5, 3, 0, 2, 4, 5, 2, 4, 6, 2, 7, 4,
6, 3, 7, 0, 0, 4, 6, 4, 6, 4, 1, 5, 1, 1, 2, 1, 7, 7, 7, 7, 6, 0, 5, 0, 2, 0, 3, 4, 7, 4, 6, 0, 5,
6, 2, 0, 5, 0, 3, 5, 0, 7, 4, 6, 2, 2, 0, 0, 4, 7, 3, 3, 0, 0, 3, 0, 0, 6, 5, 0, 0, 5, 6, 6, 0, 7,
0, 1, 2, 0, 5, 5, 1, 3, 1, 1, 5, 0, 0, 2, 2, 4, 2, 7, 6, 1, 1, 6, 1, 3, 0, 5, 4, 6, 5, 2, 0, 0, 3,
6, 2, 0, 4, 6, 6, 7, 2, 1, 6, 6, 6, 6, 2, 2, 3, 3, 1, 2, 3, 1, 1, 2, 1, 4, 7, 1, 5, 2, 3, 3, 4, 1,
0, 3, 3, 3, 7, 6, 4, 2, 4, 2, 0, 7, 2, 4, 4, 1, 7, 1, 5, 5, 1, 4, 3, 6, 4, 3, 0, 7, 1, 0, 7, 5, 4,
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3, 3, 2, 2, 2, 4, 3, 7, 4, 7, 5, 0, 3, 3, 3, 2, 6, 1, 5, 2, 3, 6, 1, 2, 4, 5, 5, 3, 2, 4, 3, 4, 0,
1, 0, 5, 0, 2, 5, 1]
Generation’s best community (list of genes):
MAST2 RAD52 RAD9A CDK19 FKBP5 ATF1 TOPORS ATG13 SUMO1 RPA2
MRC1 BACH1 E2F1 ATR HIPK3 RPA1 PIAS1 UBE2I FAM175A CASP1 ATN1
RPL5 PTN SUMO2 SP1 YLPM1 HMG20B JUNB RASGRP3 ACACA CUL9 PTK2
PIAS4 KIAA1377 CDK7 CCNH SMAD3 IKBKG UBE2D3 ATG12 ERCC2 HDAC2
GTF2F1 AIMP2 RPA3 HDAC1 SLC9A3R2 DEDD E2F4 RARA CLSPN RBMX
DAXX DARS RAD54L2 ELK4 IARS HIF1A FAIM2 PDGFRB
Number of genes inside the community: 60
********************Generation 6********************
Generation’s average fitness: 0.1301322682531589
Generation’s best fitness: 0.16981132075471697
Generation’s best individual:
[0, 6, 6, 4, 1, 1, 6, 6, 2, 7, 1, 4, 5, 6, 4, 5, 7, 3, 6, 0, 3, 5, 4, 2, 6, 3, 7, 0, 7, 3, 1, 4,
7, 7, 1, 2, 1, 7, 1, 3, 6, 5, 6, 4, 5, 5, 4, 3, 7, 5, 3, 6, 0, 3, 3, 0, 7, 5, 0, 7, 4, 5, 1, 3, 7,
6, 3, 0, 4, 3, 4, 4, 2, 2, 1, 5, 1, 0, 0, 1, 4, 4, 0, 3, 5, 2, 0, 2, 1, 6, 2, 6, 1, 7, 0, 0, 5, 7,
5, 7, 3, 1, 5, 3, 0, 2, 4, 5, 6, 6, 3, 0, 7, 0, 7, 0, 4, 4, 0, 1, 1, 4, 5, 2, 3, 4, 6, 7, 1, 2, 6,
1, 5, 4, 4, 6, 4, 2, 1, 7, 5, 4, 1, 0, 1, 5, 1, 4, 5, 7, 0, 7, 2, 5, 4, 1, 4, 5, 2, 1, 2, 5, 6, 1,
6, 7, 3, 1, 1, 4, 5, 5, 7, 0, 4, 3, 3, 4, 6, 7, 0, 4, 3, 6, 6, 0, 7, 0, 0, 1, 3, 0, 3, 0, 7, 3, 6,
0, 5, 0, 4, 3, 3, 5, 1, 3, 0, 4, 4, 2, 3, 7, 3, 1, 1, 3, 2, 2, 7, 2, 0, 1, 2, 7, 2, 1, 3, 2, 5, 3,
6, 0, 4, 0, 1, 7, 4, 2, 4, 7, 2, 3, 4, 0, 3, 4, 3, 1, 6, 7, 0, 5, 2, 6, 3, 3, 2, 4, 6, 5, 7, 3, 3,
4, 0, 2, 1, 7, 7, 1, 2, 5, 6, 6, 4, 6, 4, 4, 7, 3, 3, 4, 1, 1, 4, 6, 4, 1, 1, 5, 6, 5, 7, 0, 7, 7,
3, 0, 0, 1, 4, 1, 3, 0, 2, 0, 1, 0, 3, 6, 1, 0, 1, 3, 0, 3, 5, 3, 0, 0, 0, 6, 5, 1, 2, 3, 3, 5, 2,
4, 4, 1, 0, 2, 4, 7, 6, 2, 1, 4, 3, 6, 2, 5, 5, 5, 6, 4, 5, 6, 1, 1, 4, 1, 6, 4, 2, 0, 1, 1, 7, 7,
4, 7, 7, 0, 3, 5, 4, 3, 2, 6, 4, 7, 2, 6, 2, 1, 0, 5, 2, 3, 7, 7, 7, 0, 0, 7, 3, 5, 2, 5, 5, 1, 2,
5, 2, 3, 2, 5, 6, 6, 1, 5, 4, 4, 1, 4, 1, 4, 3, 1, 4, 1, 4, 5, 4, 7, 1, 7, 5, 3, 7, 6, 5, 6, 5, 2,
1, 2, 6, 1, 1, 4, 6, 0, 0, 0, 2, 2, 5, 0, 0, 1, 5, 2, 5, 1, 1, 5, 5, 5, 3, 7, 2, 7, 5, 5, 3, 0, 7,
5, 1, 1, 5, 3, 1, 2, 7, 4, 0, 3, 4, 6, 4, 7, 6, 2, 6, 0, 5, 3, 5, 0, 7, 0, 3, 2, 4, 4, 6, 6, 4, 4,
4, 7, 6, 0, 4, 2, 7]
Generation’s best community (list of genes):
ATAD2 MAST2 PALB2 FANCD2 ERCC6L TAB1 TRAF6 SNRK CSTF1 SUMO1
ING5 MDC1 IKBKAP E2F1 ING1 ABL1 NUFIP1 RBBP8 RHEB MSH2 TP53BP1
GCN1L1 TERF2 MDM4 RNF4 MUS81 MAGI3 ESR1 EP300 CASP3 RYBP BAG1
SP1 IL17RD MED12L SETDB1 PIAS4 NCL KIAA1377 MDN1 BRE CTBP1 RNF14
CDK7 NRG1 PEBP1 CHEK1 MAP2K6 NR3C1 PA2G4 ZMIZ1 SMAD6 MAP4K1
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HMGB1 MAP1LC3C E4F1 DGKZ ATRX NR0B2 SRY SERPINH1 RARA UBA1
ETS2 NAIP DAXX HIPK2 RAD54L2 TERF2IP ERCC6 RAD17
Number of genes inside the community: 71
********************Generation 7********************
Generation’s average fitness: 0.1323757861344664
Generation’s best fitness: 0.1766323024054983
Generation’s best individual:
[0, 7, 6, 7, 4, 4, 6, 6, 6, 2, 4, 2, 2, 4, 0, 0, 1, 5, 3, 0, 5, 0, 0, 3, 7, 4, 3, 3, 0, 0, 1, 5,
4, 5, 4, 3, 0, 5, 5, 3, 1, 4, 7, 4, 6, 0, 5, 3, 4, 6, 5, 1, 6, 0, 1, 3, 4, 1, 3, 7, 3, 5, 2, 6, 4,
0, 0, 7, 1, 0, 0, 4, 0, 7, 3, 7, 0, 4, 5, 1, 6, 2, 0, 6, 3, 4, 0, 2, 2, 1, 7, 1, 0, 0, 3, 1, 1, 1,
5, 0, 3, 1, 4, 4, 1, 4, 6, 4, 2, 3, 2, 7, 4, 3, 6, 2, 3, 7, 6, 7, 1, 5, 6, 4, 0, 3, 2, 7, 0, 6, 1,
1, 4, 6, 5, 6, 0, 7, 2, 7, 2, 4, 6, 2, 1, 1, 6, 3, 2, 2, 6, 0, 5, 3, 7, 0, 6, 0, 4, 6, 3, 0, 0, 4,
0, 3, 0, 2, 6, 3, 4, 4, 7, 0, 1, 1, 1, 7, 4, 2, 6, 5, 7, 7, 2, 0, 7, 5, 6, 7, 4, 1, 2, 3, 5, 3, 1,
7, 6, 5, 6, 2, 7, 1, 7, 6, 6, 5, 3, 1, 1, 6, 0, 0, 7, 7, 0, 2, 2, 2, 7, 0, 4, 6, 2, 2, 7, 5, 5, 3,
4, 6, 7, 4, 7, 2, 1, 4, 6, 2, 5, 0, 2, 6, 3, 0, 0, 3, 3, 7, 4, 4, 7, 4, 6, 4, 7, 2, 6, 6, 5, 3, 1,
4, 2, 7, 5, 2, 3, 2, 1, 2, 5, 4, 5, 0, 4, 6, 7, 3, 2, 3, 2, 0, 7, 2, 1, 3, 1, 1, 7, 2, 1, 7, 1, 1,
7, 6, 1, 0, 7, 0, 5, 5, 4, 1, 1, 4, 3, 6, 5, 1, 5, 4, 0, 5, 2, 2, 4, 0, 7, 4, 0, 1, 5, 7, 4, 5, 1,
5, 6, 3, 7, 2, 7, 3, 7, 5, 3, 3, 4, 1, 0, 0, 0, 1, 2, 3, 0, 4, 7, 6, 3, 2, 2, 1, 5, 5, 7, 1, 4, 5,
7, 7, 0, 1, 6, 5, 6, 3, 3, 3, 0, 3, 1, 7, 2, 6, 0, 6, 1, 2, 2, 5, 4, 0, 3, 2, 7, 0, 4, 4, 5, 2, 2,
1, 0, 0, 6, 1, 3, 4, 5, 5, 7, 3, 3, 4, 4, 6, 4, 1, 6, 0, 4, 3, 7, 6, 4, 2, 6, 3, 4, 6, 6, 3, 7, 6,
1, 3, 6, 4, 1, 3, 2, 6, 6, 2, 4, 0, 0, 5, 2, 3, 3, 0, 5, 5, 2, 0, 6, 5, 2, 0, 4, 7, 6, 3, 1, 3, 0,
4, 5, 6, 0, 0, 3, 7, 7, 4, 5, 5, 3, 7, 4, 1, 5, 0, 3, 4, 7, 0, 5, 7, 0, 2, 7, 1, 5, 3, 1, 7, 1, 2,
6, 0, 0, 5, 1, 6, 7]
Generation’s best community (list of genes):
H2AFX FANCD2 RECQL4 BLM DMC1 TGFB1I1 RAD50 ING5 RIPK3 HRAS
TFAP2C HSPA1A KAT2B E2F1 CREBBP ABL1 TMF1 RBBP8 TP53BP1 BRAP
JUND TOPBP1 MRE11A GSK3B PTN GPRASP2 SUMO2 CDS1 COX5B XRCC6
RB1 HIST3H3 BRE NR1H3 PRKDC NR5A2 SMARCA4 AIF1 PTS CDK7 IKBKG
CHEK1 GPS2 TXN C16orf53 PMEPA1 HMGB1 TINF2 CABLES1 DDX17 BFAR
UBE2L3 SRY UBA1 NAIP UPF1 KPNA2 MED17 RBAK TOP2A CDK1
Number of genes inside the community: 61
********************Generation 8********************
Generation’s average fitness: 0.13455985118457658
Generation’s best fitness: 0.17372881355932204
Generation’s best individual:
[0, 0, 6, 2, 7, 5, 2, 3, 3, 4, 7, 1, 3, 3, 4, 0, 1, 7, 1, 4, 6, 4, 1, 5, 6, 7, 4, 1, 2, 7, 0, 6,
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7, 5, 6, 6, 6, 5, 4, 2, 0, 4, 6, 1, 0, 2, 2, 7, 0, 3, 4, 3, 6, 7, 2, 7, 6, 5, 7, 2, 2, 1, 6, 0, 5,
4, 3, 5, 6, 5, 3, 7, 2, 1, 3, 2, 1, 3, 2, 3, 0, 1, 1, 2, 7, 5, 6, 5, 5, 7, 2, 4, 6, 7, 2, 4, 4, 6,
6, 3, 1, 1, 6, 0, 0, 6, 3, 6, 0, 5, 4, 3, 1, 1, 6, 2, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 6, 6, 4,
6, 1, 3, 4, 6, 2, 6, 7, 1, 5, 7, 1, 4, 6, 2, 0, 5, 4, 4, 7, 0, 4, 4, 6, 5, 7, 5, 4, 1, 4, 3, 0, 6,
2, 1, 6, 4, 7, 6, 4, 0, 7, 6, 0, 5, 0, 4, 3, 6, 6, 2, 0, 0, 5, 5, 3, 4, 0, 7, 4, 7, 4, 2, 4, 6, 5,
1, 7, 1, 4, 0, 1, 2, 2, 4, 2, 7, 5, 4, 5, 5, 1, 3, 0, 5, 2, 6, 3, 7, 6, 4, 7, 2, 1, 1, 1, 7, 6, 2,
5, 6, 7, 7, 5, 5, 1, 4, 1, 7, 7, 4, 7, 2, 2, 5, 3, 4, 0, 3, 5, 4, 5, 4, 2, 7, 6, 5, 6, 3, 4, 7, 1,
3, 2, 0, 7, 7, 0, 5, 3, 4, 4, 0, 7, 4, 5, 1, 4, 6, 6, 1, 6, 4, 5, 7, 2, 7, 0, 5, 6, 3, 1, 6, 7, 6,
4, 2, 2, 5, 6, 5, 4, 7, 3, 7, 1, 1, 1, 2, 3, 1, 0, 1, 6, 7, 5, 3, 2, 6, 4, 5, 5, 1, 4, 2, 0, 2, 6,
2, 5, 0, 5, 3, 3, 4, 3, 2, 6, 3, 1, 1, 0, 7, 5, 4, 0, 1, 5, 5, 4, 2, 6, 6, 1, 7, 2, 6, 0, 1, 1, 4,
4, 6, 3, 3, 7, 0, 0, 2, 1, 2, 0, 7, 6, 5, 0, 6, 5, 2, 5, 6, 3, 4, 6, 2, 3, 3, 4, 4, 0, 3, 5, 5, 5,
1, 5, 2, 1, 1, 0, 1, 7, 0, 7, 0, 3, 5, 7, 4, 6, 5, 4, 2, 1, 4, 3, 3, 2, 4, 7, 2, 4, 7, 6, 2, 7, 0,
3, 1, 1, 0, 2, 4, 2, 5, 7, 6, 4, 3, 3, 7, 0, 2, 5, 6, 1, 3, 7, 4, 2, 1, 5, 2, 3, 3, 3, 5, 3, 5, 4,
2, 4, 7, 6, 0, 3, 0, 3, 4, 2, 6, 3, 3, 3, 5, 2, 3, 2, 7, 6, 3, 6, 6, 1, 1, 7, 6, 2, 6, 5, 2, 6, 1,
3, 5, 2, 6, 3, 5, 5]
Generation’s best community (list of genes):
NBN H2AFX LGTN AP2M1 CDK19 ATF1 TOPORS ATG13 SUMO1 RPA2
MRC1 BACH1 E2F1 ATR HIPK3 ABL1 RPA1 PER3 PPM1L MED1 MSH2 MDM4
RAD54B TRADD TSSK1B NOL3 HSP90AA1 HSPA5 SP1 SAFB2 COX5B CHD3
XRCC6 PLK1 POU2F1 PRKDC CDK7 CASP14 CCNH IKBKG ERCC3 CHEK1
RFWD2 TXN BUB1B XIAP HMGB1 SLC9A3 ERCC2 BFAR KRAS UBE2L3 MARK2
CSNK2A2 PPP2R2A NR4A1 PBK RBBP4 SAFB PARN NR2F1
Number of genes inside the community: 61
********************Generation 9********************
Generation’s average fitness: 0.1369551159777728
Generation’s best fitness: 0.17246273953158267
Generation’s best individual:
[7, 0, 7, 1, 5, 0, 6, 7, 0, 1, 0, 2, 3, 2, 2, 0, 2, 4, 5, 5, 2, 6, 1, 7, 0, 0, 4, 4, 3, 1, 3, 7,
2, 2, 7, 6, 3, 1, 5, 6, 0, 4, 3, 2, 7, 2, 0, 4, 6, 4, 1, 3, 6, 4, 2, 3, 4, 1, 7, 7, 5, 6, 2, 2, 2,
4, 0, 7, 4, 6, 6, 2, 5, 4, 1, 7, 0, 2, 0, 3, 0, 3, 6, 6, 6, 0, 5, 1, 1, 4, 1, 5, 5, 4, 7, 4, 7, 1,
6, 2, 7, 6, 2, 5, 1, 4, 4, 3, 3, 0, 0, 6, 6, 6, 1, 3, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 6, 1, 7,
4, 5, 2, 1, 7, 4, 1, 3, 1, 6, 4, 1, 5, 1, 1, 6, 7, 2, 7, 0, 0, 6, 5, 7, 4, 1, 1, 7, 4, 5, 1, 0, 0,
6, 2, 2, 3, 5, 0, 3, 1, 5, 7, 6, 6, 2, 0, 3, 7, 2, 0, 0, 5, 6, 4, 5, 6, 1, 6, 3, 6, 6, 4, 3, 0, 3,
5, 3, 1, 5, 7, 1, 6, 6, 0, 7, 4, 6, 7, 6, 7, 4, 5, 4, 3, 6, 3, 2, 0, 2, 3, 1, 6, 0, 2, 0, 6, 4, 1,
5, 1, 7, 4, 4, 6, 6, 5, 1, 6, 6, 7, 7, 0, 2, 4, 6, 6, 4, 3, 5, 0, 2, 5, 4, 4, 4, 6, 3, 2, 0, 5, 5,
1, 3, 7, 3, 5, 0, 0, 1, 0, 6, 2, 0, 3, 4, 7, 3, 2, 7, 0, 4, 4, 6, 7, 7, 3, 7, 4, 3, 6, 3, 2, 5, 6,
APPENDIX A. SAMPLE OUTPUT OF GENETIC ALGORITHM 66
5, 2, 3, 1, 1, 5, 4, 3, 6, 4, 7, 3, 6, 6, 6, 3, 5, 0, 6, 2, 7, 4, 4, 5, 6, 5, 2, 4, 0, 6, 3, 6, 5,
7, 6, 5, 0, 3, 7, 2, 6, 6, 1, 3, 6, 0, 2, 3, 4, 6, 7, 3, 3, 1, 4, 3, 7, 7, 1, 7, 3, 3, 0, 2, 7, 7,
5, 0, 7, 5, 4, 2, 4, 3, 2, 2, 7, 7, 7, 1, 6, 3, 4, 0, 5, 4, 1, 3, 4, 4, 5, 5, 2, 3, 0, 4, 0, 4, 4,
7, 0, 7, 3, 6, 2, 5, 3, 1, 7, 4, 6, 7, 1, 2, 7, 3, 1, 1, 5, 7, 5, 4, 3, 4, 4, 3, 4, 4, 4, 3, 4, 0,
1, 2, 2, 1, 2, 0, 7, 1, 5, 0, 6, 3, 0, 4, 2, 2, 5, 1, 6, 7, 5, 1, 2, 6, 4, 2, 2, 2, 4, 2, 3, 5, 3,
7, 2, 0, 6, 2, 1, 5, 1, 7, 7, 3, 7, 3, 0, 1, 0, 3, 3, 4, 3, 4, 4, 6, 5, 5, 7, 1, 0, 3, 0, 5, 1, 2,
1, 0, 4, 3, 2, 2, 2]
Generation’s best community (list of genes):
PRKAA2 BRIP1 AP2M1 FKBP5 RXRB PLAGL1 TGFB1I1 CSTF1 THRB MDC1
BRD7 KAT2B CREBBP VDR ABL1 RPA1 PER3 CXXC5 PIAS1 IFI16 MED1
MSH2 TP53BP1 BRAP ZHX1 MDM2 RARG C11orf30 RASA4 TSSK1B NOL3
NR2C2 MCPH1 RAD51B CHD3 LRIF1 RB1 CTBP1 APEX1 NR3C1 UBE3A XIAP
ARHGEF1 AIMP2 HDAC1 NR0B2 SLC9A3R2 SERPINH1 UBA1 ETS2 PPARG
DARS NRIP1 RAD17 TIRAP KPNA2 MED17 TOP2A FAIM2
Number of genes inside the community: 59
********************Generation 10********************
Generation’s average fitness: 0.13936486620546543
Generation’s best fitness: 0.17532467532467533
Generation’s best individual:
[0, 2, 4, 1, 1, 4, 6, 4, 0, 5, 2, 5, 1, 3, 0, 4, 4, 0, 6, 0, 1, 3, 7, 4, 7, 6, 4, 1, 6, 1, 7, 4,
4, 1, 0, 6, 0, 5, 5, 6, 6, 1, 3, 0, 5, 3, 3, 1, 1, 2, 2, 4, 6, 3, 0, 1, 3, 7, 2, 6, 3, 5, 7, 6, 0,
1, 2, 7, 3, 4, 0, 4, 7, 1, 4, 7, 5, 7, 2, 6, 4, 1, 2, 0, 2, 6, 2, 6, 3, 3, 6, 2, 0, 7, 4, 0, 4, 3,
2, 3, 3, 6, 0, 2, 3, 6, 3, 4, 2, 2, 1, 2, 4, 2, 1, 4, 0, 3, 2, 2, 1, 4, 7, 6, 1, 4, 6, 1, 2, 5, 5,
6, 5, 0, 3, 3, 1, 3, 1, 2, 1, 1, 2, 4, 7, 3, 5, 5, 3, 7, 1, 6, 0, 1, 2, 6, 4, 3, 5, 3, 0, 1, 5, 1,
7, 6, 6, 0, 4, 1, 6, 6, 2, 7, 6, 7, 0, 1, 7, 1, 6, 7, 0, 2, 5, 5, 1, 4, 4, 1, 7, 7, 6, 2, 4, 4, 5,
7, 3, 5, 7, 7, 4, 7, 0, 3, 2, 3, 6, 3, 7, 2, 5, 4, 1, 1, 0, 1, 1, 5, 7, 3, 1, 0, 7, 4, 1, 4, 6, 2,
5, 0, 2, 3, 5, 7, 5, 7, 1, 5, 0, 6, 0, 4, 4, 4, 4, 5, 4, 6, 4, 4, 2, 4, 3, 2, 4, 2, 6, 7, 1, 5, 1,
6, 3, 4, 5, 3, 7, 1, 7, 1, 6, 6, 5, 2, 3, 1, 7, 6, 6, 4, 0, 5, 2, 7, 2, 3, 2, 3, 4, 3, 3, 1, 0, 3,
3, 5, 3, 4, 0, 5, 7, 1, 5, 0, 0, 3, 3, 1, 3, 0, 4, 2, 4, 2, 5, 0, 0, 4, 3, 0, 1, 6, 1, 5, 5, 5, 1,
3, 5, 6, 7, 3, 0, 6, 7, 5, 1, 6, 6, 4, 2, 0, 6, 6, 5, 2, 2, 2, 0, 6, 5, 5, 0, 3, 0, 1, 2, 3, 2, 6,
1, 3, 2, 4, 0, 5, 1, 1, 4, 2, 4, 2, 0, 7, 7, 1, 3, 3, 3, 5, 4, 1, 0, 2, 2, 6, 2, 1, 2, 2, 4, 6, 2,
0, 1, 7, 7, 6, 4, 0, 4, 3, 1, 5, 6, 7, 4, 6, 6, 2, 6, 7, 2, 5, 2, 0, 4, 0, 6, 2, 7, 0, 7, 6, 0, 6,
2, 3, 2, 0, 1, 4, 5, 1, 6, 4, 4, 6, 5, 2, 3, 1, 3, 2, 5, 2, 6, 6, 0, 1, 3, 1, 5, 1, 3, 2, 5, 6, 1,
7, 1, 5, 1, 0, 4, 1, 2, 6, 2, 6, 2, 3, 0, 4, 5, 1, 4, 7, 3, 7, 6, 4, 1, 1, 3, 1, 1, 7, 7, 5, 5, 7,
7, 5, 2, 2, 2, 0, 3]
Generation’s best community (list of genes):
APPENDIX A. SAMPLE OUTPUT OF GENETIC ALGORITHM 67
PRKAA2 ATAD2 RAD52 RAD9A CDK19 FKBP5 WRN AP1B1 ERBB3 OTUD7B
SPDEF FADD ATG13 RPA2 RRM1 VDR ABL1 RPA1 RAD51AP2 NCOA1 RHEB
NTHL1 UBE2I ETV5 CASP1 RARG RNF4 NFYA MSH6 RPL5 IRS4 ESR1 RYBP
ULK2 IRS1 CHUK NR2C2 SAFB2 CHD3 MSH3 XRCC6 PIAS4 ESRRA PLK1
DCLRE1C CFLAR SMAD3 PPP2R2B GTF2B GPS2 NR3C1 SRA1 DNAJA3 ATG12
XRCC1 MAP1LC3C ZNF350 FANCF FOXA1 ULK1 NAIP PPARG DAXX RBBP4
STAT5A MAP3K5 ETS1 TERF2IP PTTG1 TRAF2 TICAM1 SAFB PARN MED17
SHISA5
Number of genes inside the community: 75
********************Generation 11********************
Generation’s average fitness: 0.1412690438334024
Generation’s best fitness: 0.17893315327481432
Generation’s best individual:
[4, 3, 3, 2, 4, 2, 5, 5, 7, 4, 6, 6, 6, 1, 3, 3, 1, 0, 5, 5, 1, 2, 0, 4, 7, 0, 0, 6, 0, 7, 1, 6,
7, 7, 2, 3, 0, 3, 2, 0, 3, 5, 7, 1, 1, 7, 7, 3, 2, 5, 6, 2, 5, 5, 0, 7, 2, 4, 2, 7, 6, 7, 1, 1, 5,
4, 3, 5, 6, 5, 3, 7, 2, 1, 3, 2, 1, 3, 2, 3, 0, 1, 1, 2, 7, 5, 6, 5, 5, 7, 2, 4, 6, 7, 2, 4, 4, 6,
6, 3, 1, 1, 6, 0, 0, 6, 3, 6, 0, 5, 4, 3, 1, 1, 6, 2, 7, 2, 2, 7, 0, 0, 4, 5, 1, 5, 7, 4, 5, 0, 2,
0, 4, 0, 1, 5, 0, 4, 0, 0, 0, 2, 1, 6, 6, 1, 4, 2, 0, 2, 6, 5, 1, 0, 0, 6, 6, 1, 4, 1, 0, 3, 7, 5,
5, 3, 3, 1, 4, 3, 7, 1, 3, 5, 4, 1, 1, 6, 7, 7, 0, 0, 7, 7, 6, 6, 6, 0, 7, 7, 4, 4, 1, 6, 6, 5, 3,
4, 4, 4, 1, 4, 5, 7, 1, 7, 6, 2, 7, 3, 2, 0, 7, 1, 2, 4, 7, 4, 5, 2, 4, 3, 0, 4, 6, 1, 4, 7, 7, 6,
6, 3, 5, 5, 0, 1, 6, 5, 0, 3, 1, 6, 3, 3, 0, 0, 1, 0, 0, 3, 6, 6, 0, 0, 3, 6, 4, 0, 6, 4, 5, 3, 7,
0, 2, 7, 0, 0, 6, 5, 5, 7, 0, 5, 1, 6, 3, 0, 4, 6, 2, 2, 3, 4, 3, 4, 5, 3, 6, 2, 4, 7, 1, 5, 4, 3,
7, 7, 4, 0, 5, 7, 6, 6, 5, 6, 2, 3, 1, 5, 1, 5, 7, 6, 7, 2, 2, 4, 3, 2, 0, 1, 4, 2, 4, 0, 7, 7, 1,
2, 6, 5, 1, 2, 6, 6, 6, 5, 6, 3, 2, 2, 1, 6, 5, 5, 4, 7, 2, 7, 4, 2, 0, 0, 5, 3, 3, 7, 6, 6, 5, 1,
3, 4, 3, 6, 4, 1, 0, 7, 4, 6, 2, 0, 4, 2, 0, 5, 1, 6, 3, 3, 4, 6, 7, 4, 2, 3, 3, 5, 1, 0, 0, 1, 5,
7, 6, 7, 1, 5, 4, 4, 0, 3, 5, 5, 4, 4, 6, 3, 2, 1, 0, 6, 3, 3, 6, 0, 3, 7, 3, 2, 4, 1, 0, 4, 2, 6,
3, 6, 2, 4, 4, 1, 5, 1, 6, 1, 1, 5, 3, 0, 0, 2, 2, 3, 2, 7, 3, 5, 7, 2, 6, 2, 5, 3, 0, 1, 6, 0, 6,
1, 0, 2, 0, 0, 2, 2, 1, 3, 7, 3, 1, 3, 7, 2, 5, 6, 2, 7, 4, 0, 2, 1, 6, 0, 4, 6, 5, 6, 7, 6, 7, 3,
7, 6, 2, 1, 1, 3, 7]
Generation’s best community (list of genes):
PIK3R1 H2AFX RAD9A FANCD2 ATF1 ANAPC7 SNRK RAD51AP1 ATG13
SUMO1 RPA2 MRC1 BACH1 E2F1 ATR HIPK3 RPA1 PIAS1 MSH2 BRAP FAM175A
MDM2 MDM4 MUS81 C11orf30 TOPBP1 MRE11A RELA MAK EP300 CASP3 SP1
IFT57 PRMT1 NLRP10 CCND1 PRKDC CCNH NRG1 TNFRSF10B GPS2 CNTN2
RECQL5 DEDD2 RNF20 PPARA CDC25C E4F1 KRAS SRY CHGB HTT PPARG
RHEBL1 AKT1 TRIM68 PARS2 TIRAP RPL31 HIF1A EME1 CDK1
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Number of genes inside the community: 62
********************Generation 12********************
Generation’s average fitness: 0.14387642364218087
Generation’s best fitness: 0.1874189364461738
Generation’s best individual:
[3, 3, 2, 2, 2, 5, 3, 4, 4, 1, 0, 7, 7, 6, 2, 6, 1, 2, 4, 3, 6, 3, 3, 0, 5, 6, 2, 1, 7, 2, 1, 6,
2, 2, 7, 6, 3, 1, 5, 6, 0, 4, 3, 2, 7, 2, 0, 4, 6, 4, 1, 3, 6, 4, 2, 3, 4, 1, 7, 7, 5, 6, 2, 2, 2,
4, 0, 7, 4, 6, 6, 2, 5, 4, 1, 7, 0, 2, 0, 3, 0, 3, 6, 6, 6, 0, 5, 1, 1, 4, 1, 5, 5, 4, 7, 4, 7, 1,
6, 2, 7, 6, 2, 5, 1, 4, 4, 3, 3, 0, 0, 6, 6, 6, 1, 3, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 6, 6, 4,
6, 1, 3, 4, 6, 2, 6, 7, 1, 5, 7, 1, 4, 6, 2, 0, 5, 5, 6, 4, 2, 2, 3, 0, 5, 0, 1, 7, 7, 3, 4, 3, 4,
6, 2, 7, 5, 6, 3, 4, 7, 5, 4, 6, 1, 2, 4, 1, 0, 4, 0, 3, 4, 4, 3, 2, 7, 4, 2, 4, 1, 1, 1, 7, 3, 0,
1, 3, 2, 7, 0, 3, 4, 2, 0, 7, 5, 2, 7, 3, 3, 1, 3, 4, 4, 5, 5, 7, 6, 5, 2, 2, 2, 1, 1, 4, 7, 3, 6,
1, 7, 7, 1, 2, 7, 5, 5, 5, 0, 4, 3, 6, 0, 5, 1, 6, 7, 1, 6, 1, 3, 7, 3, 0, 6, 1, 4, 2, 7, 2, 7, 1,
7, 4, 0, 4, 5, 0, 6, 3, 2, 3, 5, 6, 5, 2, 1, 2, 1, 2, 7, 3, 0, 4, 5, 1, 5, 1, 5, 7, 0, 2, 4, 6, 1,
2, 2, 4, 1, 0, 7, 0, 4, 4, 5, 0, 5, 7, 0, 0, 0, 3, 1, 4, 3, 5, 2, 5, 6, 4, 7, 5, 0, 1, 3, 3, 7, 4,
0, 4, 7, 5, 0, 1, 1, 0, 7, 5, 6, 7, 4, 2, 6, 6, 3, 7, 6, 4, 1, 4, 7, 1, 3, 6, 2, 4, 0, 6, 7, 4, 4,
0, 6, 7, 2, 3, 1, 5, 1, 5, 1, 3, 7, 7, 3, 3, 4, 2, 4, 1, 0, 2, 2, 3, 5, 5, 3, 7, 2, 3, 3, 2, 3, 6,
0, 2, 5, 5, 0, 2, 5, 4, 1, 2, 6, 6, 4, 0, 6, 7, 2, 1, 6, 5, 0, 2, 6, 0, 0, 0, 6, 7, 0, 0, 4, 7, 7,
1, 2, 4, 5, 7, 1, 1, 0, 5, 5, 4, 2, 4, 7, 5, 0, 3, 6, 6, 0, 2, 0, 6, 2, 3, 4, 5, 4, 5, 7, 1, 0, 6,
4, 2, 1, 5, 4, 2, 3, 7, 6, 2, 3, 6, 5, 2, 6, 7, 3, 2, 4, 4, 4, 3, 2, 5, 6, 2, 2, 1, 1, 4, 6, 2, 3,
5, 5, 5, 3, 2, 0, 7]
Generation’s best community (list of genes):
BRIP1 H2AFX CDK19 FANCD2 RXRB PLAGL1 TGFB1I1 CSTF1 THRB MDC1
BRD7 KAT2B CREBBP VDR ABL1 RPA1 PER3 PPM1L MED1 MSH2 MDM2
TOPBP1 HIST2H2AB GSK3B RELA WHSC1 TRADD HSP90AA1 HSPA5 SP1
WNT2B DCLRE1A STMN1 BCL2L1 HBA1 JUNB XRCC6 PLK1 NR1I2 HIST3H3
BRE SMARCA4 CTBP1 ERCC3 GTF2B MMS19 RXRA UBE3A BCL3 RNF20
XRCC1 HDAC2 DDX17 HDAC1 SLC9A3R2 UBA1 HTT NOD1 UPF1 ERCC6 SHISA5
YWHAH
Number of genes inside the community: 62
********************Generation 13********************
Generation’s average fitness: 0.14629853416116823
Generation’s best fitness: 0.18
Generation’s best individual:
[0, 0, 2, 4, 0, 2, 2, 2, 4, 7, 1, 3, 3, 0, 0, 4, 1, 3, 0, 6, 4, 6, 6, 5, 4, 4, 0, 7, 3, 4, 0, 2,
0, 7, 7, 0, 5, 0, 6, 0, 7, 0, 0, 6, 4, 2, 1, 7, 7, 5, 2, 3, 7, 1, 6, 5, 4, 6, 1, 5, 7, 7, 0, 7, 0,
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6, 3, 1, 1, 0, 2, 2, 1, 3, 3, 6, 1, 3, 7, 3, 3, 3, 7, 2, 6, 6, 4, 0, 7, 3, 6, 5, 3, 0, 0, 4, 4, 3,
6, 0, 7, 1, 2, 7, 4, 4, 3, 5, 5, 3, 6, 3, 7, 1, 2, 5, 5, 2, 3, 0, 4, 0, 5, 1, 7, 7, 0, 5, 3, 6, 7,
1, 0, 0, 1, 2, 6, 0, 2, 2, 2, 1, 2, 5, 0, 3, 7, 0, 6, 6, 7, 1, 3, 3, 0, 0, 5, 4, 1, 5, 4, 2, 2, 1,
0, 7, 1, 7, 4, 7, 6, 7, 7, 6, 4, 0, 6, 5, 5, 4, 2, 1, 3, 1, 1, 6, 4, 2, 5, 1, 4, 3, 1, 0, 7, 0, 4,
4, 4, 2, 0, 3, 7, 5, 1, 0, 2, 4, 0, 3, 2, 0, 2, 6, 2, 1, 4, 6, 5, 7, 6, 4, 7, 5, 2, 1, 3, 0, 5, 0,
5, 7, 7, 1, 0, 3, 2, 1, 6, 7, 3, 0, 3, 0, 4, 7, 3, 1, 2, 3, 5, 7, 5, 7, 6, 6, 5, 7, 6, 0, 5, 2, 3,
1, 2, 0, 7, 7, 6, 1, 0, 2, 6, 3, 0, 1, 2, 7, 3, 2, 6, 0, 0, 6, 4, 3, 4, 3, 7, 6, 3, 0, 3, 4, 1, 1,
2, 3, 4, 6, 3, 6, 5, 7, 7, 4, 1, 7, 3, 1, 3, 1, 2, 5, 5, 7, 1, 0, 7, 7, 4, 5, 3, 3, 0, 1, 0, 4, 7,
1, 7, 1, 4, 3, 2, 5, 3, 1, 4, 3, 1, 0, 2, 5, 4, 4, 3, 3, 7, 6, 7, 2, 7, 7, 4, 6, 5, 7, 2, 2, 3, 3,
1, 6, 2, 3, 7, 7, 4, 5, 2, 4, 4, 4, 0, 6, 1, 7, 3, 4, 6, 1, 5, 5, 0, 1, 3, 5, 3, 6, 2, 5, 3, 4, 5,
4, 4, 0, 4, 7, 4, 3, 2, 1, 6, 2, 4, 3, 1, 1, 6, 5, 0, 3, 1, 6, 5, 6, 4, 3, 5, 1, 2, 1, 0, 3, 4, 6,
4, 6, 2, 7, 5, 6, 6, 7, 3, 0, 7, 0, 2, 4, 5, 6, 4, 6, 3, 1, 5, 2, 0, 7, 5, 4, 5, 2, 6, 6, 2, 1, 1,
3, 6, 2, 7, 4, 4, 4, 2, 7, 3, 3, 3, 4, 7, 1, 4, 5, 4, 7, 0, 7, 7, 3, 7, 0, 0, 1, 3, 0, 0, 4, 5, 6,
7, 3, 6, 0, 3, 1, 0]
Generation’s best community (list of genes):
PALB2 H2AFX BAP1 KBTBD7 VCP RRM2B RAD50 KAT5 SUMO1 E2F1
HIPK3 SQSTM1 RBBP8 PIAS1 UBE2I PLK3 RIPK1 RNF4 HAP1 MOB4 POLR1E
PTK2B ESR1 RELA EP300 ULK2 SP1 DCLRE1A CASP7 MED12L LRIF1 PIAS4
UBE2U NR5A2 SMARCA4 CDK7 SMAD3 IKBKG CDC5L JUN MBD3 MAP2K6
TAOK3 RFWD2 DNAJA3 FASLG GTF2F1 ACACB HDAC1 NR0B2 APLP2 CSNK2A2
CLSPN CHGB HIPK2 PPP2R5C ETS1 KPNA2 MED17 NSD1
Number of genes inside the community: 60
********************Generation 14********************
Generation’s average fitness: 0.14870902320618978
Generation’s best fitness: 0.19056486654252017
Generation’s best individual:
[7, 0, 1, 3, 6, 4, 6, 4, 0, 5, 2, 5, 1, 5, 2, 4, 7, 3, 3, 0, 1, 7, 7, 4, 0, 6, 2, 1, 6, 1, 7, 6,
7, 5, 6, 6, 6, 5, 4, 2, 0, 4, 6, 1, 0, 2, 2, 7, 0, 3, 4, 3, 6, 7, 2, 7, 6, 5, 7, 2, 2, 1, 6, 0, 5,
4, 3, 5, 6, 5, 3, 7, 2, 1, 3, 2, 1, 3, 2, 3, 0, 1, 6, 6, 6, 0, 5, 1, 1, 4, 1, 5, 5, 4, 7, 4, 7, 1,
6, 2, 7, 6, 2, 5, 1, 4, 4, 3, 3, 0, 0, 6, 6, 6, 1, 3, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 6, 6, 4,
6, 1, 3, 4, 6, 2, 6, 7, 1, 5, 7, 1, 4, 6, 2, 0, 5, 4, 4, 6, 2, 0, 0, 6, 2, 2, 1, 0, 4, 5, 6, 3, 3,
2, 2, 7, 0, 5, 7, 0, 0, 6, 6, 3, 5, 3, 4, 2, 3, 4, 4, 6, 3, 5, 3, 2, 3, 5, 1, 4, 3, 1, 0, 7, 0, 4,
4, 4, 2, 0, 3, 7, 5, 1, 0, 2, 4, 0, 3, 2, 0, 2, 6, 2, 1, 4, 6, 5, 7, 6, 4, 7, 5, 2, 1, 3, 0, 5, 0,
5, 7, 7, 1, 0, 3, 2, 1, 6, 7, 3, 0, 3, 0, 4, 7, 3, 1, 2, 3, 5, 7, 5, 7, 6, 6, 5, 7, 6, 0, 5, 2, 3,
1, 2, 0, 7, 7, 6, 1, 0, 2, 6, 3, 0, 1, 2, 7, 3, 2, 6, 0, 0, 6, 4, 3, 4, 3, 7, 6, 3, 0, 3, 4, 1, 1,
2, 3, 4, 6, 3, 6, 5, 7, 7, 4, 1, 7, 3, 1, 3, 1, 2, 5, 5, 7, 1, 0, 7, 7, 4, 5, 3, 3, 0, 1, 0, 4, 7,
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1, 7, 1, 4, 3, 2, 5, 3, 1, 4, 3, 1, 0, 2, 5, 4, 4, 3, 3, 7, 6, 7, 2, 7, 7, 4, 6, 5, 7, 2, 2, 3, 3,
1, 6, 2, 3, 7, 7, 4, 5, 2, 4, 4, 4, 0, 6, 1, 7, 3, 4, 6, 1, 5, 5, 0, 1, 3, 5, 3, 6, 2, 5, 3, 4, 5,
4, 4, 0, 4, 7, 4, 3, 2, 1, 6, 2, 4, 3, 1, 1, 6, 5, 0, 3, 1, 6, 5, 6, 4, 3, 5, 1, 2, 1, 0, 3, 4, 6,
4, 6, 2, 7, 5, 6, 6, 7, 3, 0, 7, 0, 2, 4, 5, 6, 3, 4, 2, 7, 6, 3, 5, 0, 5, 5, 7, 5, 6, 4, 2, 4, 1,
7, 2, 0, 2, 5, 0, 3, 4, 6, 0, 2, 2, 3, 1, 1, 2, 3, 3, 4, 6, 1, 0, 4, 0, 5, 4, 1, 5, 7, 2, 1, 4, 5,
1, 4, 0, 4, 4, 3, 3]
Generation’s best community (list of genes):
SHFM1 RAD52 RAD9A CDK19 FKBP5 ATF1 TOPORS ATG13 SUMO1 RPA2
THRB MDC1 BRD7 KAT2B CREBBP VDR ABL1 RPA1 PER3 PPM1L MED1
MSH2 MDM2 ESR1 RELA EP300 ULK2 SP1 DCLRE1A CASP7 MED12L LRIF1
PIAS4 UBE2U NR5A2 SMARCA4 CDK7 SMAD3 IKBKG CDC5L JUN MBD3
MAP2K6 TAOK3 RFWD2 DNAJA3 FASLG GTF2F1 ACACB HDAC1 NR0B2 APLP2
CSNK2A2 CLSPN CHGB ETS1 AATF KPNA2 VRK1 MED17 FBXO11 FAIM2
Number of genes inside the community: 62
********************Generation 15********************
Generation’s average fitness: 0.1511111573474144
Generation’s best fitness: 0.19302775984506132
Generation’s best individual:
[3, 6, 1, 2, 2, 5, 2, 3, 5, 4, 0, 6, 0, 0, 7, 2, 5, 0, 0, 2, 6, 6, 3, 5, 7, 2, 7, 4, 3, 0, 1, 0,
6, 6, 2, 3, 4, 5, 4, 6, 1, 1, 5, 7, 0, 6, 6, 6, 6, 5, 5, 2, 5, 1, 1, 3, 7, 1, 2, 1, 4, 4, 5, 6, 2,
4, 7, 5, 5, 5, 6, 0, 4, 6, 7, 5, 1, 5, 0, 1, 2, 3, 3, 0, 2, 4, 6, 0, 1, 0, 5, 4, 3, 4, 6, 2, 2, 5,
5, 7, 4, 1, 2, 4, 1, 1, 6, 2, 3, 3, 7, 0, 7, 1, 5, 2, 2, 0, 5, 3, 5, 2, 3, 4, 4, 2, 7, 6, 1, 5, 3,
7, 3, 5, 1, 7, 2, 6, 4, 5, 6, 1, 4, 7, 4, 3, 4, 0, 3, 3, 7, 0, 5, 2, 2, 1, 2, 2, 4, 1, 5, 2, 2, 1,
3, 3, 6, 6, 0, 2, 1, 0, 2, 7, 2, 7, 6, 1, 5, 3, 1, 1, 2, 2, 7, 6, 2, 5, 5, 6, 0, 7, 5, 2, 6, 3, 2,
0, 5, 4, 0, 4, 0, 6, 1, 7, 4, 3, 5, 7, 2, 1, 4, 1, 4, 3, 3, 2, 3, 7, 5, 7, 6, 4, 7, 1, 5, 1, 2, 5,
1, 3, 0, 2, 5, 2, 5, 4, 1, 7, 5, 7, 0, 2, 4, 4, 6, 5, 0, 1, 6, 4, 5, 3, 4, 5, 4, 2, 0, 0, 7, 6, 1,
1, 1, 3, 1, 6, 6, 1, 3, 3, 3, 5, 4, 5, 4, 3, 4, 1, 4, 4, 7, 4, 7, 6, 3, 0, 1, 4, 3, 0, 1, 5, 0, 5,
5, 4, 2, 7, 5, 2, 3, 0, 5, 7, 7, 0, 0, 1, 2, 1, 0, 3, 6, 4, 3, 5, 6, 0, 3, 2, 2, 1, 1, 5, 7, 5, 0,
0, 0, 4, 0, 4, 5, 7, 5, 7, 1, 4, 3, 6, 4, 2, 2, 2, 6, 1, 0, 6, 7, 4, 0, 7, 3, 6, 2, 5, 0, 2, 5, 1,
4, 2, 5, 7, 7, 7, 7, 6, 0, 6, 5, 4, 6, 2, 6, 5, 2, 7, 1, 3, 7, 7, 7, 7, 0, 0, 6, 5, 5, 4, 5, 1, 0,
5, 7, 3, 5, 5, 4, 0, 1, 3, 5, 4, 2, 7, 6, 1, 4, 1, 4, 4, 1, 6, 4, 7, 1, 5, 2, 6, 5, 4, 3, 6, 2, 2,
6, 2, 2, 1, 2, 1, 7, 1, 6, 0, 2, 2, 7, 5, 3, 2, 5, 1, 6, 7, 5, 3, 2, 6, 4, 2, 2, 2, 4, 2, 6, 2, 1,
3, 0, 2, 7, 7, 0, 4, 2, 1, 3, 1, 3, 4, 7, 1, 4, 5, 4, 3, 0, 7, 7, 5, 7, 0, 5, 1, 3, 0, 0, 4, 3, 6,
6, 3, 6, 0, 3, 2, 0]
Generation’s best community (list of genes):
SHFM1 FANCD2 RECQL4 AP1B1 KBTBD7 DMC1 TGFB1I1 RAD51D SUMO1
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ING5 MDC1 E2F1 CREBBP TFAP2A HIPK3 NUFIP1 PIAS1 UBE2I TERF2 MDM4
RNF4 FEZ1 MSH6 UIMC1 MOB4 EP300 BCCIP CASP3 SP1 YLPM1 WNT2B
CHD3 WDR16 XRCC6 LRIF1 ACACA SETDB1 PIAS4 NR1I2 BRE PRKDC SMAD3
IKBKG CHEK1 GTF2B NR3C1 BUB1B DEDD2 DDX17 E4F1 DGKZ APLP2 SRY
CSNK2A2 RARA ETS2 HTT PPARG DARS ETS1 PPP2R5E TP63 KPNA2 MED17
Number of genes inside the community: 64
********************Generation 16********************
Generation’s average fitness: 0.15366877405510673
Generation’s best fitness: 0.19961612284069097
Generation’s best individual:
[5, 7, 7, 3, 1, 7, 7, 7, 2, 4, 6, 1, 4, 0, 4, 6, 2, 7, 2, 5, 3, 5, 3, 6, 2, 2, 3, 1, 4, 3, 1, 4,
0, 0, 7, 3, 2, 5, 5, 4, 0, 5, 0, 3, 1, 4, 2, 6, 5, 0, 4, 1, 2, 3, 5, 3, 0, 3, 0, 3, 4, 1, 4, 7, 2,
1, 6, 4, 0, 7, 7, 2, 1, 0, 5, 0, 1, 1, 6, 7, 5, 4, 1, 7, 4, 3, 6, 2, 1, 4, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 2, 4, 0, 1, 0, 0, 6, 1, 6, 1, 3, 2, 1, 0, 5, 1, 7, 5, 5, 1, 5, 1, 4, 1, 0, 4,
6, 7, 7, 4, 6, 2, 7, 7, 1, 7, 7, 5, 4, 6, 2, 6, 5, 4, 6, 4, 2, 0, 7, 6, 1, 2, 1, 0, 4, 5, 6, 5, 3,
2, 0, 7, 4, 0, 5, 0, 5, 0, 6, 3, 2, 3, 4, 2, 3, 4, 4, 6, 3, 5, 3, 2, 3, 4, 6, 5, 3, 6, 4, 3, 5, 0,
7, 5, 2, 3, 3, 5, 7, 2, 5, 0, 6, 5, 3, 4, 7, 3, 7, 2, 5, 4, 6, 7, 2, 4, 7, 6, 7, 5, 1, 4, 5, 2, 7,
1, 4, 3, 6, 0, 0, 2, 2, 3, 7, 2, 7, 6, 5, 6, 0, 3, 2, 5, 6, 1, 3, 4, 2, 2, 7, 1, 4, 7, 3, 0, 1, 5,
5, 5, 0, 6, 0, 3, 1, 5, 3, 4, 6, 0, 0, 6, 0, 3, 6, 6, 7, 1, 7, 6, 6, 4, 7, 3, 1, 5, 4, 0, 7, 4, 1,
6, 7, 6, 5, 4, 5, 1, 7, 1, 6, 2, 7, 4, 1, 4, 2, 6, 3, 6, 3, 7, 0, 7, 0, 0, 6, 4, 4, 6, 6, 4, 5, 2,
4, 6, 4, 5, 5, 4, 3, 6, 5, 2, 3, 0, 5, 1, 5, 7, 2, 4, 3, 7, 1, 4, 1, 1, 1, 5, 4, 4, 4, 4, 2, 1, 0,
7, 6, 6, 6, 5, 5, 7, 2, 5, 1, 0, 2, 0, 2, 2, 5, 4, 0, 1, 7, 6, 4, 2, 2, 3, 3, 0, 2, 0, 2, 0, 4, 4,
7, 0, 7, 3, 6, 2, 5, 3, 1, 7, 4, 6, 7, 1, 2, 7, 3, 1, 1, 5, 7, 5, 4, 3, 4, 4, 3, 4, 4, 4, 3, 4, 0,
1, 2, 2, 1, 2, 0, 7, 1, 5, 7, 4, 2, 3, 6, 6, 3, 0, 6, 2, 4, 3, 7, 2, 0, 1, 2, 7, 4, 6, 7, 7, 6, 1,
0, 5, 5, 5, 6, 7, 2, 3, 3, 7, 0, 2, 3, 5, 1, 7, 1, 3, 3, 7, 2, 5, 0, 3, 5, 2, 3, 6, 1, 2, 4, 1, 0,
5, 6, 4, 7, 1, 4, 1]
Generation’s best community (list of genes):
ATAD2 NBN CDK19 FANCD2 ANAPC7 BLM TOPORS FADD KAT5 SUMO1
KAT7 MRC1 MDC1 KAT2B E2F1 CREBBP PPP1R13L ATR VDR XRCC5 ABL1
RPA1 PER3 NUFIP1 MED1 TERF2 MDM2 SP1 WNT2B HBA1 JUNB GABRB1
PIAS4 NCL NR1H3 SMARCA4 ADAP1 PPM1B SMAD3 RECQL5 UBE3A ZMIZ1
BCL3 SMAD6 SLC9A3 HDAC2 DDX17 HDAC1 NR0B2 SLC9A3R2 SERPINH1
UBA1 ETS2 PPARG BID ETS1 KPNA2 TICAM1 YWHAH TOP2A CDK1 PDGFRB
Number of genes inside the community: 62
********************Generation 17********************
Generation’s average fitness: 0.1560841262853778
APPENDIX A. SAMPLE OUTPUT OF GENETIC ALGORITHM 72
Generation’s best fitness: 0.19627966645285438
Generation’s best individual:
[3, 3, 2, 2, 2, 5, 3, 4, 4, 1, 0, 7, 7, 6, 2, 6, 1, 2, 4, 3, 6, 3, 3, 0, 5, 6, 4, 4, 3, 4, 1, 7,
1, 5, 3, 3, 3, 3, 3, 5, 6, 0, 7, 0, 6, 2, 2, 3, 0, 0, 5, 1, 3, 7, 5, 4, 2, 6, 1, 6, 7, 0, 5, 0, 6,
5, 3, 2, 2, 1, 6, 3, 7, 6, 4, 7, 1, 1, 0, 1, 7, 1, 6, 2, 6, 0, 0, 2, 1, 4, 6, 5, 4, 5, 2, 3, 4, 0,
6, 3, 3, 1, 4, 3, 4, 4, 0, 4, 3, 7, 2, 7, 0, 7, 2, 0, 6, 0, 5, 2, 6, 5, 3, 7, 6, 4, 4, 6, 2, 7, 5,
5, 7, 5, 1, 6, 4, 1, 7, 4, 1, 1, 0, 5, 1, 6, 6, 4, 2, 3, 1, 2, 6, 1, 2, 7, 4, 4, 5, 4, 0, 2, 5, 1,
7, 6, 5, 4, 4, 1, 6, 6, 2, 7, 6, 3, 0, 7, 3, 0, 6, 7, 0, 2, 1, 6, 4, 2, 5, 1, 4, 3, 1, 0, 7, 0, 4,
4, 4, 2, 0, 3, 7, 5, 1, 0, 2, 4, 0, 3, 2, 0, 2, 6, 2, 1, 4, 6, 5, 7, 6, 4, 7, 1, 4, 1, 3, 7, 5, 1,
7, 4, 6, 0, 5, 2, 2, 2, 3, 6, 2, 4, 5, 0, 1, 3, 0, 2, 5, 6, 6, 7, 5, 3, 6, 0, 1, 4, 7, 1, 0, 4, 7,
7, 2, 7, 3, 7, 3, 5, 1, 7, 7, 1, 1, 2, 4, 0, 2, 6, 3, 1, 1, 3, 3, 1, 3, 7, 1, 7, 1, 3, 1, 4, 2, 7,
0, 4, 6, 4, 2, 4, 1, 4, 0, 1, 4, 6, 5, 2, 6, 3, 5, 0, 1, 7, 1, 4, 3, 7, 0, 7, 7, 7, 3, 4, 7, 1, 6,
5, 6, 2, 5, 6, 4, 3, 1, 4, 1, 0, 2, 3, 4, 7, 6, 2, 2, 6, 4, 0, 1, 3, 4, 3, 0, 4, 7, 2, 2, 0, 3, 2,
5, 2, 5, 0, 7, 6, 5, 3, 1, 1, 1, 2, 0, 2, 2, 5, 0, 0, 4, 7, 0, 7, 4, 4, 6, 5, 5, 6, 2, 7, 2, 2, 5,
5, 6, 7, 5, 7, 7, 4, 7, 1, 1, 7, 7, 1, 2, 4, 4, 5, 0, 4, 0, 2, 3, 4, 4, 3, 4, 2, 6, 6, 2, 3, 2, 4,
2, 2, 4, 2, 6, 3, 6, 2, 3, 3, 5, 5, 7, 3, 6, 6, 2, 3, 3, 6, 4, 3, 0, 7, 1, 2, 6, 6, 7, 3, 0, 7, 0,
2, 3, 5, 6, 3, 1, 2, 2, 3, 4, 7, 6, 5, 5, 1, 7, 7, 0, 6, 2, 1, 5, 5, 7, 3, 5, 4, 7, 5, 2, 5, 1, 6,
2, 2, 4, 5, 1, 7, 5]
Generation’s best community (list of genes):
BRIP1 H2AFX FANCD2 STK11IP BLM VCP ATRIP SUMO1 KAT7 ING5
RPA2 MDC1 E2F1 PIAS1 IFI16 NTHL1 UBE2I TP53BP1 ETV5 CASP1 RNF4
NFYA PTK2B ESR1 RELA EP300 ULK2 ZNF280B SP1 MCPH1 ING4 JUNB
HUWE1 RB1 ANG CCND1 POU2F1 NCL MAP4K4 BRE TIPARP PRKDC ADAP1
PTS CDC14B CDC5L APOL2 NKX2-1 NR3C1 PA2G4 ERCC2 HDAC2 RALBP1
HDAC1 ULK1 BAK1 BID RAD17 KPNA2 VRK1 TOP2A CDK1
Number of genes inside the community: 62
********************Generation 18********************
Generation’s average fitness: 0.1585739672687739
Generation’s best fitness: 0.1974479516453996
Generation’s best individual:
[6, 2, 3, 7, 4, 4, 4, 3, 0, 2, 5, 3, 3, 5, 4, 0, 1, 7, 3, 6, 2, 7, 2, 6, 2, 2, 7, 3, 4, 4, 1, 3,
4, 1, 5, 4, 7, 6, 0, 6, 2, 0, 2, 0, 5, 2, 0, 2, 2, 6, 2, 6, 4, 3, 4, 5, 6, 1, 3, 0, 2, 1, 3, 3, 6,
5, 2, 6, 1, 1, 2, 0, 3, 6, 7, 3, 1, 7, 3, 5, 2, 3, 5, 5, 0, 4, 3, 0, 6, 7, 6, 4, 5, 1, 5, 5, 6, 0,
2, 6, 4, 1, 1, 4, 7, 5, 3, 6, 7, 3, 4, 0, 1, 3, 6, 1, 6, 7, 2, 1, 4, 3, 4, 0, 0, 1, 6, 7, 2, 6, 2,
5, 3, 2, 6, 2, 3, 4, 0, 0, 0, 2, 1, 6, 6, 1, 4, 2, 0, 2, 6, 5, 1, 0, 0, 6, 6, 1, 4, 1, 0, 3, 7, 5,
5, 3, 3, 1, 4, 3, 7, 1, 3, 5, 4, 1, 1, 6, 7, 7, 0, 0, 7, 3, 7, 7, 0, 0, 5, 3, 1, 2, 3, 1, 7, 2, 6,
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4, 5, 4, 5, 7, 2, 0, 1, 0, 3, 5, 7, 0, 0, 3, 7, 1, 1, 5, 3, 7, 6, 4, 7, 3, 7, 4, 4, 0, 3, 0, 4, 5,
6, 5, 5, 3, 5, 4, 6, 0, 3, 1, 0, 4, 6, 1, 0, 3, 6, 7, 6, 7, 1, 7, 2, 6, 0, 7, 7, 7, 6, 0, 2, 3, 1,
2, 7, 4, 4, 6, 6, 0, 1, 1, 7, 7, 1, 2, 4, 5, 2, 6, 3, 1, 0, 6, 3, 0, 3, 7, 1, 4, 1, 3, 1, 7, 2, 7,
0, 4, 5, 4, 2, 4, 2, 4, 7, 1, 1, 6, 5, 4, 6, 7, 7, 3, 1, 7, 1, 4, 2, 7, 0, 0, 7, 7, 5, 4, 6, 2, 6,
5, 3, 6, 5, 4, 1, 3, 5, 4, 0, 7, 7, 3, 4, 7, 6, 2, 2, 5, 7, 6, 7, 3, 2, 2, 6, 6, 5, 7, 4, 5, 7, 5,
1, 5, 2, 6, 6, 3, 3, 7, 5, 2, 2, 0, 5, 0, 7, 0, 7, 1, 1, 6, 3, 1, 4, 0, 4, 4, 2, 5, 2, 4, 0, 1, 2,
7, 4, 7, 3, 6, 0, 5, 0, 1, 5, 4, 7, 2, 0, 7, 5, 7, 5, 6, 1, 7, 1, 6, 1, 5, 0, 7, 0, 4, 2, 7, 3, 0,
1, 7, 4, 4, 2, 7, 5, 2, 6, 5, 1, 3, 0, 4, 2, 7, 0, 5, 2, 4, 1, 3, 1, 1, 6, 4, 3, 5, 3, 7, 0, 3, 2,
2, 2, 3, 7, 4, 5, 6, 7, 6, 3, 4, 3, 6, 1, 3, 5, 4, 3, 3, 6, 0, 7, 6, 2, 6, 6, 5, 3, 2, 3, 4, 1, 2,
7, 3, 3, 6, 7, 6, 0]
Generation’s best community (list of genes):
H2AFX FANCD2 WRN TGFB1I1 TOPORS RAD50 ATRIP SUMO1 DBNL
E2F1 CUL3 ATR GINS2 ING1 FOXO3 MSH2 BRAP FAM175A MDM2 MDM4
MUS81 C11orf30 TOPBP1 MRE11A DDX5 WHSC1 EP300 CASP3 RYBP TIMM13
HMG20B HBA1 XRCC6 RB1 ESRRA CCND1 POU2F1 BRE TIPARP PRKDC PTS
CDK7 CDC14B CDC5L MMS19 DNAJA3 PPP2R5B DDX17 ZNF350 E4F1 HDAC1
CSNK2A2 E2F4 RARA UBA1 AKT1 RAD54L2 MTA1 RBBP4 AATF TOP2A
Number of genes inside the community: 61
********************Generation 19********************
Generation’s average fitness: 0.16144249532069577
Generation’s best fitness: 0.19702842377260982
Generation’s best individual:
[0, 0, 3, 6, 3, 6, 0, 2, 5, 0, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 2, 4, 6, 4, 7, 6, 7, 1, 0,
2, 7, 2, 2, 0, 1, 0, 7, 6, 5, 3, 3, 0, 6, 1, 5, 6, 3, 4, 1, 3, 3, 4, 4, 0, 5, 7, 2, 2, 1, 6, 0, 5,
4, 3, 5, 6, 5, 3, 7, 2, 1, 3, 2, 1, 3, 5, 6, 0, 3, 6, 6, 6, 0, 5, 1, 1, 4, 1, 5, 5, 4, 7, 4, 7, 1,
6, 2, 7, 6, 2, 5, 1, 4, 4, 3, 3, 0, 0, 6, 6, 6, 1, 3, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 1, 2, 4,
7, 3, 0, 5, 7, 3, 0, 0, 2, 5, 4, 5, 4, 4, 1, 3, 7, 4, 0, 0, 6, 6, 3, 1, 5, 3, 1, 0, 1, 4, 0, 5, 5,
5, 5, 3, 6, 2, 6, 6, 0, 5, 1, 3, 0, 7, 1, 2, 5, 2, 7, 3, 6, 3, 5, 6, 6, 0, 7, 0, 2, 4, 2, 5, 3, 2,
5, 6, 4, 4, 6, 2, 5, 1, 6, 5, 6, 6, 6, 5, 2, 5, 1, 0, 0, 4, 5, 7, 4, 2, 7, 4, 6, 5, 6, 5, 5, 1, 7,
5, 6, 5, 2, 3, 7, 7, 7, 0, 0, 5, 0, 6, 1, 7, 4, 1, 3, 1, 6, 0, 5, 3, 2, 6, 0, 0, 6, 2, 2, 1, 2, 6,
4, 3, 6, 5, 7, 1, 2, 1, 0, 2, 5, 1, 4, 3, 6, 3, 2, 1, 4, 4, 4, 4, 5, 4, 4, 1, 2, 3, 4, 1, 7, 5, 4,
0, 7, 6, 7, 2, 5, 4, 3, 0, 5, 7, 6, 3, 1, 2, 0, 0, 4, 3, 1, 5, 7, 7, 0, 4, 0, 4, 5, 7, 4, 7, 4, 6,
2, 6, 6, 7, 7, 2, 6, 4, 4, 1, 5, 4, 7, 6, 3, 6, 6, 1, 5, 5, 1, 2, 1, 4, 5, 0, 3, 2, 6, 7, 1, 5, 6,
7, 1, 4, 5, 0, 5, 1, 4, 6, 4, 3, 2, 4, 4, 0, 2, 4, 2, 4, 5, 4, 3, 3, 3, 4, 1, 0, 6, 6, 3, 7, 4, 5,
2, 5, 7, 6, 2, 5, 2, 4, 3, 0, 7, 5, 5, 2, 3, 0, 6, 6, 7, 3, 2, 0, 7, 2, 5, 3, 2, 2, 3, 3, 5, 7, 3,
6, 5, 2, 0, 5, 0, 3, 1, 2, 5, 1, 3, 6, 7, 5, 6, 4, 6, 3, 1, 0, 0, 0, 2, 0, 6, 4, 0, 2, 4, 4, 1, 5,
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6, 5, 4, 0, 4, 6, 2, 7, 4, 1, 1, 5, 7, 0, 7, 3, 2, 6, 3, 2, 6, 1, 2, 0, 2, 0, 0, 5, 3, 3, 2, 1, 6,
7, 3, 4, 1, 1, 6, 6]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 RXRB BAP1 BLM TOPORS ATG13 SUMO1
THRB MDC1 BRD7 KAT2B CREBBP VDR ABL1 RPA1 PER3 NUFIP1 BRAP
ATN1 MDM2 MDM4 TNFRSF10A MSH6 EP300 CASP3 BCL2 HMG20B NLRP10
BCL2L1 MSH3 TOP3A RB1 CCND1 RCHY1 BRE PRKDC SMAD3 NR1H4 NR3C1
MYCBPAP UBE3A ZMIZ1 HMGB1 UBE2D3 ATG12 GSK3A PPARG AKT1 HIPK2
PPP2R5C PPP2R5D TP63 AXL TOP2A EME1 CDK1
Number of genes inside the community: 59
********************Generation 20********************
Generation’s average fitness: 0.16426696559494613
Generation’s best fitness: 0.20320855614973263
Generation’s best individual:
[5, 0, 2, 5, 7, 2, 2, 2, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 2, 4, 6, 4, 7, 6, 7, 1, 0,
2, 7, 2, 2, 3, 7, 7, 5, 3, 0, 0, 4, 4, 7, 0, 5, 3, 4, 6, 2, 3, 7, 5, 6, 0, 5, 7, 2, 3, 5, 6, 2, 2,
2, 6, 7, 3, 2, 4, 5, 6, 0, 3, 1, 1, 4, 1, 1, 5, 7, 4, 5, 2, 7, 6, 5, 1, 3, 4, 1, 0, 0, 5, 3, 6, 3,
3, 0, 4, 1, 5, 4, 4, 1, 1, 4, 6, 4, 3, 0, 1, 6, 1, 3, 2, 5, 3, 5, 1, 7, 4, 5, 1, 5, 1, 4, 6, 6, 4,
6, 1, 3, 4, 6, 2, 6, 7, 1, 5, 7, 1, 4, 6, 2, 0, 5, 4, 4, 6, 2, 0, 0, 6, 2, 2, 1, 0, 4, 5, 6, 3, 3,
2, 2, 7, 0, 5, 7, 1, 0, 5, 7, 6, 7, 6, 1, 5, 3, 1, 1, 2, 2, 7, 4, 2, 5, 0, 6, 0, 7, 5, 2, 6, 3, 7,
0, 5, 4, 0, 4, 0, 6, 1, 7, 4, 3, 5, 7, 2, 0, 4, 1, 4, 3, 3, 2, 3, 7, 5, 7, 6, 4, 7, 1, 5, 1, 1, 5,
5, 3, 0, 2, 5, 2, 5, 4, 1, 7, 5, 7, 0, 2, 4, 4, 6, 5, 0, 1, 6, 4, 0, 3, 4, 5, 4, 2, 2, 4, 5, 6, 3,
4, 2, 3, 4, 0, 0, 2, 1, 6, 4, 4, 5, 5, 6, 5, 2, 4, 7, 6, 4, 4, 3, 3, 1, 4, 7, 1, 7, 6, 1, 6, 3, 5,
2, 6, 3, 3, 6, 7, 3, 6, 4, 6, 0, 7, 1, 1, 4, 1, 1, 0, 0, 1, 0, 3, 4, 5, 2, 0, 0, 5, 7, 1, 4, 3, 6,
5, 4, 5, 6, 2, 7, 3, 6, 5, 1, 0, 0, 7, 7, 0, 7, 6, 5, 1, 3, 7, 1, 2, 1, 7, 1, 7, 7, 0, 0, 1, 0, 6,
2, 1, 7, 0, 2, 4, 5, 2, 0, 2, 5, 7, 2, 3, 7, 4, 7, 1, 3, 5, 6, 3, 0, 3, 2, 7, 3, 5, 1, 5, 6, 6, 0,
7, 7, 6, 6, 0, 5, 3, 2, 1, 4, 4, 7, 3, 7, 0, 3, 3, 1, 1, 4, 5, 1, 3, 6, 6, 4, 4, 2, 4, 2, 0, 5, 7,
4, 4, 5, 5, 7, 4, 4, 3, 6, 5, 0, 3, 7, 2, 4, 1, 6, 6, 4, 0, 7, 5, 1, 2, 2, 2, 0, 2, 7, 4, 3, 3, 7,
4, 2, 0, 6, 6, 5, 5, 0, 2, 5, 3, 0, 2, 0, 1, 2, 2, 3, 6, 0, 6, 4, 1, 6, 4, 7, 3, 5, 2, 6, 5, 0, 3,
7, 2, 0, 7, 1, 1, 4]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 ESRRB SUMO1 MAST3 ING5 MDC1 HRAS
E2F1 TFAP2A ATMIN ATR VDR ABL1 RPA1 PER3 PPM1L MED1 MSH2 MDM2
FEZ1 MSH6 UIMC1 MOB4 EP300 CASP3 SP1 YLPM1 BCL2 CHD3 WDR16 RB1
HIST3H3 NR1H3 PRKDC CCNH SMAD3 IKBKG PEBP1 NR1H4 JUN NR3C1
BUB1B PA2G4 BCL3 XIAP HMGB1 UBE2D3 PPP2R5B CDC25C HDAC1 SLC9A3R2
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SERPINH1 E2F4 DAXX MTA1 KPNA2 HIF1A CDK1 NSD1
Number of genes inside the community: 62
A.2 Generations 291 to 300
********************Generation 291********************
Generation’s average fitness: 0.5431339581075925
Generation’s best fitness: 0.55404699738903395
Generation’s best individual:
[5, 0, 2, 5, 7, 2, 2, 2, 3, 7, 7, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 2, 4, 6, 4, 7, 6, 4, 1, 2,
7, 1, 6, 4, 7, 3, 0, 2, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 0, 5, 4, 2, 0, 3, 0, 4, 7, 5, 6, 7, 0,
6, 2, 6, 1, 3, 4, 7, 1, 0, 6, 0, 1, 4, 4, 2, 7, 1, 6, 2, 6, 0, 0, 2, 1, 3, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 1, 5, 1, 3, 4, 3, 3, 0, 0, 6, 1, 2, 3, 6, 5, 1, 4, 1, 1, 5, 7, 3, 1, 6, 4, 4, 6, 6, 4,
6, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 3, 1, 2, 0, 5, 2, 0, 5, 7, 3, 4, 4, 5, 2, 1, 7, 3, 2, 6, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 1, 6, 2, 6, 5, 2, 4, 4, 7, 5, 7, 1, 3, 7, 0, 1,
7, 5, 2, 6, 7, 2, 0, 2, 1, 5, 3, 6, 4, 2, 1, 0, 0, 4, 7, 4, 4, 4, 5, 4, 3, 4, 7, 2, 6, 6, 7, 3, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 1, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 0, 0, 7, 3, 2, 5, 4, 3, 2, 1, 3, 2, 7, 5, 4, 4, 7, 0, 1, 0, 3, 6, 0, 1, 7, 1, 4, 3, 6,
5, 4, 5, 6, 6, 7, 3, 7, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 0, 3, 5, 5, 2, 1, 2, 0,
2, 5, 2, 6, 2, 3, 5, 3, 5, 1, 0, 2, 7, 2, 2, 5, 7, 7, 1, 3, 7, 7, 7, 6, 7, 6, 7, 3, 3, 2, 3, 2, 7,
7, 2, 6, 5, 0, 2, 5, 2, 1, 2, 6, 6, 3, 0, 0, 3, 3, 5, 0, 6, 0, 5, 3, 6, 6, 4, 2, 5, 0, 7, 7, 7, 6,
0, 6, 5, 5, 3, 0, 2, 3, 4, 6, 4, 6, 3, 2, 3, 1, 0, 3, 4, 1, 2, 2, 0, 1, 7, 1, 1, 2, 4, 6, 5, 2, 1,
3, 2, 6, 3, 7, 3, 7, 5, 5, 4, 2, 7, 4, 0, 1, 4, 5, 4, 0, 1, 7, 6, 1, 4, 4, 2, 0, 7, 5, 2, 5, 1, 6,
2, 2, 0, 5, 1, 5, 0]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CUL3 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I MSH2
TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 RYBP SP1 MCPH1
CHD3 ING4 XRCC6 PIAS4 RB1 CCND1 NR1I2 POU2F1 NCL PRKDC DCLRE1C
SMARCA4 SMAD3 NPAS2 CHEK1 JUN NR3C1 RECQL5 HMGB1 HDAC2 DDX17
HDAC1 DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A
CDK1
Number of genes inside the community: 67
********************Generation 292********************
Generation’s average fitness: 0.54278249459636606
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Generation’s best fitness: 0.5527272727272727
Generation’s best individual:
[5, 0, 2, 2, 2, 5, 3, 4, 3, 4, 3, 1, 4, 7, 1, 3, 1, 6, 5, 5, 1, 0, 0, 2, 3, 6, 4, 7, 6, 4, 1, 7,
4, 1, 5, 4, 7, 3, 3, 2, 2, 0, 2, 0, 5, 2, 0, 2, 5, 3, 4, 1, 2, 3, 5, 3, 0, 3, 0, 4, 7, 7, 0, 7, 0,
0, 4, 1, 1, 4, 7, 2, 1, 0, 6, 0, 1, 4, 4, 2, 2, 1, 6, 2, 0, 0, 2, 2, 1, 3, 4, 4, 0, 4, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 0, 4, 0, 0, 6, 1, 7, 3, 6, 5, 1, 7, 1, 1, 0, 7, 3, 1, 6, 6, 4, 6, 0, 6,
6, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 5, 1, 3, 0, 5, 2, 0, 5, 4, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 3, 3, 7, 3, 0, 3, 4, 3, 5, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 1, 3, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 4, 6, 1, 6, 5, 7, 6, 4, 2, 4, 6, 1, 3, 7, 0, 1,
7, 6, 0, 2, 3, 5, 0, 2, 1, 5, 3, 6, 4, 6, 7, 0, 7, 4, 7, 7, 6, 0, 4, 5, 4, 7, 7, 2, 6, 3, 4, 7, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 6, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 4, 6, 2, 1, 1, 5, 1,
0, 3, 7, 6, 0, 0, 7, 2, 0, 2, 7, 3, 2, 1, 6, 5, 4, 5, 4, 2, 4, 0, 0, 0, 3, 4, 5, 1, 7, 1, 4, 3, 6,
4, 0, 2, 5, 6, 7, 0, 6, 4, 1, 3, 3, 6, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 2, 3, 5, 5, 2, 1, 3, 5,
4, 2, 3, 6, 1, 3, 5, 3, 3, 1, 6, 6, 7, 5, 0, 3, 4, 0, 1, 4, 7, 7, 7, 6, 4, 6, 7, 5, 3, 2, 3, 2, 7,
7, 7, 5, 5, 1, 7, 3, 2, 1, 5, 4, 7, 3, 2, 4, 4, 3, 5, 2, 6, 7, 5, 6, 4, 3, 3, 4, 5, 0, 3, 0, 7, 7,
4, 6, 5, 5, 3, 0, 2, 3, 4, 5, 7, 3, 7, 2, 4, 1, 6, 6, 5, 1, 6, 0, 0, 1, 7, 1, 1, 3, 4, 6, 5, 2, 1,
4, 3, 7, 3, 7, 3, 7, 5, 5, 4, 2, 7, 0, 0, 1, 1, 7, 4, 2, 1, 3, 6, 1, 4, 4, 2, 0, 7, 2, 4, 0, 1, 6,
2, 2, 3, 5, 1, 7, 5]
Generation’s best community (list of genes):
NBN LRIT3 H2AFX RAD9A FANCD2 WRN BLM RRM2B RAD50 KAT5 SUMO1
RPA2 MDC1 KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I
MSH2 TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA NOL3 EP300 SUMO2 GIT1
SP1 MCPH1 CHD3 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C
SMARCA4 SMAD3 CHEK1 JUN NR3C1 RECQL5 HMGB1 PCYT1A HDAC2 DDX17
UBE2L3 HDAC1 DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 TP53INP1
PGR HIF1A TOP2A CDK1
Number of genes inside the community: 69
********************Generation 293********************
Generation’s average fitness: 0.54337012377776394
Generation’s best fitness: 0.5489473684210526
Generation’s best individual:
[5, 0, 2, 5, 4, 2, 2, 2, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 4, 4, 6, 4, 7, 6, 4, 1, 2,
4, 1, 5, 4, 7, 6, 0, 5, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 0, 3, 5, 5, 6, 5, 0, 4, 7, 7, 0, 3, 6,
5, 2, 6, 1, 3, 4, 7, 1, 0, 3, 6, 1, 4, 4, 2, 7, 1, 6, 2, 6, 0, 0, 2, 1, 3, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 3, 0, 0, 6, 1, 4, 4, 3, 4, 1, 4, 1, 1, 5, 5, 6, 1, 6, 4, 3, 3, 6, 4,
6, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 7, 1, 2, 3, 5, 2, 0, 5, 7, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
APPENDIX A. SAMPLE OUTPUT OF GENETIC ALGORITHM 77
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 4, 6, 2, 6, 5, 2, 5, 7, 6, 4, 7, 1, 3, 7, 0, 1,
7, 6, 2, 6, 7, 5, 7, 2, 1, 5, 3, 6, 4, 6, 0, 0, 7, 7, 7, 4, 6, 0, 4, 5, 4, 7, 6, 5, 6, 3, 4, 1, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 4, 0, 7, 2, 0, 2, 7, 3, 2, 1, 3, 2, 4, 5, 4, 2, 7, 0, 0, 0, 3, 6, 5, 1, 7, 1, 4, 3, 6,
5, 7, 6, 6, 2, 6, 2, 2, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 2, 3, 5, 5, 2, 1, 2, 1,
7, 2, 2, 4, 2, 3, 5, 3, 3, 1, 6, 6, 7, 5, 5, 4, 7, 7, 1, 0, 7, 4, 7, 6, 7, 6, 7, 2, 6, 6, 2, 3, 6,
0, 2, 5, 6, 0, 4, 5, 4, 1, 2, 0, 7, 3, 7, 0, 3, 3, 5, 0, 6, 0, 5, 3, 6, 6, 4, 2, 5, 0, 3, 0, 5, 5,
6, 2, 5, 3, 7, 4, 6, 0, 4, 3, 7, 3, 3, 3, 6, 1, 6, 3, 4, 1, 6, 0, 0, 1, 7, 1, 1, 2, 4, 4, 3, 2, 1,
3, 2, 6, 3, 7, 3, 7, 5, 5, 4, 2, 6, 5, 5, 1, 4, 5, 4, 2, 1, 3, 6, 1, 4, 6, 4, 0, 7, 3, 6, 5, 1, 6,
2, 2, 4, 5, 1, 7, 4]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I MSH2
TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1 CHD3
GABRB1 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
SMAD3 CHEK1 JUN NR3C1 RECQL5 HMGB1 DEDD2 HDAC2 DDX17 HDAC1
DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A CDK1
Number of genes inside the community: 64
********************Generation 294********************
Generation’s average fitness: 0.54259412369513204
Generation’s best fitness: 0.55170603674540685
Generation’s best individual:
[5, 0, 2, 5, 7, 2, 2, 2, 3, 2, 2, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 2, 4, 6, 4, 7, 6, 7, 1, 3,
4, 1, 6, 4, 6, 6, 0, 5, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 0, 3, 4, 5, 0, 3, 0, 3, 7, 3, 3, 3, 6,
5, 2, 6, 1, 4, 3, 7, 1, 0, 6, 0, 1, 4, 4, 2, 4, 1, 6, 2, 1, 0, 0, 2, 1, 3, 0, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 3, 0, 0, 6, 1, 4, 4, 3, 4, 1, 7, 1, 1, 3, 4, 6, 1, 6, 4, 4, 6, 6, 4,
4, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 0, 1, 2, 0, 5, 2, 0, 5, 7, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 2, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 4, 6, 2, 6, 5, 2, 5, 7, 7, 4, 4, 1, 3, 7, 0, 1,
7, 6, 0, 2, 5, 5, 2, 2, 1, 5, 3, 6, 4, 6, 0, 0, 0, 4, 7, 4, 4, 4, 5, 4, 3, 4, 7, 2, 6, 6, 7, 3, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 0, 0, 7, 3, 2, 5, 4, 3, 2, 1, 3, 4, 7, 5, 4, 2, 7, 4, 5, 2, 7, 6, 0, 1, 3, 1, 4, 3, 6,
4, 0, 5, 3, 0, 2, 2, 2, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 0, 3, 3, 4, 2, 1, 3, 0,
2, 5, 0, 4, 2, 3, 5, 3, 3, 1, 6, 6, 7, 5, 5, 3, 4, 0, 1, 7, 6, 4, 2, 5, 5, 3, 7, 2, 0, 0, 2, 3, 7,
7, 7, 3, 5, 0, 5, 3, 4, 1, 2, 4, 6, 3, 0, 2, 4, 4, 3, 0, 6, 7, 3, 6, 6, 0, 7, 3, 2, 4, 2, 0, 5, 7,
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4, 4, 5, 5, 7, 4, 6, 0, 4, 3, 6, 3, 3, 3, 6, 1, 6, 6, 2, 1, 6, 0, 5, 1, 7, 1, 1, 2, 4, 6, 1, 3, 1,
3, 0, 7, 3, 7, 3, 7, 2, 7, 4, 7, 6, 5, 5, 1, 4, 5, 4, 2, 1, 3, 6, 1, 4, 4, 2, 0, 7, 5, 2, 0, 1, 5,
2, 2, 4, 5, 1, 1, 4]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 FANCG
MDC1 KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I
MSH2 TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1
CHD3 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
SMAD3 CHEK1 JUN NR3C1 RECQL5 HMGB1 HDAC2 DDX17 HDAC1 DAXX
HIPK2 RBBP4 STAT5A PCNA UPF1 ETS1 KPNA2 PGR HIF1A TOP2A CDK1
NSD1
Number of genes inside the community: 65
********************Generation 295********************
Generation’s average fitness: 0.54271337308023037
Generation’s best fitness: 0.54944823962165
Generation’s best individual:
[5, 2, 2, 5, 7, 7, 7, 7, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 7, 0, 2, 4, 6, 4, 7, 6, 7, 1, 3,
0, 1, 5, 4, 5, 6, 0, 5, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 2, 5, 2, 7, 6, 6, 0, 4, 7, 7, 0, 7, 0,
0, 2, 6, 1, 3, 4, 7, 1, 0, 6, 0, 1, 4, 4, 2, 7, 1, 6, 2, 6, 0, 2, 2, 1, 3, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 2, 4, 0, 3, 0, 0, 6, 1, 2, 3, 6, 5, 1, 4, 1, 1, 5, 4, 5, 1, 5, 7, 5, 3, 1, 4,
4, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 0, 1, 2, 3, 5, 2, 0, 5, 7, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 4, 6, 2, 6, 5, 2, 5, 7, 6, 4, 7, 1, 3, 7, 0, 1,
7, 6, 4, 2, 5, 2, 0, 2, 1, 5, 3, 6, 4, 2, 4, 6, 7, 4, 7, 4, 6, 0, 4, 5, 4, 0, 7, 5, 6, 3, 7, 7, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 4, 6, 7, 4, 5, 0, 0, 3, 3, 1, 6, 0, 3, 1, 4, 2, 7, 4, 5, 4, 1, 2, 0, 1, 3, 1, 4, 3, 6,
4, 0, 5, 6, 2, 2, 2, 2, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 6, 6, 5, 0, 2, 3, 3, 4, 2, 1, 2, 0,
2, 5, 0, 4, 2, 3, 5, 3, 3, 1, 4, 2, 0, 2, 2, 5, 4, 7, 1, 3, 7, 2, 7, 6, 7, 6, 0, 5, 3, 2, 3, 2, 7,
7, 7, 5, 5, 0, 2, 5, 4, 1, 2, 6, 6, 6, 2, 0, 5, 2, 7, 2, 5, 3, 3, 6, 6, 6, 4, 4, 5, 2, 2, 7, 7, 6,
4, 4, 5, 5, 3, 0, 2, 3, 4, 3, 7, 3, 7, 2, 4, 1, 6, 6, 2, 1, 2, 2, 0, 1, 7, 1, 1, 2, 4, 6, 5, 2, 1,
3, 2, 6, 3, 7, 3, 7, 5, 7, 0, 2, 4, 2, 0, 1, 4, 7, 0, 2, 1, 3, 6, 1, 5, 4, 2, 0, 7, 3, 2, 7, 1, 6,
2, 2, 4, 5, 1, 7, 5]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 CXXC5 PIAS1 UBE2I
MSH2 TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1
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CHD3 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
SMAD3 ERCC3 USP1 CHEK1 JUN NR3C1 RECQL5 HMGB1 HDAC2 DDX17
HDAC1 DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A
CDK1
Number of genes inside the community: 65
********************Generation 296********************
Generation’s average fitness: 0.54266199127150265
Generation’s best fitness: 0.55520833333333335
Generation’s best individual:
[5, 0, 2, 5, 7, 2, 0, 2, 5, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 4, 1, 6, 0, 2, 4, 6, 4, 4, 6, 4, 1, 3,
4, 1, 5, 4, 7, 6, 0, 2, 2, 0, 2, 2, 5, 2, 0, 2, 5, 0, 4, 1, 7, 3, 5, 3, 0, 3, 0, 3, 7, 7, 3, 3, 6,
5, 4, 0, 1, 3, 4, 7, 1, 0, 3, 0, 1, 4, 4, 2, 7, 1, 6, 2, 6, 0, 0, 2, 1, 3, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 3, 0, 0, 6, 1, 2, 3, 6, 3, 1, 7, 1, 1, 5, 4, 5, 1, 6, 4, 3, 3, 6, 4,
6, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 7, 1, 0, 4, 5, 2, 0, 5, 7, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 6, 2, 3, 2, 5, 4, 0, 1, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 6, 6, 4, 0, 2, 6, 5, 2, 5, 7, 7, 5, 2, 1, 1, 7, 0, 1,
7, 6, 2, 2, 5, 5, 4, 4, 1, 5, 3, 6, 4, 6, 0, 0, 7, 4, 7, 4, 6, 0, 4, 1, 4, 7, 6, 5, 6, 3, 4, 7, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 1, 0, 5, 0, 7, 6, 1, 1, 7, 4, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 2, 4, 4, 3, 2, 5, 7, 3, 3, 1, 3, 0, 4, 5, 4, 2, 6, 0, 0, 0, 3, 6, 1, 1, 6, 1, 4, 3, 6,
4, 4, 5, 6, 2, 6, 2, 6, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 6, 0, 5, 6, 5, 0, 0, 3, 3, 4, 2, 1, 2, 0,
2, 5, 0, 6, 5, 5, 7, 2, 5, 1, 6, 1, 7, 5, 3, 2, 7, 7, 1, 3, 7, 7, 7, 6, 7, 6, 7, 2, 3, 3, 2, 3, 7,
7, 2, 6, 5, 0, 2, 5, 4, 1, 2, 6, 7, 3, 7, 0, 3, 1, 5, 0, 6, 7, 5, 3, 6, 6, 4, 4, 2, 4, 7, 0, 5, 5,
6, 2, 5, 3, 7, 4, 6, 0, 4, 3, 7, 3, 3, 3, 6, 1, 6, 3, 4, 1, 6, 0, 0, 1, 7, 1, 1, 2, 4, 4, 3, 2, 1,
3, 2, 7, 3, 7, 3, 7, 5, 5, 4, 2, 6, 5, 5, 1, 4, 5, 4, 2, 1, 3, 6, 1, 4, 4, 2, 0, 5, 5, 2, 5, 1, 6,
2, 2, 6, 5, 1, 6, 7]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I MSH2
TP53BP1 MDM2 PSMB9 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 SAFB2
MCPH1 CHD3 RRM2 XRCC6 PIAS4 RB1 CCND1 UBE2U POU2F1 NCL PRKDC
DCLRE1C SMARCA4 SMAD3 PPP2R2B CHEK1 JUN NR3C1 RECQL5 HMGB1
HDAC2 CBR3 DDX17 HDAC1 SRY DAXX HIPK2 RBBP4 STAT5A PCNA ETS1
KPNA2 PGR HIF1A TOP2A CDK1
Number of genes inside the community: 69
********************Generation 297********************
Generation’s average fitness: 0.54358081972197413
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Generation’s best fitness: 0.55049921177088805
Generation’s best individual:
[5, 0, 2, 5, 7, 2, 2, 2, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 2, 4, 6, 4, 7, 1, 4, 1, 3,
4, 1, 5, 4, 7, 5, 0, 5, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 2, 3, 5, 3, 0, 3, 0, 4, 7, 7, 0, 7, 6,
5, 2, 6, 1, 4, 3, 2, 1, 3, 6, 5, 1, 4, 4, 2, 7, 1, 6, 2, 0, 0, 2, 2, 1, 3, 4, 4, 0, 4, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 6, 5, 6, 2, 1, 4, 4, 6, 5, 1, 7, 1, 1, 0, 7, 3, 1, 6, 4, 4, 6, 6, 4,
0, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 4, 1, 2, 3, 5, 2, 0, 5, 7, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 5, 4, 0, 3, 0, 4, 4, 3, 6, 6, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 7, 4, 5, 1, 2, 2, 4, 3, 1, 3, 5, 3, 6, 4, 6, 6, 2, 0, 5, 4, 4, 2, 4, 7, 1, 6, 7, 0, 1,
7, 5, 2, 6, 7, 5, 0, 2, 1, 4, 3, 6, 4, 6, 0, 0, 7, 4, 7, 4, 6, 0, 4, 5, 4, 7, 7, 2, 6, 3, 4, 7, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 4, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 4, 0, 7, 2, 0, 2, 7, 3, 2, 1, 3, 7, 6, 5, 4, 2, 3, 5, 7, 0, 3, 6, 5, 1, 7, 1, 4, 3, 6,
4, 4, 5, 6, 0, 2, 2, 2, 3, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 0, 3, 5, 4, 2, 1, 2, 0,
2, 5, 2, 6, 6, 0, 4, 7, 5, 1, 3, 6, 7, 5, 5, 4, 7, 7, 1, 3, 7, 2, 7, 6, 7, 6, 7, 2, 3, 3, 2, 3, 0,
0, 2, 1, 5, 0, 3, 3, 4, 1, 2, 0, 6, 3, 0, 2, 1, 3, 3, 0, 6, 7, 3, 6, 6, 0, 7, 3, 2, 4, 2, 0, 5, 7,
4, 4, 5, 5, 7, 4, 6, 0, 4, 3, 7, 3, 3, 3, 6, 1, 6, 6, 2, 1, 6, 0, 7, 1, 7, 1, 1, 2, 4, 2, 3, 2, 1,
3, 2, 2, 7, 4, 3, 7, 5, 7, 4, 2, 7, 2, 4, 1, 4, 5, 4, 2, 1, 3, 6, 1, 4, 6, 2, 4, 7, 5, 2, 5, 1, 4,
6, 6, 7, 4, 1, 7, 5]
Generation’s best community (list of genes):
NBN H2AFX RAD9A TDP1 FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2
MDC1 KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I
MSH2 TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1
CHD3 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
SMAD3 CHEK1 JUN NR3C1 RECQL5 HMGB1 HDAC2 DDX17 AURKA HDAC1
NUCB1 DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A
CDK1
Number of genes inside the community: 65
********************Generation 298********************
Generation’s average fitness: 0.5429945322133931
Generation’s best fitness: 0.55170603674540685
Generation’s best individual:
[5, 0, 2, 5, 6, 2, 2, 2, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 4, 4, 6, 4, 7, 6, 4, 1, 3,
4, 1, 5, 4, 7, 2, 3, 2, 2, 0, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 2, 3, 5, 3, 0, 5, 0, 3, 7, 5, 6, 7, 0,
7, 0, 0, 1, 4, 3, 2, 1, 3, 3, 6, 1, 4, 4, 2, 7, 1, 6, 2, 5, 6, 0, 6, 1, 3, 4, 4, 0, 0, 3, 6, 3, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 3, 0, 0, 6, 1, 2, 3, 6, 4, 1, 7, 1, 1, 5, 5, 6, 1, 6, 4, 3, 3, 6, 6,
4, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 0, 1, 2, 3, 4, 2, 0, 5, 7, 6, 0, 6, 7, 2, 1, 7, 3, 2, 2, 5, 6,
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4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 3, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 3, 4, 5, 1, 5, 2, 4, 3, 1, 3, 6, 3, 6, 4, 2, 7, 4, 5, 2, 6, 4, 6, 4, 4, 1, 3, 2, 0, 1,
7, 5, 2, 2, 5, 2, 0, 2, 1, 5, 3, 6, 4, 6, 0, 0, 7, 4, 7, 7, 6, 0, 4, 5, 4, 7, 6, 5, 6, 3, 7, 3, 1,
3, 0, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 6, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 0, 0, 7, 2, 0, 0, 7, 3, 2, 1, 6, 0, 3, 5, 4, 2, 7, 0, 6, 0, 3, 5, 5, 1, 7, 1, 4, 3, 6,
4, 0, 5, 6, 0, 7, 3, 6, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 4, 3, 0, 5, 6, 5, 0, 0, 3, 3, 4, 2, 1, 3, 0,
4, 5, 0, 4, 2, 3, 5, 3, 3, 1, 6, 6, 7, 2, 2, 5, 7, 7, 1, 3, 7, 7, 7, 6, 7, 6, 7, 3, 1, 2, 3, 2, 7,
7, 2, 6, 5, 0, 2, 5, 2, 1, 2, 6, 6, 3, 0, 0, 3, 3, 5, 0, 6, 0, 5, 3, 6, 6, 4, 2, 5, 4, 2, 0, 5, 6,
0, 4, 5, 5, 7, 4, 6, 0, 4, 3, 7, 3, 3, 3, 6, 1, 2, 7, 4, 1, 6, 0, 0, 1, 7, 1, 1, 2, 0, 6, 1, 2, 1,
3, 2, 7, 3, 7, 3, 7, 5, 5, 4, 3, 7, 4, 0, 1, 4, 5, 4, 2, 1, 3, 6, 1, 4, 4, 2, 0, 7, 5, 2, 5, 1, 6,
2, 2, 4, 5, 1, 7, 3]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I MSH2
TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1 CHD3
XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4 SMAD3
CHEK1 JUN NR3C1 RECQL5 HMGB1 HDAC2 DDX17 CDC25C HDAC1 DAXX
HIPK2 RBBP4 STAT5A PCNA UPF1 ETS1 KPNA2 PGR HIF1A TOP2A CDK1
Number of genes inside the community: 64
********************Generation 299********************
Generation’s average fitness: 0.5431369249076504
Generation’s best fitness: 0.5535882661079099
Generation’s best individual:
[0, 0, 2, 5, 7, 2, 2, 2, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5, 1, 6, 0, 4, 4, 6, 4, 7, 6, 4, 1, 2,
4, 1, 5, 4, 5, 6, 0, 5, 2, 0, 2, 0, 5, 2, 0, 2, 5, 6, 4, 1, 0, 3, 5, 2, 5, 5, 0, 4, 7, 3, 0, 7, 0,
0, 2, 6, 1, 3, 4, 7, 1, 0, 6, 0, 1, 4, 4, 2, 7, 1, 6, 2, 6, 5, 2, 6, 1, 3, 4, 4, 0, 0, 3, 4, 7, 1,
7, 3, 3, 1, 0, 5, 1, 3, 4, 3, 3, 0, 6, 6, 1, 2, 3, 6, 5, 1, 4, 1, 1, 0, 4, 5, 1, 5, 7, 4, 6, 6, 4,
6, 4, 0, 1, 6, 0, 4, 5, 5, 7, 1, 1, 0, 1, 2, 3, 5, 4, 4, 4, 6, 3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6,
4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4, 4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4,
0, 5, 4, 0, 2, 4, 5, 1, 2, 2, 4, 3, 1, 3, 4, 3, 6, 4, 6, 2, 6, 5, 2, 5, 7, 7, 5, 2, 1, 3, 7, 0, 1,
7, 6, 2, 6, 7, 5, 0, 2, 1, 5, 6, 6, 4, 6, 0, 0, 7, 4, 7, 4, 6, 0, 4, 1, 3, 4, 7, 5, 6, 3, 5, 7, 1,
3, 2, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 0, 3, 7, 6, 1, 1, 7, 3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1,
0, 3, 7, 6, 0, 0, 7, 4, 2, 2, 7, 3, 2, 1, 6, 0, 5, 5, 4, 2, 7, 0, 0, 0, 3, 6, 5, 1, 7, 1, 4, 3, 6,
5, 4, 5, 6, 2, 2, 3, 2, 1, 1, 6, 3, 5, 1, 5, 0, 5, 4, 4, 3, 4, 5, 6, 5, 0, 0, 3, 5, 5, 2, 1, 2, 5,
7, 2, 0, 4, 2, 3, 5, 3, 3, 1, 6, 6, 7, 5, 5, 4, 7, 7, 1, 7, 6, 6, 2, 2, 3, 3, 7, 2, 3, 5, 6, 6, 2,
0, 0, 5, 5, 0, 2, 5, 4, 1, 6, 6, 7, 6, 7, 0, 3, 3, 5, 0, 6, 7, 5, 6, 4, 3, 4, 3, 5, 2, 2, 7, 7, 6,
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4, 4, 5, 5, 7, 4, 6, 0, 3, 3, 7, 3, 3, 3, 6, 1, 2, 7, 4, 1, 6, 0, 1, 1, 7, 1, 1, 6, 4, 4, 3, 2, 1,
3, 2, 7, 3, 7, 3, 7, 5, 5, 4, 2, 7, 4, 0, 1, 4, 5, 4, 2, 1, 3, 5, 1, 4, 4, 2, 0, 7, 5, 6, 5, 1, 6,
2, 2, 4, 5, 1, 7, 4]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 PIAS1 UBE2I MSH2
TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1 CHD3
RRM2 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
SMAD3 CHEK1 JUN TAOK3 NR3C1 RECQL5 HMGB1 HDAC2 DDX17 HDAC1
DAXX HIPK2 MTA1 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A
CDK1
Number of genes inside the community: 65
********************Generation 300********************
Generation’s average fitness: 0.54361712080152834
Generation’s best fitness: 0.5512374934175882
Generation’s best individual: [5, 0, 2, 2, 2, 5, 0, 4, 3, 2, 3, 1, 4, 7, 2, 3, 1, 4, 5, 5,
1, 0, 0, 2, 4, 6, 4, 4, 6, 4, 1, 3, 4, 1, 5, 4, 7, 6, 0, 5, 2, 4, 2, 0, 5, 2, 0, 2, 5, 0, 4, 1, 2,
3, 5, 3, 6, 5, 0, 7, 7, 7, 0, 7, 0, 5, 3, 0, 1, 4, 4, 7, 1, 0, 6, 0, 1, 4, 4, 2, 7, 1, 6, 2, 6, 0,
2, 6, 1, 3, 4, 4, 0, 0, 3, 4, 7, 1, 7, 3, 3, 1, 0, 5, 1, 2, 4, 0, 6, 0, 0, 6, 1, 2, 3, 6, 5, 1, 4,
1, 1, 5, 5, 6, 1, 6, 4, 3, 3, 1, 7, 4, 4, 0, 1, 5, 0, 4, 5, 5, 7, 1, 1, 0, 1, 2, 3, 5, 2, 0, 5, 4,
3, 4, 4, 7, 2, 1, 7, 3, 2, 3, 5, 6, 4, 0, 2, 3, 2, 5, 4, 0, 6, 2, 0, 6, 1, 1, 2, 6, 4, 0, 3, 0, 4,
4, 3, 6, 5, 1, 4, 3, 1, 0, 7, 0, 4, 0, 5, 4, 0, 3, 4, 5, 1, 2, 2, 4, 3, 1, 3, 6, 3, 6, 4, 6, 2, 6,
5, 2, 4, 4, 2, 4, 7, 1, 3, 7, 0, 1, 7, 6, 2, 6, 7, 5, 0, 2, 1, 5, 3, 6, 4, 6, 0, 0, 7, 4, 7, 7, 4,
4, 5, 5, 4, 7, 6, 5, 6, 3, 4, 7, 1, 3, 3, 0, 7, 7, 0, 1, 1, 5, 5, 7, 1, 4, 0, 5, 0, 7, 6, 1, 1, 7,
3, 7, 6, 7, 3, 0, 6, 7, 1, 1, 5, 1, 0, 3, 7, 6, 0, 0, 7, 4, 5, 0, 0, 3, 3, 1, 3, 0, 4, 5, 4, 2, 7,
0, 6, 0, 3, 6, 5, 1, 7, 1, 4, 3, 6, 5, 4, 5, 6, 2, 6, 2, 2, 4, 1, 3, 3, 5, 1, 5, 0, 5, 4, 1, 3, 0,
5, 6, 5, 0, 0, 3, 5, 5, 6, 1, 7, 0, 4, 5, 0, 4, 2, 3, 5, 3, 3, 1, 6, 6, 3, 5, 5, 4, 7, 7, 1, 3, 7,
7, 7, 6, 7, 6, 6, 2, 3, 2, 3, 2, 7, 7, 3, 3, 5, 0, 2, 5, 6, 1, 6, 6, 6, 3, 0, 2, 4, 6, 3, 5, 6, 7,
5, 7, 7, 3, 4, 4, 2, 2, 7, 5, 5, 6, 0, 6, 5, 5, 7, 4, 6, 0, 4, 3, 7, 3, 3, 2, 6, 1, 0, 3, 4, 1, 6,
0, 0, 1, 7, 1, 1, 2, 4, 6, 5, 2, 1, 3, 2, 6, 3, 7, 3, 4, 2, 3, 5, 2, 6, 5, 5, 1, 4, 5, 4, 2, 1, 3,
6, 1, 4, 4, 2, 0, 7, 5, 2, 5, 1, 6, 2, 2, 4, 5, 1, 7, 0]
Generation’s best community (list of genes):
NBN H2AFX RAD9A FANCD2 WRN BLM RAD50 KAT5 SUMO1 RPA2 MDC1
KAT2B E2F1 CREBBP ATR XRCC5 ING1 ABL1 RPA1 CXXC5 PIAS1 UBE2I
MSH2 TP53BP1 MDM2 MRE11A MSH6 ESR1 RELA EP300 SUMO2 SP1 MCPH1
CHD3 XRCC6 PIAS4 RB1 CCND1 POU2F1 NCL PRKDC DCLRE1C SMARCA4
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SMAD3 CHEK1 JUN NR3C1 RECQL5 BUB1B HMGB1 HDAC2 DDX17 HDAC1
DAXX HIPK2 RBBP4 STAT5A PCNA ETS1 KPNA2 PGR HIF1A TOP2A CDK1
Number of genes inside the community: 64
Appendix B
Samples of generated candidate
genes ranking
B.1 A candidate genes ranking for Breast Cancer
This is a candidate genes ranking generated by our method for the Breast Cancer
experiment (Section 8.1) while the known disease gene BRCA1 is taken out in leave-
one-out cross validation. The scores assigned to the genes are in front of the genes’
names in the ranking. Here, we show the top 100 genes in the ranking.
0) BRCA1: 369454.94228473795
1) MDM2: 365856.40243225696
2) H2AFX: 365237.2320897151
3) SUMO1: 364293.4178539702
4) HDAC1: 362886.60125484853
5) SP1: 362874.9776684882
6) ESR1: 361630.4298796606
7) KAT5: 361257.9720975167
8) NR3C1: 360883.2030843063
9) RELA: 359544.9900832348
10) SMAD3: 358477.115271801
11) MDM4: 355867.4739784314
12) PRKDC: 355018.0532636549
13) ABL1: 353907.1203097202
14) JUN: 353339.7953658223
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15) E2F1: 352549.3955796374
16) CREBBP: 349253.1080401208
17) POU2F1: 348262.4847448964
18) EP300: 347403.97396584525
19) UBE2I: 346219.77838602086
20) ETS1: 345556.8781321825
21) DAXX: 344091.03157358
22) PIAS4: 343545.1564074639
23) YWHAH: 342920.3874388374
24) HIF1A: 339962.5300479148
25) MDC1: 339732.12818675727
26) AKT1: 339502.7485254788
27) TOP2A: 339092.5080355513
28) PIAS1: 336002.2311787074
29) RB1: 336001.3209315408
30) HSP90AA1: 335861.6493675062
31) XRCC6: 335697.49964056996
32) HIPK2: 334935.9014436146
33) TP53BP1: 333485.33286573633
34) KAT2B: 333377.67930907797
35) CCND1: 332936.77745437383
36) HDAC2: 330880.3869432769
37) PLAGL1: 329302.65018068627
38) FOXO3: 326577.7248249773
39) NBN: 324070.81259756564
40) CHUK: 322317.60499559686
41) SMARCA4: 310588.1376046659
42) SIRT1: 308388.9244616711
43) CHEK1: 305480.56542420975
44) HMGB1: 301342.0173945646
45) XRCC5: 299469.47085596377
46) CTBP1: 272690.1749045091
47) WRN: 266131.3596648345
48) RBBP4: 250985.69499962227
49) DDX5: 224903.51704771272
50) NCL: 126840.421261955
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51) FANCD2: 101600.45916398258
52) CHD3: 96326.29414206218
53) CDK1: 90571.79220528794
54) MRE11A: 54911.26557501975
55) WHSC1: 36001.443298332735
56) ATR: 31125.17269410985
57) MMS19: 31094.612380380306
58) CSNK2A2: 30034.350954123107
59) HAP1: 23725.391412693112
60) MED1: 20633.865453793773
61) E4F1: 19860.279556357083
62) MTA3: 19542.109175809474
63) IKBKB: 19376.1666742751
64) BRE: 19118.485820483253
65) KAT7: 18502.845784892746
66) NR0B2: 18449.536790455604
67) BRCC3: 16065.606781765428
68) ESRRA: 15971.35206842881
69) CNTN2: 15694.080402161117
70) PLK1: 14493.024891180312
71) VDR: 13364.963237045538
72) RAD9A: 13060.451853699244
73) PTK2: 12771.512829408597
74) CASP3: 12609.978851736856
75) MED17: 12448.436116885665
76) UBE3A: 11680.659205093381
77) FLNA: 11487.892863898282
78) MSH2: 11381.53438558635
79) RCHY1: 11244.836174057624
80) KPNA2: 11046.0458324487
81) BLM: 10819.456320267906
82) PPP2R2B: 10770.971832395737
83) NRIP1: 10732.09559316361
84) HTT: 10272.060948911978
85) RPA1: 10268.327869469502
86) CTDSP2: 9890.459988378514
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87) GPR25: 9260.253646191584
88) PIK3R1: 9110.426947089396
89) IKBKG: 9045.73201802221
90) IFI16: 8931.097621089097
91) AATF: 8353.544101357822
92) ZMIZ1: 8129.712555231577
93) SRA1: 7932.790750478763
94) CARM1: 7907.00907829512
95) MAST1: 7747.4187911663
96) PPARG: 7674.949592467252
97) NCOA2: 7667.309422367735
98) FOXA1: 7556.888859662708
99) ERCC2: 7208.141947439502
100) ING1: 7107.157733510438
B.2 A candidate genes ranking for Parkinson’s dis-
ease
This is a candidate genes ranking generated by our method for the Parkinson’s disease
experiment (Section 8.1) while all the known disease genes provided in Section 8.3.1
are in the known disease gene set. The scores assigned to the genes are in front of
the genes’ names in the ranking. Here, we show the top 100 genes in the ranking.
0) UBC: 4144932.8105707495
1) TAT: 4128398.286184617
2) SMAD3: 4117814.8295134627
3) TP53: 4114948.6209134124
4) EP300: 4114724.3239404806
5) SRC: 4113482.1294503445
6) EGFR: 4112064.4392586253
7) CREBBP: 4111022.0977524514
8) SP1: 4105014.840084765
9) ABL1: 4104748.7384657217
10) JUN: 4103186.5143881436
11) RELA: 4102431.8847347354
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12) HSP90AA1: 4102178.605043044
13) AKT1: 4095084.991584094
14) STAT3: 4093262.201525781
15) HDAC1: 4092874.878398885
16) MYOD1: 4090765.7342951
17) LYN: 4089375.436431014
18) ESR1: 4088046.2204013253
19) GRB2: 4086223.208137686
20) HDAC3: 4082942.1262650196
21) AR: 4081947.020808688
22) STAT5A: 4077919.927194697
23) ESR2: 4076391.7036378426
24) HSPA8: 4074203.9452217068
25) BAD: 4066635.5092346147
26) RB1: 4065199.3373429505
27) SMARCA4: 4065085.3752701147
28) MDM2: 4063539.3668733574
29) SYK: 4057721.61894727
30) MYC: 4056827.3936953745
31) HIF1A: 4056087.9086310626
32) CDK1: 4056026.209885783
33) CHUK: 4053287.7350594043
34) YWHAH: 4050678.335009849
35) LCK: 4043770.109977208
36) EIF2AK2: 4043697.3419758556
37) HSPA4: 4042615.6230233596
38) KLF6: 4042590.7282105037
39) SMAD2: 4037764.3273650063
40) PRKCA: 4037578.2941328348
41) BRCA1: 4035108.802434509
42) MAPK1: 4034171.2175798165
43) NCOR2: 4033360.6318513053
44) NFKBIA: 4033242.3780480307
45) CSNK2A1: 4033131.8388114134
46) NR3C1: 4032370.851070569
47) ETS1: 4024623.570533809
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48) CEBPA: 4024610.5106870024
49) CSK: 4023375.9459752073
50) EPHA1: 4020423.8736465573
51) CASP8: 4019355.1507314397
52) PRKCZ: 4018673.224499437
53) SHC1: 4016726.7234874023
54) EGR1: 4016269.0185094913
55) STUB1: 4015350.104557534
56) SIN3A: 4014752.863356188
57) STAT5B: 4008235.459306945
58) CRKL: 4004772.156934122
59) PTPN1: 4003784.895714837
60) SMAD4: 4003559.2876090994
61) PRKCD: 4003477.4780933433
62) FANCG: 4002672.348805875
63) PTK2: 4000161.655493187
64) PXN: 3995887.0923527624
65) CDKN1B: 3995754.0823792685
66) PIK3R1: 3992324.183723157
67) MAPK3: 3990811.4157836037
68) MAPK8: 3984679.7284387522
69) UBE3A: 3983827.2541076583
70) SIRT1: 3982848.98963996
71) CAV1: 3980913.693707568
72) RAF1: 3979357.6771421265
73) CCND1: 3977433.727264135
74) CTNNB1: 3977162.5125806155
75) PTK2B: 3965741.111429293
76) IGF1R: 3965466.2120283684
77) NFATC2: 3965301.584928153
78) PIAS3: 3962397.4256757107
79) BAG1: 3961988.3006393053
80) JAK2: 3954214.122580029
81) RPS6KA5: 3953046.4416621784
82) CDKN1A: 3952485.009627919
83) KRT18: 3946100.961114532
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84) MAP3K5: 3945876.2108147405
85) TP73: 3944474.9916920615
86) FYN: 3943866.974338102
87) BCL2: 3941653.613609305
88) PPP1CA: 3938345.2998506497
89) YWHAZ: 3936490.3977781427
90) FOXO1: 3935436.835571163
91) HDAC2: 3929580.74902719
92) FOXO3: 3922362.575982028
93) PRKCE: 3919600.5134588154
94) YWHAE: 3919510.434878021
95) CASP3: 3909988.523816787
96) MAP3K7: 3908175.90877334
97) RPS6KB1: 3907969.56665488
98) CCNE1: 3907285.010561756
99) FOXO4: 3904962.5682972665
100) GSK3B: 3903640.0271610236
Appendix C
Sample disease genes communities
In this appendix, we provide the disease gene communities with the highest modu-
larity (Q - see equation6.1)) given by our method for the experiments explained in
Chapter 8.
C.1 Breast Cancer
The best community produced by our method for Breast Cancer experiment (Sec-
tion 8.1) contained the following 97 genes (not in any order of ranking): USP9Y,
MAP1LC3B, CDKN1B, SEPT4, HSPA8, RNF41, MARK4, AXIN1, CDC42SE1,
NDUFS4, CYP19A1, LIMK1, SLC25A1, GNAZ, THY1, SULT1A2, RBCK1, PCSK9,
GRK6, CDKN2A, MTF1, SIGLEC10, SLC25A12, PPP1R2, PPP2CA, ITGB1BP1,
TMEM160, ESR1, ADRBK1, NUMA1, B2M, TSC1, LRP1B, DRD1, KARS, ANXA6,
S1PR1, OSGEP, CYTH2, DYNLL2, SLC29A2, PPP1CA, RARS, ARHGAP1, SLX4,
SDC3, GJB3, DVL1, CDK6, PTPRO, ETHE1, GPS1, CDKN2AIP, AIMP1, CNT-
NAP4, EIF2C4, ACTG1, L1CAM, RBX1, IQGAP1, KIF20B, FOXO3, MAPK8IP3,
ITGB4, TFB2M, LARP4B, ANXA1, STOML2, CHORDC1, RPE65, FOXM1, SMAD2,
SLC8A1, TJAP1, EMD, ALDOB, ZNF91, NKD2, XBP1, TUBB4B, PHOX2A, KPNA1,
EID3, HSPB1, MDN1, VAV2, RIC8A, UBE2A, GNA12, EREG, CLTB, ABI1, EID1,
CDC40, PTRF, TTN, MKKS,
C.2 Parkinson’s disease
The best community produced by our method for Parkinson’s disease experiment
(Section 8.3) contained the following 100 genes (not in any order of ranking): NTRK2,
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SCARB2, NTF4, NTRK1, ALK, UBASH3A, SNX17, SH2B1, FRS2, PTPN1, FRS3,
EGFR, PLCG1, FYN, NCK2, MATK, CSK, FGR, ARHGAP32, CTNND1, CAV2,
MST1R, SHC1, DOCK1, GRB2, PLD2, INSR, ERBB3, IRS1, ABL1, NCK1, GHR,
FGFR1, PAX7, ITGB3, JAK2, PTPRB, PIK3R1, PTPRJ, PTPN12, IL6ST, RET,
FLT1, PTK2B, PDGFRB, SYK, CBL, PTPRO, SRC, AXL, BCAR1, LYN, LTK,
STAT3, MET, CRK, BMX, ,PTK2, SNX3, PTPRC, PDGFRA, GAB1, KDR, IGF1R,
SOS1, PTPN11, PXN, LCK, DDR1, ERBB2, IRS2, KIT, SYNJ2, DLGAP2, IL4R,
RASA1, CD2AP, VAV3, SOCS7, JAK3, SOCS1, CEACAM1, VAV1, EFS, DLGAP1,
CXCR4, DOK1, EPOR, CRKL, AKAP2, SOS2, PTPN6, STAT5A, GRB7, DOCK3,
ABI1, BCR, STAT5B, PDIA2, PIK3C2B, PIK3R2.
